<drug type="small molecule" created="2005-06-13" updated="2021-01-01">
  <drugbank-id primary="true">DB00145</drugbank-id>
  <drugbank-id>NUTR00028</drugbank-id>
  <name>Glycine</name>
  <description>A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.</description>
  <cas-number>56-40-6</cas-number>
  <unii>TE7660XO1C</unii>
  <average-mass>75.0666</average-mass>
  <monoisotopic-mass>75.032028409</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>nutraceutical</group>
    <group>vet_approved</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links>
      <link>
        <ref-id>L12237</ref-id>
        <title>FDA Approved Drug Products: Glycine Irrigation Solution</title>
        <url>https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016784s035lbl.pdf</url>
      </link>
    </links>
    <attachments/>
  </general-references>
  <synthesis-reference>Koichi Niimura, Takako Kawabe, Takao Ando, Kenichi Saito, "Phenylalanine-glycine compounds having anti-tumor activity, process for preparation thereof, and pharmaceutical composition containing said compounds." U.S. Patent US5411964, issued August, 1908.</synthesis-reference>
  <indication>Supplemental glycine may have antispastic activity. Very early findings suggest it may also have antipsychotic activity as well as antioxidant and anti-inflammatory activities.</indication>
  <pharmacodynamics>Helps trigger the release of oxygen to the energy requiring cell-making process; Important in the manufacturing of hormones responsible for a strong immune system.</pharmacodynamics>
  <mechanism-of-action>In the CNS, there exist strychnine-sensitive glycine binding sites as well as strychnine-insensitive glycine binding sites. The strychnine-insensitive glycine-binding site is located on the NMDA receptor complex. The strychnine-sensitive glycine receptor complex is comprised of a chloride channel and is a member of the ligand-gated ion channel superfamily. The putative antispastic activity of supplemental glycine could be mediated by glycine's binding to strychnine-sensitive binding sites in the spinal cord. This would result in increased chloride conductance and consequent enhancement of inhibitory neurotransmission. The ability of glycine to potentiate NMDA receptor-mediated neurotransmission raised the possibility of its use in the management of neuroleptic-resistant negative symptoms in schizophrenia. &lt;br/&gt;Animal studies indicate that supplemental glycine protects against endotoxin-induced lethality, hypoxia-reperfusion injury after liver transplantation, and D-galactosamine-mediated liver injury. Neutrophils are thought to participate in these pathologic processes via invasion of tissue and releasing such reactive oxygen species as superoxide. In vitro studies have shown that neutrophils contain a glycine-gated chloride channel that can attenuate increases in intracellular calcium and diminsh neutrophil oxidant production. This research is ealy-stage, but suggests that supplementary glycine may turn out to be useful in processes where neutrophil infiltration contributes to toxicity, such as ARDS.</mechanism-of-action>
  <toxicity>ORL-RAT LD&lt;sub&gt;50&lt;/sub&gt; 7930 mg/kg, SCU-RAT LD&lt;sub&gt;50&lt;/sub&gt; 5200 mg/kg, IVN-RAT LD&lt;sub&gt;50&lt;/sub&gt; 2600 mg/kg, ORL-MUS LD&lt;sub&gt;50&lt;/sub&gt; 4920 mg/kg; Doses of 1 gram daily are very well tolerated. Mild gastrointestinal symptoms are infrequently noted. In one study doses of 90 grams daily were also well tole.</toxicity>
  <metabolism>Hepatic</metabolism>
  <absorption>Absorbed from the small intestine via an active transport mechanism.</absorption>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon).</description>
    <direct-parent>Alpha amino acids</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organic acids and derivatives</superclass>
    <class>Carboxylic acids and derivatives</class>
    <subclass>Amino acids, peptides, and analogues</subclass>
    <alternative-parent>Amino acids</alternative-parent>
    <alternative-parent>Carbonyl compounds</alternative-parent>
    <alternative-parent>Carboxylic acids</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Monoalkylamines</alternative-parent>
    <alternative-parent>Monocarboxylic acids and derivatives</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <substituent>Aliphatic acyclic compound</substituent>
    <substituent>Alpha-amino acid</substituent>
    <substituent>Amine</substituent>
    <substituent>Amino acid</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Carboxylic acid</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Monocarboxylic acid or derivatives</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Primary aliphatic amine</substituent>
    <substituent>Primary amine</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="english" coder="iupac">Aminoacetic acid</synonym>
    <synonym language="german" coder="">Aminoessigsäure</synonym>
    <synonym language="english" coder="">Aminoethanoic acid</synonym>
    <synonym language="spanish" coder="">Glicina</synonym>
    <synonym language="english" coder="">Gly</synonym>
    <synonym language="german" coder="">Glycin</synonym>
    <synonym language="english" coder="inn">Glycine</synonym>
    <synonym language="english" coder="">Glycocoll</synonym>
    <synonym language="german" coder="">Glykokoll</synonym>
    <synonym language="german" coder="">Glyzin</synonym>
    <synonym language="german" coder="">Leimzucker</synonym>
  </synonyms>
  <products>
    <product>
      <name>2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143267</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose Clinimix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013975</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.5% Travasol Amino Acid Injection Without Electrolytes In 10% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014106</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.5%travasol Amino Acid InJ.W.eleC.W.25%dex</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143259</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-07-30</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.75% Travas. Amino Acid InJ.W.elecw.25%dex</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143232</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-07-30</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.75% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014009</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-02-02</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.75% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013991</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.75%travasol Amino Acid InJ.W.eleC.W.5%dex.</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143240</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>20% Prosol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02141450</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-10-09</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Amino Acid Injection Without Electrolytes In 20% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013908</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142414</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142406</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014033</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142392</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014017</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection Without Electrlytes In 10% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142317</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142309</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142295</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Without Electrolytes In 5% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013894</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25%trav. Amino Acid InJ.W.O.elect.5%dext.</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142325</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25%travasol Amino Acid InJ.W.elecw.5%dex.</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143224</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>5% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142368</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>5% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142252</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>5% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142244</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>8.5% Freamine III</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02158647</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-05-17</started-marketing-on>
      <ended-marketing-on>2012-04-16</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminoderm Poudre</name>
      <labeller>Desbergers LtÉe, Division Of Technilab Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00086649</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1968-12-31</started-marketing-on>
      <ended-marketing-on>2004-08-09</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-2992</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1975-12-03</started-marketing-on>
      <ended-marketing-on>2005-09-13</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-5855</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1975-12-03</started-marketing-on>
      <ended-marketing-on>2008-08-13</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-2991</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1975-12-03</started-marketing-on>
      <ended-marketing-on>2006-06-12</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-2989</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1976-05-14</started-marketing-on>
      <ended-marketing-on>2005-09-13</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017789</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-2990</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1975-12-03</started-marketing-on>
      <ended-marketing-on>2005-09-13</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA017673</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4168</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-06-01</started-marketing-on>
      <ended-marketing-on>2015-06-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019374</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4187</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-03-06</started-marketing-on>
      <ended-marketing-on>2017-02-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4191</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-03-06</started-marketing-on>
      <ended-marketing-on>2017-11-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4184</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-10-01</started-marketing-on>
      <ended-marketing-on>2010-11-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4159</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-12-01</started-marketing-on>
      <ended-marketing-on>2011-01-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017789</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4181</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-05-01</started-marketing-on>
      <ended-marketing-on>2010-06-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4196</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-03-23</started-marketing-on>
      <ended-marketing-on>2017-11-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017789</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4200</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-04-01</started-marketing-on>
      <ended-marketing-on>2010-08-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017789</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4203</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-11-01</started-marketing-on>
      <ended-marketing-on>2015-04-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Icu Medical Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00454907</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>2019-01-24</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 10% W Electrolytes</name>
      <labeller>Abbott</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00558966</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 3.5% M</name>
      <labeller>Abbott</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00510629</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 5%</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00404160</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1977-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 7%</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00523232</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 8.5%</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00613320</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 8.5% Injection With Electrolytes</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00613339</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn HF</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4167</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2006-01-30</started-marketing-on>
      <ended-marketing-on>2010-03-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA020345</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7172</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-12-19</started-marketing-on>
      <ended-marketing-on>2020-12-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020015</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7171</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-12-19</started-marketing-on>
      <ended-marketing-on>2023-12-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020041</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4160</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2005-11-01</started-marketing-on>
      <ended-marketing-on>2010-12-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019438</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4162</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2005-07-29</started-marketing-on>
      <ended-marketing-on>2017-06-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019438</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4164</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2005-09-01</started-marketing-on>
      <ended-marketing-on>2017-12-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019438</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7122</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-12-19</started-marketing-on>
      <ended-marketing-on>2011-10-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020041</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7121</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-12-19</started-marketing-on>
      <ended-marketing-on>2013-09-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020015</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Icu Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0990-7172</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-11-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020015</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Icu Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0990-7171</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-11-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020041</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Icu Medical Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742619</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Icu Medical Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02126745</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 10% With Electrolytes</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742651</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 5% Inj</name>
      <labeller>Abbott</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742643</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 7% Injection</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742635</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 7% M In 10% Dextrose(dual Chamber)</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742724</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 7% With 10% Dextrose</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742740</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 7% With 50% Dextrose</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742759</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 8.5% Injection</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742627</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 8.5% M In 20% Dextrose (dual Chamber)</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742716</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 8.5% With 50% Dextrose</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742767</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II and Dextrose</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7742</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-11-01</started-marketing-on>
      <ended-marketing-on>2010-01-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019682</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II and Dextrose</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7702</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-11-01</started-marketing-on>
      <ended-marketing-on>2009-06-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019681</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II in Dextrose</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7701</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-11-01</started-marketing-on>
      <ended-marketing-on>2009-05-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019681</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II in Dextrose</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7740</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-11-01</started-marketing-on>
      <ended-marketing-on>2010-01-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019682</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II in Dextrose</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7744</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-11-01</started-marketing-on>
      <ended-marketing-on>2009-12-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019681</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II in Dextrose</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7700</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-11-01</started-marketing-on>
      <ended-marketing-on>2009-05-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019681</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II In Dextrose Injection</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742783</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II In Dextrose Injection</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00839302</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II In Dextrose Injection</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00839310</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II with Electrolytes</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4171</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1986-04-03</started-marketing-on>
      <ended-marketing-on>2017-09-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019437</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II with Electrolytes in Dextrose with Calcium</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7753</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-11-01</started-marketing-on>
      <ended-marketing-on>2009-09-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019683</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II with Electrolytes in Dextrose with Calcium</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7756</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-11-01</started-marketing-on>
      <ended-marketing-on>2009-09-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019683</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II with Electrolytes in Dextrose with Calcium</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7757</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-11-07</started-marketing-on>
      <ended-marketing-on>2010-01-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019683</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn Sulfite Free</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4192</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-11-01</started-marketing-on>
      <ended-marketing-on>2009-11-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn-PF</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4178</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1985-09-06</started-marketing-on>
      <ended-marketing-on>2023-12-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019398</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn-PF</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4179</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1986-10-17</started-marketing-on>
      <ended-marketing-on>2020-03-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019492</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn-PF</name>
      <labeller>Icu Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0990-4179</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-11-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019492</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn-PF 10%</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00731366</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn-PF 7%</name>
      <labeller>Hospira Healthcare Ulc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00731358</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Antacid 2 Tablets</name>
      <labeller>Advertising Unlimited Inc. (A.U.I.)</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01904310</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2010-02-10</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>BANACOCica-aid Centella Peptide emulsion</name>
      <labeller>Cleoslab Co.,Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>79540-305</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2020-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part347</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>CAREDO Repair Cracked Teeth Toothpastes 100g</name>
      <labeller>Hong Kong Prosthodontics Medicine Limited</labeller>
      <ndc-id/>
      <ndc-product-code>72415-215</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-07-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Paste, dentifrice</dosage-form>
      <strength>0.5 g/100g</strength>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>CAREDO Treating Gingivitis Toothpastes 100g</name>
      <labeller>Hong Kong Prosthodontics Medicine Limited</labeller>
      <ndc-id/>
      <ndc-product-code>72415-211</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-07-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Paste, dentifrice</dosage-form>
      <strength>0.5 g/100g</strength>
      <route>Dental</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cicatrin Powder</name>
      <labeller>Glaxosmithkline Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00666173</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2009-01-19</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1132</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on>2018-05-14</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1083</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on>2018-05-14</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1133</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1089</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1134</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-03-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1091</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1135</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on>2018-05-14</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1093</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on>2018-05-14</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1136</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on>2020-02-29</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1095</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on>2018-05-14</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1137</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1099</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1138</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1101</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1139</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on>2020-02-29</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1103</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on>2018-05-14</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-9566</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-10-25</started-marketing-on>
      <ended-marketing-on>2019-11-30</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-9570</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-10-25</started-marketing-on>
      <ended-marketing-on>2019-11-30</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-9587</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-10-25</started-marketing-on>
      <ended-marketing-on>2019-11-30</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0198</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0188</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0194</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0180</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0184</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142260</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-07-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142279</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02498448</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02498456</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02498464</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013959</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2018-06-28</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013886</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013940</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02046709</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013932</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013916</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-15</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013924</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-15</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix 2.5% Travasol Aa Without Electrolytes In 10% Dextrose Injec</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142333</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1142</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1107</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on>2019-08-31</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1143</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on>2019-08-31</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1109</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on>2018-05-14</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1144</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1113</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1145</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1115</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1146</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on>2019-08-31</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1119</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on>2019-08-31</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1147</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1123</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1148</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1125</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1149</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on>2018-05-14</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1127</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on>2018-05-14</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0202</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2020-09-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0206</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2020-09-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0210</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2020-09-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0214</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2020-09-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142341</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2018-06-28</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142376</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142384</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02498413</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02498421</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014025</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2018-06-28</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014041</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2018-06-28</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014076</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013967</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014068</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014084</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-15</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinisol</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0502</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-08-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA020512</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>FreAmine HBC</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9350</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1971-09-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA016822</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>FreAmine III</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9030</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1971-09-24</started-marketing-on>
      <ended-marketing-on>2013-05-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA016822</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>FreAmine III</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9031</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1971-09-24</started-marketing-on>
      <ended-marketing-on>2013-05-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA016822</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>FreAmine III</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9040</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1971-09-24</started-marketing-on>
      <ended-marketing-on>2013-08-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA016822</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>FreAmine III</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9010</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1971-09-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA016822</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>FreAmine III</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9011</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1971-09-24</started-marketing-on>
      <ended-marketing-on>2012-05-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA016822</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Glycine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-2302</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1978-02-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Irrigant</dosage-form>
      <strength>1.5 g/100mL</strength>
      <route>Irrigation</route>
      <fda-application-number>NDA016784</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Glycine</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0289</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1980-05-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>1.5 g/100mL</strength>
      <route>Irrigation</route>
      <fda-application-number>NDA017865</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Glycine</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7974</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2005-07-27</started-marketing-on>
      <ended-marketing-on>2021-04-01</ended-marketing-on>
      <dosage-form>Irrigant</dosage-form>
      <strength>1.5 g/100mL</strength>
      <route>Irrigation</route>
      <fda-application-number>NDA018315</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Glycine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-7390</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-12-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Irrigant</dosage-form>
      <strength>1.5 g/100mL</strength>
      <route>Irrigation</route>
      <fda-application-number>NDA016784</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Glycine</name>
      <labeller>Icu Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0990-7974</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-07-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Irrigant</dosage-form>
      <strength>1.5 g/100mL</strength>
      <route>Irrigation</route>
      <fda-application-number>NDA018315</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Glycine 1.5% Irrigation USP Sol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00799955</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Irrigation</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Glycine Irrigation 1.5% USP</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01963945</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Irrigation</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Glycine Irrigation USP</name>
      <labeller>Icu Medical Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00498793</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Irrigation</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>HepatAmine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9371</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1982-08-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018676</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hepatasol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0497</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-04-04</started-marketing-on>
      <ended-marketing-on>2007-12-02</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA020360</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hepatasol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0504</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-04-04</started-marketing-on>
      <ended-marketing-on>2013-08-31</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA020360</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Kabiven</name>
      <labeller>Fresenius Kabi USA, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>63323-712</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-08-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA200656</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Novamine</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-0468</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2006-03-21</started-marketing-on>
      <ended-marketing-on>2007-04-01</ended-marketing-on>
      <dosage-form>Injection, solution, concentrate</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017957</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Nutrineal Pd4</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230810</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-09-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 3.3% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352508</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 4.4%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352524</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 4.4% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352516</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-02-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 5.7%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352540</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 5.7% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352532</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-01-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 7.6%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02477947</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 7.6% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02477955</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-10-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Perikabiven</name>
      <labeller>Fresenius Kabi USA, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>63323-714</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-08-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA200656</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Periolimel 2.5% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352494</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-02-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Ph 12 Sterile Diluent for Flolan</name>
      <labeller>Glaxosmithkline Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02443651</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-08-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Plenamine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-3200</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-01-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA091112</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Plenamine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-3205</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-01-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA091112</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Plenamine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-4500</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-09-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA091112</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1130</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-06-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA075880</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1131</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-06-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA075880</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Primene</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-9577</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-11-22</started-marketing-on>
      <ended-marketing-on>2019-05-31</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Primene 10%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02236875</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-11-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Primene 10%-liq IV</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02161192</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>ProcalAmine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-1915</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1982-05-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018582</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ProSol</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0499</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020849</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Quick Mix 2.5% Travasol Aa With Electrolytes With 25% Dextrose Injec</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013983</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2000-07-20</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>RenAmin</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0471</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1976-03-24</started-marketing-on>
      <ended-marketing-on>2012-10-23</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017493</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Renamin (amino Acids) Injection</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02020564</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-02-02</started-marketing-on>
      <ended-marketing-on>2011-05-10</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Smofkabiven</name>
      <labeller>Fresenius Kabi</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02440695</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-09-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Smofkabiven Electrolyte Free</name>
      <labeller>Fresenius Kabi</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02440687</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-09-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Smofkabiven Extra Nitrogen</name>
      <labeller>Fresenius Kabi</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02501813</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Smofkabiven Extra Nitrogen Electrolyte Free</name>
      <labeller>Fresenius Kabi</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02501775</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Smofkabiven Peripheral</name>
      <labeller>Fresenius Kabi</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02456206</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-02-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sterile Diluent for Flolan Injection</name>
      <labeller>Glaxosmithkline Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230857</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-07-28</started-marketing-on>
      <ended-marketing-on>2017-11-22</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Synthamin</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-9575</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-11-03</started-marketing-on>
      <ended-marketing-on>2020-06-30</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Travasol</name>
      <labeller>Baxter Healthcare Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0644</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-08-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018931</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Travasol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00872296</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0458</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-10-27</started-marketing-on>
      <ended-marketing-on>2010-04-30</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020173</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Travasol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0460</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-10-27</started-marketing-on>
      <ended-marketing-on>2010-07-31</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020173</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Travasol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0628</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-11-30</started-marketing-on>
      <ended-marketing-on>2010-08-31</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA020177</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Travasol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0624</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-08-23</started-marketing-on>
      <ended-marketing-on>2010-06-30</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018931</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Travasol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0626</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-08-23</started-marketing-on>
      <ended-marketing-on>2010-06-30</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018931</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Travasol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00388769</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on>2016-08-11</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol Amino Acid Inj 5.5%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00306444</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol Amino Acid Inj 8.5%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00306436</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on>2008-03-26</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00285528</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1974-12-31</started-marketing-on>
      <ended-marketing-on>2017-10-19</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol Inj Without Electrolytes 5.5%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00388742</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol Inj Without Electrolytes 8.5%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00388750</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>2008-03-26</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>TrophAmine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9361</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-07-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019018</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>TrophAmine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9341</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-07-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019018</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>TrophAmine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-1933</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2020-10-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019018</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vamin 18 Electrolyte-free</name>
      <labeller>Fresenius Kabi Ab</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02059711</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-30</started-marketing-on>
      <ended-marketing-on>2006-07-17</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vamin N</name>
      <labeller>Fresenius Kabi Ab</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02065665</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2006-07-17</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands>
    <international-brand>
      <name>Gyn-Hydralin</name>
      <company/>
    </international-brand>
  </international-brands>
  <mixtures>
    <mixture>
      <name>Aminosyn II in Dextrose</name>
      <ingredients>Alanine + Arginine + Aspartic acid + D-glucose + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II in Dextrose</name>
      <ingredients>Alanine + Arginine + Aspartic acid + D-glucose + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + N-acetyltyrosine + Phenylalanine + Potassium chloride + Proline + Serine + Sodium chloride + Sodium phosphate, dibasic, unspecified form + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II and Dextrose</name>
      <ingredients>Alanine + Arginine + Aspartic acid + D-glucose + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + N-acetyltyrosine + Phenylalanine + Potassium chloride + Proline + Serine + Sodium chloride + Sodium phosphate, dibasic + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>FreAmine III</name>
      <ingredients>Alanine + Arginine + Cysteine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Phosphoric acid + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>FreAmine III</name>
      <ingredients>Alanine + Arginine + Cysteine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Phosphoric acid + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>FreAmine III</name>
      <ingredients>Alanine + Arginine + Cysteine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium acetate + Methionine + Phenylalanine + Phosphoric acid + Potassium chloride + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II with Electrolytes in Dextrose with Calcium</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Calcium chloride + D-glucose + Dipotassium phosphate + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + N-acetyltyrosine + Phenylalanine + Potassium chloride + Proline + Serine + Sodium chloride + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II with Electrolytes in Dextrose with Calcium</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Calcium chloride + D-glucose + Dipotassium phosphate + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + N-acetyltyrosine + Phenylalanine + Potassium chloride + Proline + Serine + Sodium chloride + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II with Electrolytes in Dextrose with Calcium</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Calcium chloride + D-glucose + Dipotassium phosphate + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + N-acetyltyrosine + Phenylalanine + Potassium chloride + Proline + Serine + Sodium chloride + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II in Dextrose</name>
      <ingredients>Alanine + Arginine + Aspartic acid + D-glucose + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II in Dextrose</name>
      <ingredients>Alanine + Arginine + Aspartic acid + D-glucose + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II and Dextrose</name>
      <ingredients>Alanine + Arginine + Aspartic acid + D-glucose + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol</name>
      <ingredients>Alanine + Arginine + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol</name>
      <ingredients>Alanine + Arginine + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol</name>
      <ingredients>Alanine + Arginine + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Proline + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Hepatasol</name>
      <ingredients>Alanine + Arginine + Cysteine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>RenAmin</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Hepatasol</name>
      <ingredients>Alanine + Arginine + Cysteine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Plenamine</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Plenamine</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn HF</name>
      <ingredients>Alanine + Arginine + Cysteine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>CAREDO Treating Gingivitis Toothpastes 100g</name>
      <ingredients>Glycine</ingredients>
    </mixture>
    <mixture>
      <name>CAREDO Repair Cracked Teeth Toothpastes 100g</name>
      <ingredients>Glycine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Kabiven</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Calcium chloride + D-glucose + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium sulfate + Methionine + Phenylalanine + Potassium chloride + Proline + Serine + Sodium acetate + Sodium glycerophosphate + Soybean oil + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Perikabiven</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Calcium chloride + D-glucose + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium sulfate + Methionine + Phenylalanine + Potassium chloride + Proline + Serine + Sodium acetate + Sodium glycerophosphate + Soybean oil + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>HepatAmine</name>
      <ingredients>Alanine + Arginine + Cysteine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Phosphoric acid + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>FreAmine III</name>
      <ingredients>Alanine + Arginine + Cysteine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Phosphoric acid + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>FreAmine III</name>
      <ingredients>Alanine + Arginine + Cysteine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Phosphoric acid + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Calcium chloride + D-glucose + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Calcium chloride + D-glucose + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Calcium chloride + D-glucose + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Plenamine</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Taurine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Glycine</name>
      <ingredients>Glycine</ingredients>
    </mixture>
    <mixture>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Cysteine + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Taurine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Cysteine + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Taurine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>FreAmine HBC</name>
      <ingredients>Alanine + Arginine + Cysteine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>8.5% Freamine III</name>
      <ingredients>Alanine + Arginine + Cysteine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Phenylalanine + Proline + Racemethionine + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminoderm Poudre</name>
      <ingredients>Cysteine + Glycine + Neomycin + Threonine</ingredients>
    </mixture>
    <mixture>
      <name>Cicatrin Powder</name>
      <ingredients>Bacitracin + Cysteine + Glycine + Neomycin + Threonine</ingredients>
    </mixture>
    <mixture>
      <name>Vamin N</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Calcium chloride + Cysteine + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium sulfate + Methionine + Phenylalanine + Potassium chloride + Potassium hydroxide + Proline + Serine + Sodium hydroxide + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Vamin 18 Electrolyte-free</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Cysteine + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Primene 10%</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Cysteine + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Ornithine + Phenylalanine + Proline + Serine + Taurine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinisol</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Glycine</name>
      <ingredients>Glycine</ingredients>
    </mixture>
    <mixture>
      <name>Synthamin</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>TrophAmine</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Cysteine + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Taurine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>TrophAmine</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Cysteine + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Taurine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>ProSol</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>ProcalAmine</name>
      <ingredients>Alanine + Arginine + Calcium acetate + Cysteine + Glycerin + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium acetate + Methionine + Phenylalanine + Phosphoric acid + Potassium chloride + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Glycine</name>
      <ingredients>Glycine</ingredients>
    </mixture>
    <mixture>
      <name>Glycine</name>
      <ingredients>Glycine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Primene</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Cysteine + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Ornithine + Phenylalanine + Proline + Serine + Taurine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn Sulfite Free</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Novamine</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Taurine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II with Electrolytes</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + N-acetyltyrosine + Phenylalanine + Potassium chloride + Proline + Serine + Sodium chloride + Sodium phosphate, dibasic, unspecified form + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium acetate + Methionine + Phenylalanine + Phosphoric acid + Potassium acetate + Proline + Serine + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Potassium chloride + Proline + Serine + Sodium chloride + Sodium phosphate, dibasic, unspecified form + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Potassium chloride + Proline + Serine + Sodium chloride + Sodium phosphate, dibasic, unspecified form + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Taurine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Glycine</name>
      <ingredients>Glycine</ingredients>
    </mixture>
    <mixture>
      <name>BANACOCica-aid Centella Peptide emulsion</name>
      <ingredients>Dimethicone + Glycerin + Glycine + Methionine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>TrophAmine</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Cysteine + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Taurine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>20% Prosol</name>
      <ingredients>Alanine + Arginine + Aspartic acid + D-Methionine + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Nutrineal Pd4</name>
      <ingredients>Alanine + Arginine + Calcium chloride + D-Methionine + Glycine + Histidine + Isoleucine + L-Lysine + Lactic acid + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Glycine 1.5% Irrigation USP Sol</name>
      <ingredients>Glycine</ingredients>
    </mixture>
    <mixture>
      <name>Antacid 2 Tablets</name>
      <ingredients>Calcium carbonate + Glycine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol Inj Without Electrolytes 8.5%</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Phenylalanine + Proline + Racemethionine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Periolimel 2.5% E</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Calcium chloride + Dextrose, unspecified form + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Olive oil + Phenylalanine + Potassium chloride + Proline + Serine + Sodium acetate + Sodium glycerophosphate + Soybean oil + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 4.4% E</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Calcium chloride + Dextrose, unspecified form + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Olive oil + Phenylalanine + Potassium chloride + Proline + Serine + Sodium acetate + Sodium glycerophosphate + Soybean oil + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 5.7% E</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Calcium chloride + Dextrose, unspecified form + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Olive oil + Phenylalanine + Potassium chloride + Proline + Serine + Sodium acetate + Sodium glycerophosphate + Soybean oil + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Smofkabiven Electrolyte Free</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Fish oil + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Medium-chain triglycerides + Methionine + Nitrogen + Olive oil + Phenylalanine + Proline + Serine + Soybean oil + Taurine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Smofkabiven</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Fish oil + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium sulfate + Medium-chain triglycerides + Methionine + Nitrogen + Olive oil + Phenylalanine + Potassium chloride + Proline + Serine + Sodium acetate + Sodium glycerophosphate + Soybean oil + Taurine + Threonine + Tryptophan + Tyrosine + Valine + Zinc sulfate</ingredients>
    </mixture>
    <mixture>
      <name>2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>2.75% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Quick Mix 2.5% Travasol Aa With Electrolytes With 25% Dextrose Injec</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 7% With 50% Dextrose</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Dextrose, unspecified form + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 8.5% M In 20% Dextrose (dual Chamber)</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Dextrose, unspecified form + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + N-acetyltyrosine + Phenylalanine + Potassium chloride + Proline + Serine + Sodium chloride + Sodium phosphate, dibasic + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 7% M In 10% Dextrose(dual Chamber)</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Dextrose, unspecified form + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + N-acetyltyrosine + Phenylalanine + Potassium chloride + Proline + Serine + Sodium chloride + Sodium phosphate, dibasic + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II In Dextrose Injection</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Dextrose, unspecified form + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II In Dextrose Injection</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Dextrose, unspecified form + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 7% With 10% Dextrose</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Dextrose, unspecified form + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 8.5% With 50% Dextrose</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Dextrose, unspecified form + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II In Dextrose Injection</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Dextrose, unspecified form + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Primene 10%-liq IV</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Cysteine + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Ornithine + Phenylalanine + Proline + Serine + Taurine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Renamin (amino Acids) Injection</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Without Electrolytes In 5% Dextrose Quickmix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Amino Acid Injection Without Electrolytes In 20% Dextrose Quickmix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>2.5% Travasol Amino Acid Injection Without Electrolytes In 10% Dextrose Quickmix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>2.75% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose Quickmix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose Quickmix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>2.5%travasol Amino Acid InJ.W.eleC.W.25%dex</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>2.75%travasol Amino Acid InJ.W.eleC.W.5%dex.</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>2.75% Travas. Amino Acid InJ.W.elecw.25%dex</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25%travasol Amino Acid InJ.W.elecw.5%dex.</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>5% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>5% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>5% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix 2.5% Travasol Aa Without Electrolytes In 10% Dextrose Injec</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25%trav. Amino Acid InJ.W.O.elect.5%dext.</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection Without Electrlytes In 10% Dextrose</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol Inj Without Electrolytes 5.5%</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 3.5% M</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium acetate + Methionine + Phenylalanine + Potassium acetate + Proline + Serine + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol Amino Acid Inj 8.5%</name>
      <ingredients>Alanine + Arginine + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol Amino Acid Inj 5.5%</name>
      <ingredients>Alanine + Arginine + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 10% W Electrolytes</name>
      <ingredients>Alanine + Arginine + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 8.5% Injection With Electrolytes</name>
      <ingredients>Alanine + Arginine + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 5% Inj</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 3.3% E</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Calcium chloride + Dextrose, unspecified form + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Olive oil + Phenylalanine + Potassium chloride + Proline + Serine + Sodium acetate + Sodium glycerophosphate + Soybean oil + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Ph 12 Sterile Diluent for Flolan</name>
      <ingredients>Glycine + Sodium chloride + Water</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF 10%</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Taurine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 8.5% Injection</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 7% Injection</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 10% With Electrolytes</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Dipotassium phosphate + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + N-acetyltyrosine + Phenylalanine + Potassium chloride + Proline + Serine + Sodium chloride + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF 7%</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Taurine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 5%</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 7%</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 8.5%</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Smofkabiven Peripheral</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Fish oil + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium sulfate + Medium-chain triglycerides + Methionine + Olive oil + Phenylalanine + Potassium chloride + Proline + Serine + Sodium acetate + Sodium glycerophosphate + Soybean oil + Taurine + Threonine + Tryptophan + Tyrosine + Valine + Zinc sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Glycine Irrigation 1.5% USP</name>
      <ingredients>Glycine</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 4.4%</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Dextrose, unspecified form + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Olive oil + Phenylalanine + Proline + Serine + Soybean oil + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 5.7%</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Dextrose, unspecified form + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Olive oil + Phenylalanine + Proline + Serine + Soybean oil + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Glycine Irrigation USP</name>
      <ingredients>Glycine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol E</name>
      <ingredients>Alanine + Arginine + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Sodium acetate + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Sterile Diluent for Flolan Injection</name>
      <ingredients>Glycine + Sodium chloride + Water</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + N-acetyltyrosine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Alanine + Arginine + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 7.6% E</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Calcium chloride + Dextrose, unspecified form + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Olive oil + Phenylalanine + Potassium chloride + Proline + Serine + Sodium acetate + Sodium glycerophosphate + Soybean oil + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 7.6%</name>
      <ingredients>Alanine + Arginine + Aspartic acid + Dextrose, unspecified form + Glutamic acid + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Olive oil + Phenylalanine + Proline + Serine + Soybean oil + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Dipotassium phosphate + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium chloride + Methionine + Phenylalanine + Proline + Serine + Sodium chloride + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Methionine + Phenylalanine + Proline + Serine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Smofkabiven Extra Nitrogen Electrolyte Free</name>
      <ingredients>Alanine + Arginine + Dextrose, unspecified form + Fish oil + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Medium-chain triglycerides + Methionine + Nitrogen + Olive oil + Phenylalanine + Proline + Serine + Soybean oil + Taurine + Threonine + Tryptophan + Tyrosine + Valine</ingredients>
    </mixture>
    <mixture>
      <name>Smofkabiven Extra Nitrogen</name>
      <ingredients>Alanine + Arginine + Calcium chloride + Dextrose, unspecified form + Fish oil + Glycine + Histidine + Isoleucine + L-Lysine + Leucine + Magnesium sulfate + Medium-chain triglycerides + Methionine + Nitrogen + Olive oil + Phenylalanine + Potassium chloride + Proline + Serine + Sodium acetate + Sodium glycerophosphate + Soybean oil + Taurine + Threonine + Tryptophan + Tyrosine + Valine + Zinc sulfate</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>Amend</name>
      <url/>
    </packager>
    <packager>
      <name>B. Braun Melsungen AG</name>
      <url>http://www.bbraun.com</url>
    </packager>
    <packager>
      <name>Baxter International Inc.</name>
      <url>http://www.baxter.com</url>
    </packager>
    <packager>
      <name>Chattem Chemicals Inc.</name>
      <url>http://www.chattem.com</url>
    </packager>
    <packager>
      <name>GlaxoSmithKline Inc.</name>
      <url>http://www.gsk.com</url>
    </packager>
    <packager>
      <name>Hospira Inc.</name>
      <url>http://www.hospira.com</url>
    </packager>
    <packager>
      <name>Mallinckrodt Inc.</name>
      <url>http://www.mallinckrodt.com</url>
    </packager>
    <packager>
      <name>Yuki Gosei Kogyo</name>
      <url>http://www.yuki-gosei.co.jp</url>
    </packager>
  </packagers>
  <manufacturers>
    <manufacturer generic="false" url="">Baxter healthcare corp</manufacturer>
    <manufacturer generic="false" url="">B braun medical inc</manufacturer>
    <manufacturer generic="false" url="">Hospira inc</manufacturer>
  </manufacturers>
  <prices>
    <price>
      <description>Glycine 1.5% irrigation</description>
      <cost currency="USD">0.02</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Amino acetic acid powder</description>
      <cost currency="USD">0.03</cost>
      <unit>g</unit>
    </price>
    <price>
      <description>Glycine powder</description>
      <cost currency="USD">0.03</cost>
      <unit>g</unit>
    </price>
    <price>
      <description>Diluent for flolan vial</description>
      <cost currency="USD">0.31</cost>
      <unit>ml</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Amino Acids</category>
      <mesh-id>D000596</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Peptides, and Proteins</category>
      <mesh-id>D000602</mesh-id>
    </category>
    <category>
      <category>Blood and Blood Forming Organs</category>
      <mesh-id/>
    </category>
    <category>
      <category>Blood Substitutes and Perfusion Solutions</category>
      <mesh-id/>
    </category>
    <category>
      <category>Dietary Supplements</category>
      <mesh-id>D019587</mesh-id>
    </category>
    <category>
      <category>Glycine Agents</category>
      <mesh-id>D018684</mesh-id>
    </category>
    <category>
      <category>Irrigating Solutions</category>
      <mesh-id/>
    </category>
    <category>
      <category>Neurotransmitter Agents</category>
      <mesh-id>D018377</mesh-id>
    </category>
    <category>
      <category>Supplements</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Solution</form>
      <route/>
      <strength>1.5 %</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>0.25 g/mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>3.75 g/500ml</strength>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>2.5 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>2.5 g/500mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>2.55 g/L</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>0.61 g/L</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>1.79 g/L</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>22.35 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>10.5 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Parenteral</route>
      <strength>5.25 g</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>0.86 g/L</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Parenteral</route>
      <strength>2 g</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>2.453 g</strength>
    </dosage>
    <dosage>
      <form>Solution, concentrate</form>
      <route>Intravenous</route>
      <strength>5 g</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Parenteral</route>
      <strength>4.64 g</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>10.4 g/L</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>5.82 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Parenteral</route>
      <strength>14 g</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>5 g</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>1.4 g/100ml</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Parenteral</route>
      <strength>2.5 g</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>3.7 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>4.15 g</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>4.15 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>1.566 g</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intraperitoneal</route>
      <strength>951 mg/L</strength>
    </dosage>
    <dosage>
      <form>Lotion</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Irrigation</route>
      <strength>1.5 %</strength>
    </dosage>
    <dosage>
      <form>Tablet, orally disintegrating</form>
      <route>Oral</route>
      <strength>100 mg</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>100 mg</strength>
    </dosage>
    <dosage>
      <form>Paste, dentifrice</form>
      <route>Dental</route>
      <strength>0.5 g/100g</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>4.02 g/l</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>5.11 g/l</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>6.21 g/l</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>7.3 g/l</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>12.8 g/1L</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>175 mg</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>11.41 g/1435ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>11.41 g/1085ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>13.17 g/2020ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>7.08 g/1085ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>9.46 g/1450ml</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>3.99 g/1085ml</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>2.05 g/1085ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>590 mg/100mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>0.69 %</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>0.59 %</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>16 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>1.5 %</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravesical; Irrigation</route>
      <strength>1.5 g</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravesical; Irrigation</route>
      <strength>45 g</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Irrigation; Parenteral</route>
      <strength>1.5 g</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Irrigation; Topical</route>
      <strength>1.5 g</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Irrigation</route>
      <strength>45 g</strength>
    </dosage>
    <dosage>
      <form>Irrigant</form>
      <route>Irrigation</route>
      <strength>1.5 g/100mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Irrigation</route>
      <strength>1.5 g/100mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Irrigation</route>
      <strength>15 g/100mL</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Irrigation</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Irrigation</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>1.03 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>40 g/1026ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>467 mg/100mL</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>60 g/1540ml</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>110 g</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>165 g</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>220 g</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>275 g</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>107 g</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>143 g</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>178 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>1.17 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>1.56 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>1.755 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>2.34 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>3.12 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>3.51 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>4.68 g</strength>
    </dosage>
    <dosage>
      <form>Injection, solution, concentrate</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Parenteral</route>
      <strength>2.33 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>1.03 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>1.83 g</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength>1.83 g</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>1.03 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>1.6 g/100mL</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion; injection, solution</form>
      <route>Intravenous</route>
      <strength>3.2 g/100mL</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength>20 mg</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength>16 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>3.88 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>20 g/l</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>3.88 g</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength>88 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>120 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>160 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>4.66 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>1.872 g/l</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>0.222 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>150 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>225 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>300 g</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>6.792 g/l</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength>6.792 mg</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>2.4 g/l</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>2.88 g/l</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>5.82 g/1250ml</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength>4.656 g</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>6.792 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>4.25 g/625ml</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength>6.792 g</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>4.85 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Parenteral</route>
      <strength>0.5 g</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>11.64 g/2000ml</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Parenteral</route>
      <strength>1.56 g</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route/>
      <strength>0.6 g/L</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Parenteral</route>
      <strength>4.54 g</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intraperitoneal</route>
      <strength>95.1 mg/100mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intraperitoneal</route>
      <strength>951 mg/L</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Hemodialysis</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Parenteral</route>
      <strength>95.1 mg</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intraperitoneal</route>
      <strength>510 mg/l</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>120 g/1875ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>160 g/2500ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>80 g/1250ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>150 g/1250ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>225 g/1875ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>300 g/2500ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>180 g/1250ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>270 g/1875ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>360 g/2500ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>90 g/625ml</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Oral</route>
      <strength>2 mcg/100ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>12 g/1500ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>32 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>0.52 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>0.42 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>1.6 g</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>2.27 g/l</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>4.12 g/l</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength>4 g</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>7.14 g</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>9.52 g</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>11.9 g</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength>6.41 g</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength>9.61 g</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength>12.82 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>6.41 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>8.24 g</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>12.36 g</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>16.48 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>8.24 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Parenteral</route>
      <strength>1.48 g/l</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>0.67 g/100ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>3 g/100ml</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>1.26 g</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength>3 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>3.66 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>5.5 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>7.33 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>9.16 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>3.66 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>0.69 %</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>0.59 %</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>0.9 %</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>0.76 %</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>3.2 g/100mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>1.6 g/100mL</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>0.67 g/100ml</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Parenteral</route>
      <strength>800 mg</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Parenteral</route>
      <strength>3 g/100ml</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>45 mg</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>7.08 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>1.6 g/l</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>0.66 g/2531ml</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>0.61 g/l</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>440 mg</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>4.4 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>0.71 g</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>3.1 g</strength>
    </dosage>
    <dosage>
      <form>Injection, emulsion</form>
      <route>Intravenous</route>
      <strength>7.1 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>50 g</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>2 mg</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route/>
      <strength>2.5 mg</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>0.28 g</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>0.5 g</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>0.18 g</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>2.9 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>0.76 g/100mL</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>434 mg</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>594 mg</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Parenteral</route>
      <strength>1.14 mg</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Parenteral</route>
      <strength>1.76 g</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>18.75 g</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>0.45 g</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>12 g/L</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>16 g/L</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>5.1 g/16g N</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>6.3 g/1000ml</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>2.24 g</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>4.34 g</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>3.95 g</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>7 g</strength>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Parenteral</route>
      <strength>28 g/1000ml</strength>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="B05CX03">
      <level code="B05CX">Other irrigating solutions</level>
      <level code="B05C">IRRIGATING SOLUTIONS</level>
      <level code="B05">BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS</level>
      <level code="B">BLOOD AND BLOOD FORMING ORGANS</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes>
    <ahfs-code>40:36.00</ahfs-code>
  </ahfs-codes>
  <pdb-entries/>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB00145.pdf?1265922739</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB00390</drugbank-id>
      <name>Digoxin</name>
      <description>The risk or severity of adverse effects can be increased when Glycine is combined with Digoxin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00511</drugbank-id>
      <name>Acetyldigitoxin</name>
      <description>The risk or severity of adverse effects can be increased when Glycine is combined with Acetyldigitoxin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01078</drugbank-id>
      <name>Deslanoside</name>
      <description>The risk or severity of adverse effects can be increased when Glycine is combined with Deslanoside.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01396</drugbank-id>
      <name>Digitoxin</name>
      <description>The risk or severity of adverse effects can be increased when Glycine is combined with Digitoxin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13401</drugbank-id>
      <name>Metildigoxin</name>
      <description>The risk or severity of adverse effects can be increased when Glycine is combined with Metildigoxin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13467</drugbank-id>
      <name>Lanatoside C</name>
      <description>The risk or severity of adverse effects can be increased when Glycine is combined with Lanatoside C.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13537</drugbank-id>
      <name>Gitoformate</name>
      <description>The risk or severity of adverse effects can be increased when Glycine is combined with Gitoformate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13691</drugbank-id>
      <name>Acetyldigoxin</name>
      <description>The risk or severity of adverse effects can be increased when Glycine is combined with Acetyldigoxin.</description>
    </drug-interaction>
  </drug-interactions>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-3.3</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>0.87</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>5.52e+02 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-3.4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>2-aminoacetic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>palladium(2+) (4S,5S,14R,15R)-10-acetyl-4-(2-carboxyethyl)-15-ethyl-2-(2-methoxy-2-oxoethyl)-5,9,14,19-tetramethyl-20-[(2-sulfoethyl)carbamoyl]-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1,3(24),6,8,10,12,16(22),17,19-nonaene-21,23-diide</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>75.0666</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>75.032028409</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>NCC(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C2H5NO2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>DHMQDGOQFOQNFH-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>63.32</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>16</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>6.65</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>2.31</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>9.24</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>2.49E+005 mg/L (at 25 °C)</value>
      <source>YALKOWSKY,SH &amp; DANNENFELSER,RM (1992)</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>262 dec °C</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-3.21</value>
      <source>HANSCH,C ET AL. (1995)</source>
    </property>
    <property>
      <kind>pKa</kind>
      <value>2.37 (at 20 °C)</value>
      <source>KORTUM,G ET AL (1961)</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>8865</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>15428</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>750</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46508219</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C00037</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D00011</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>730</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>18133</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA449789</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>GLY</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Therapeutic Targets Database</resource>
      <identifier>DAP000288</identifier>
    </external-identifier>
    <external-identifier>
      <resource>IUPHAR</resource>
      <identifier>727</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Guide to Pharmacology</resource>
      <identifier>727</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Glycine</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL773</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ZINC</resource>
      <identifier>ZINC000004658552</identifier>
    </external-identifier>
    <external-identifier>
      <resource>RxCUI</resource>
      <identifier>4919</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>PDRhealth</resource>
      <url>http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/gly_0127.shtml</url>
    </external-link>
  </external-links>
  <pathways>
    <pathway>
      <smpdb-id>SMP0000004</smpdb-id>
      <name>Glycine and Serine Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00855</drugbank-id>
          <name>Aminolevulinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02951</drugbank-id>
          <name>3-Hydroxypyruvic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB02957</drugbank-id>
          <name>Orotidylic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03587</drugbank-id>
          <name>Pyruvaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB03843</drugbank-id>
          <name>Formaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB03915</drugbank-id>
          <name>2-Amino-3-Ketobutyric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04343</drugbank-id>
          <name>Glyoxylic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04522</drugbank-id>
          <name>Dexfosfoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>O75600</uniprot-id>
        <uniprot-id>Q9UI17</uniprot-id>
        <uniprot-id>Q9UL12</uniprot-id>
        <uniprot-id>P23378</uniprot-id>
        <uniprot-id>P48728</uniprot-id>
        <uniprot-id>P34897</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P21549</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P13196</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>Q14749</uniprot-id>
        <uniprot-id>Q8IVS8</uniprot-id>
        <uniprot-id>O43175</uniprot-id>
        <uniprot-id>Q9Y617</uniprot-id>
        <uniprot-id>P78330</uniprot-id>
        <uniprot-id>P20132</uniprot-id>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>Q9GZT4</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P49591</uniprot-id>
        <uniprot-id>P41250</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000009</smpdb-id>
      <name>Ammonia Recycling</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01971</drugbank-id>
          <name>trans-urocanic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P20132</uniprot-id>
        <uniprot-id>Q7L266</uniprot-id>
        <uniprot-id>P08243</uniprot-id>
        <uniprot-id>P42357</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>A8YXX4</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>P48728</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P23378</uniprot-id>
        <uniprot-id>P23434</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000020</smpdb-id>
      <name>Arginine and Proline Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03144</drugbank-id>
          <name>N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000024</smpdb-id>
      <name>Porphyrin Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00855</drugbank-id>
          <name>Aminolevulinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02285</drugbank-id>
          <name>Protoporphyrin</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03435</drugbank-id>
          <name>Uridine-5'-Diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB04461</drugbank-id>
          <name>Coproporphyrinogen III</name>
        </drug>
        <drug>
          <drugbank-id>DB07780</drugbank-id>
          <name>Farnesyl diphosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P13196</uniprot-id>
        <uniprot-id>P13716</uniprot-id>
        <uniprot-id>P08397</uniprot-id>
        <uniprot-id>P10746</uniprot-id>
        <uniprot-id>P06132</uniprot-id>
        <uniprot-id>P36551</uniprot-id>
        <uniprot-id>P50336</uniprot-id>
        <uniprot-id>Q8N4E7</uniprot-id>
        <uniprot-id>P22830</uniprot-id>
        <uniprot-id>Q12887</uniprot-id>
        <uniprot-id>Q7KZN9</uniprot-id>
        <uniprot-id>P09601</uniprot-id>
        <uniprot-id>P53004</uniprot-id>
        <uniprot-id>O75310</uniprot-id>
        <uniprot-id>P08236</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000050</smpdb-id>
      <name>Purine Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00173</drugbank-id>
          <name>Adenine</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>5-O-phosphono-alpha-D-ribofuranosyl diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB01700</drugbank-id>
          <name>AICA ribonucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02134</drugbank-id>
          <name>Xanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB02377</drugbank-id>
          <name>Guanine</name>
        </drug>
        <drug>
          <drugbank-id>DB02527</drugbank-id>
          <name>Cyclic adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02857</drugbank-id>
          <name>Guanosine</name>
        </drug>
        <drug>
          <drugbank-id>DB03101</drugbank-id>
          <name>Ribose-1-Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04076</drugbank-id>
          <name>Hypoxanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04335</drugbank-id>
          <name>Inosine</name>
        </drug>
        <drug>
          <drugbank-id>DB04457</drugbank-id>
          <name>2'-Deoxyguanosine-5'-Monophosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P50583</uniprot-id>
        <uniprot-id>O75414</uniprot-id>
        <uniprot-id>O75356</uniprot-id>
        <uniprot-id>Q5MY95</uniprot-id>
        <uniprot-id>Q16774</uniprot-id>
        <uniprot-id>P49902</uniprot-id>
        <uniprot-id>Q16854</uniprot-id>
        <uniprot-id>P07741</uniprot-id>
        <uniprot-id>P00491</uniprot-id>
        <uniprot-id>P00492</uniprot-id>
        <uniprot-id>Q9Y2T3</uniprot-id>
        <uniprot-id>Q9UKK9</uniprot-id>
        <uniprot-id>P21108</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P22102</uniprot-id>
        <uniprot-id>O15067</uniprot-id>
        <uniprot-id>P22234</uniprot-id>
        <uniprot-id>P30566</uniprot-id>
        <uniprot-id>P31939</uniprot-id>
        <uniprot-id>Q9BY32</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>P20839</uniprot-id>
        <uniprot-id>P36959</uniprot-id>
        <uniprot-id>P47989</uniprot-id>
        <uniprot-id>P30520</uniprot-id>
        <uniprot-id>P23109</uniprot-id>
        <uniprot-id>P00813</uniprot-id>
        <uniprot-id>P00568</uniprot-id>
        <uniprot-id>Q8NBU5</uniprot-id>
        <uniprot-id>Q08499</uniprot-id>
        <uniprot-id>Q96PN6</uniprot-id>
        <uniprot-id>P33402</uniprot-id>
        <uniprot-id>Q02153</uniprot-id>
        <uniprot-id>Q9Y233</uniprot-id>
        <uniprot-id>P10599</uniprot-id>
        <uniprot-id>P23921</uniprot-id>
        <uniprot-id>P31350</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000072</smpdb-id>
      <name>Glutamate Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>5-O-phosphono-alpha-D-ribofuranosyl diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02530</drugbank-id>
          <name>gamma-Aminobutyric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>A8YXX4</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>P27708</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>Q6IA69</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>Q5JPH6</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q99259</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P51649</uniprot-id>
        <uniprot-id>P47897</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000177</smpdb-id>
      <name>Cystathionine beta-Synthase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01917</drugbank-id>
          <name>Putrescine</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02238</drugbank-id>
          <name>4-methylthio-2-oxobutanoic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03566</drugbank-id>
          <name>Spermidine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04193</drugbank-id>
          <name>L-Homoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P42898</uniprot-id>
        <uniprot-id>Q99707</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>P26358</uniprot-id>
        <uniprot-id>P17707</uniprot-id>
        <uniprot-id>P19623</uniprot-id>
        <uniprot-id>Q13126</uniprot-id>
        <uniprot-id>P23526</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P56192</uniprot-id>
        <uniprot-id>Q96DP5</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
        <uniprot-id>Q8NE62</uniprot-id>
        <uniprot-id>Q8IXL7</uniprot-id>
        <uniprot-id>Q9Y3D2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000188</smpdb-id>
      <name>Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03144</drugbank-id>
          <name>N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000210</smpdb-id>
      <name>Purine Nucleoside Phosphorylase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00173</drugbank-id>
          <name>Adenine</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>5-O-phosphono-alpha-D-ribofuranosyl diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB01700</drugbank-id>
          <name>AICA ribonucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02134</drugbank-id>
          <name>Xanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB02377</drugbank-id>
          <name>Guanine</name>
        </drug>
        <drug>
          <drugbank-id>DB02527</drugbank-id>
          <name>Cyclic adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02857</drugbank-id>
          <name>Guanosine</name>
        </drug>
        <drug>
          <drugbank-id>DB03101</drugbank-id>
          <name>Ribose-1-Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04076</drugbank-id>
          <name>Hypoxanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04335</drugbank-id>
          <name>Inosine</name>
        </drug>
        <drug>
          <drugbank-id>DB04457</drugbank-id>
          <name>2'-Deoxyguanosine-5'-Monophosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P50583</uniprot-id>
        <uniprot-id>O75414</uniprot-id>
        <uniprot-id>O75356</uniprot-id>
        <uniprot-id>Q5MY95</uniprot-id>
        <uniprot-id>Q16774</uniprot-id>
        <uniprot-id>P49902</uniprot-id>
        <uniprot-id>Q16854</uniprot-id>
        <uniprot-id>P07741</uniprot-id>
        <uniprot-id>P00491</uniprot-id>
        <uniprot-id>P00492</uniprot-id>
        <uniprot-id>Q9Y2T3</uniprot-id>
        <uniprot-id>Q9UKK9</uniprot-id>
        <uniprot-id>P21108</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P22102</uniprot-id>
        <uniprot-id>O15067</uniprot-id>
        <uniprot-id>P22234</uniprot-id>
        <uniprot-id>P30566</uniprot-id>
        <uniprot-id>P31939</uniprot-id>
        <uniprot-id>Q9BY32</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>P20839</uniprot-id>
        <uniprot-id>P36959</uniprot-id>
        <uniprot-id>P47989</uniprot-id>
        <uniprot-id>P30520</uniprot-id>
        <uniprot-id>P23109</uniprot-id>
        <uniprot-id>P00813</uniprot-id>
        <uniprot-id>P00568</uniprot-id>
        <uniprot-id>Q8NBU5</uniprot-id>
        <uniprot-id>Q08499</uniprot-id>
        <uniprot-id>Q96PN6</uniprot-id>
        <uniprot-id>P33402</uniprot-id>
        <uniprot-id>Q02153</uniprot-id>
        <uniprot-id>Q9Y233</uniprot-id>
        <uniprot-id>P10599</uniprot-id>
        <uniprot-id>P23921</uniprot-id>
        <uniprot-id>P31350</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000314</smpdb-id>
      <name>Congenital Bile Acid Synthesis Defect Type II</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01956</drugbank-id>
          <name>Taurine</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02659</drugbank-id>
          <name>Cholic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03796</drugbank-id>
          <name>Palmitic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04348</drugbank-id>
          <name>Taurocholic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04540</drugbank-id>
          <name>Cholesterol</name>
        </drug>
        <drug>
          <drugbank-id>DB06777</drugbank-id>
          <name>Chenodeoxycholic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB08833</drugbank-id>
          <name>Taurochenodeoxycholic acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17516</uniprot-id>
        <uniprot-id>P51857</uniprot-id>
        <uniprot-id>Q02318</uniprot-id>
        <uniprot-id>Q9Y2P5</uniprot-id>
        <uniprot-id>Q9UHK6</uniprot-id>
        <uniprot-id>Q99424</uniprot-id>
        <uniprot-id>P51659</uniprot-id>
        <uniprot-id>P22307</uniprot-id>
        <uniprot-id>Q14032</uniprot-id>
        <uniprot-id>Q9H2F3</uniprot-id>
        <uniprot-id>Q9UNU6</uniprot-id>
        <uniprot-id>P22680</uniprot-id>
        <uniprot-id>P38571</uniprot-id>
        <uniprot-id>Q9Y6A2</uniprot-id>
        <uniprot-id>Q9NYL5</uniprot-id>
        <uniprot-id>O75881</uniprot-id>
        <uniprot-id>O95992</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000339</smpdb-id>
      <name>Hyperinsulinism-Hyperammonemia Syndrome</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>5-O-phosphono-alpha-D-ribofuranosyl diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02530</drugbank-id>
          <name>gamma-Aminobutyric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>A8YXX4</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>P27708</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>Q6IA69</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>Q5JPH6</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q99259</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P51649</uniprot-id>
        <uniprot-id>P47897</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000360</smpdb-id>
      <name>Hyperprolinemia Type II</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03144</drugbank-id>
          <name>N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000361</smpdb-id>
      <name>Hyperprolinemia Type I</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03144</drugbank-id>
          <name>N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000364</smpdb-id>
      <name>Lesch-Nyhan Syndrome (LNS)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00173</drugbank-id>
          <name>Adenine</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>5-O-phosphono-alpha-D-ribofuranosyl diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB01700</drugbank-id>
          <name>AICA ribonucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02134</drugbank-id>
          <name>Xanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB02377</drugbank-id>
          <name>Guanine</name>
        </drug>
        <drug>
          <drugbank-id>DB02527</drugbank-id>
          <name>Cyclic adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02857</drugbank-id>
          <name>Guanosine</name>
        </drug>
        <drug>
          <drugbank-id>DB03101</drugbank-id>
          <name>Ribose-1-Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04076</drugbank-id>
          <name>Hypoxanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04335</drugbank-id>
          <name>Inosine</name>
        </drug>
        <drug>
          <drugbank-id>DB04457</drugbank-id>
          <name>2'-Deoxyguanosine-5'-Monophosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P50583</uniprot-id>
        <uniprot-id>O75414</uniprot-id>
        <uniprot-id>O75356</uniprot-id>
        <uniprot-id>Q5MY95</uniprot-id>
        <uniprot-id>Q16774</uniprot-id>
        <uniprot-id>P49902</uniprot-id>
        <uniprot-id>Q16854</uniprot-id>
        <uniprot-id>P07741</uniprot-id>
        <uniprot-id>P00491</uniprot-id>
        <uniprot-id>P00492</uniprot-id>
        <uniprot-id>Q9Y2T3</uniprot-id>
        <uniprot-id>Q9UKK9</uniprot-id>
        <uniprot-id>P21108</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P22102</uniprot-id>
        <uniprot-id>O15067</uniprot-id>
        <uniprot-id>P22234</uniprot-id>
        <uniprot-id>P30566</uniprot-id>
        <uniprot-id>P31939</uniprot-id>
        <uniprot-id>Q9BY32</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>P20839</uniprot-id>
        <uniprot-id>P36959</uniprot-id>
        <uniprot-id>P47989</uniprot-id>
        <uniprot-id>P30520</uniprot-id>
        <uniprot-id>P23109</uniprot-id>
        <uniprot-id>P00813</uniprot-id>
        <uniprot-id>P00568</uniprot-id>
        <uniprot-id>Q8NBU5</uniprot-id>
        <uniprot-id>Q08499</uniprot-id>
        <uniprot-id>Q96PN6</uniprot-id>
        <uniprot-id>P33402</uniprot-id>
        <uniprot-id>Q02153</uniprot-id>
        <uniprot-id>Q9Y233</uniprot-id>
        <uniprot-id>P10599</uniprot-id>
        <uniprot-id>P23921</uniprot-id>
        <uniprot-id>P31350</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000365</smpdb-id>
      <name>Gout or Kelley-Seegmiller Syndrome</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00173</drugbank-id>
          <name>Adenine</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>5-O-phosphono-alpha-D-ribofuranosyl diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB01700</drugbank-id>
          <name>AICA ribonucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02134</drugbank-id>
          <name>Xanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB02377</drugbank-id>
          <name>Guanine</name>
        </drug>
        <drug>
          <drugbank-id>DB02527</drugbank-id>
          <name>Cyclic adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02857</drugbank-id>
          <name>Guanosine</name>
        </drug>
        <drug>
          <drugbank-id>DB03101</drugbank-id>
          <name>Ribose-1-Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04076</drugbank-id>
          <name>Hypoxanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04335</drugbank-id>
          <name>Inosine</name>
        </drug>
        <drug>
          <drugbank-id>DB04457</drugbank-id>
          <name>2'-Deoxyguanosine-5'-Monophosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P50583</uniprot-id>
        <uniprot-id>O75414</uniprot-id>
        <uniprot-id>O75356</uniprot-id>
        <uniprot-id>Q5MY95</uniprot-id>
        <uniprot-id>Q16774</uniprot-id>
        <uniprot-id>P49902</uniprot-id>
        <uniprot-id>Q16854</uniprot-id>
        <uniprot-id>P07741</uniprot-id>
        <uniprot-id>P00491</uniprot-id>
        <uniprot-id>P00492</uniprot-id>
        <uniprot-id>Q9Y2T3</uniprot-id>
        <uniprot-id>Q9UKK9</uniprot-id>
        <uniprot-id>P21108</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P22102</uniprot-id>
        <uniprot-id>O15067</uniprot-id>
        <uniprot-id>P22234</uniprot-id>
        <uniprot-id>P30566</uniprot-id>
        <uniprot-id>P31939</uniprot-id>
        <uniprot-id>Q9BY32</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>P20839</uniprot-id>
        <uniprot-id>P36959</uniprot-id>
        <uniprot-id>P47989</uniprot-id>
        <uniprot-id>P30520</uniprot-id>
        <uniprot-id>P23109</uniprot-id>
        <uniprot-id>P00813</uniprot-id>
        <uniprot-id>P00568</uniprot-id>
        <uniprot-id>Q8NBU5</uniprot-id>
        <uniprot-id>Q08499</uniprot-id>
        <uniprot-id>Q96PN6</uniprot-id>
        <uniprot-id>P33402</uniprot-id>
        <uniprot-id>Q02153</uniprot-id>
        <uniprot-id>Q9Y233</uniprot-id>
        <uniprot-id>P10599</uniprot-id>
        <uniprot-id>P23921</uniprot-id>
        <uniprot-id>P31350</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000428</smpdb-id>
      <name>Mercaptopurine Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00173</drugbank-id>
          <name>Adenine</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01033</drugbank-id>
          <name>Mercaptopurine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>5-O-phosphono-alpha-D-ribofuranosyl diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB01700</drugbank-id>
          <name>AICA ribonucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02134</drugbank-id>
          <name>Xanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB02377</drugbank-id>
          <name>Guanine</name>
        </drug>
        <drug>
          <drugbank-id>DB02527</drugbank-id>
          <name>Cyclic adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02857</drugbank-id>
          <name>Guanosine</name>
        </drug>
        <drug>
          <drugbank-id>DB03101</drugbank-id>
          <name>Ribose-1-Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04076</drugbank-id>
          <name>Hypoxanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04335</drugbank-id>
          <name>Inosine</name>
        </drug>
        <drug>
          <drugbank-id>DB04457</drugbank-id>
          <name>2'-Deoxyguanosine-5'-Monophosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00492</uniprot-id>
        <uniprot-id>P20839</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>P51580</uniprot-id>
        <uniprot-id>P63000</uniprot-id>
        <uniprot-id>Q06278</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>Q14542</uniprot-id>
        <uniprot-id>Q9HAS3</uniprot-id>
        <uniprot-id>Q99808</uniprot-id>
        <uniprot-id>O43868</uniprot-id>
        <uniprot-id>O15440</uniprot-id>
        <uniprot-id>O15439</uniprot-id>
        <uniprot-id>P47989</uniprot-id>
        <uniprot-id>P55263</uniprot-id>
        <uniprot-id>P50583</uniprot-id>
        <uniprot-id>O75414</uniprot-id>
        <uniprot-id>O75356</uniprot-id>
        <uniprot-id>Q5MY95</uniprot-id>
        <uniprot-id>Q16774</uniprot-id>
        <uniprot-id>P49902</uniprot-id>
        <uniprot-id>Q16854</uniprot-id>
        <uniprot-id>P07741</uniprot-id>
        <uniprot-id>P00491</uniprot-id>
        <uniprot-id>Q9Y2T3</uniprot-id>
        <uniprot-id>Q9UKK9</uniprot-id>
        <uniprot-id>P21108</uniprot-id>
        <uniprot-id>P22102</uniprot-id>
        <uniprot-id>O15067</uniprot-id>
        <uniprot-id>P22234</uniprot-id>
        <uniprot-id>P30566</uniprot-id>
        <uniprot-id>P31939</uniprot-id>
        <uniprot-id>Q9BY32</uniprot-id>
        <uniprot-id>P36959</uniprot-id>
        <uniprot-id>P30520</uniprot-id>
        <uniprot-id>P23109</uniprot-id>
        <uniprot-id>P00813</uniprot-id>
        <uniprot-id>P00568</uniprot-id>
        <uniprot-id>Q8NBU5</uniprot-id>
        <uniprot-id>Q08499</uniprot-id>
        <uniprot-id>Q96PN6</uniprot-id>
        <uniprot-id>P33402</uniprot-id>
        <uniprot-id>Q02153</uniprot-id>
        <uniprot-id>Q9Y233</uniprot-id>
        <uniprot-id>P10599</uniprot-id>
        <uniprot-id>P23921</uniprot-id>
        <uniprot-id>P31350</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000465</smpdb-id>
      <name>Carnitine Synthesis</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00123</drugbank-id>
          <name>L-Lysine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Ascorbic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00583</drugbank-id>
          <name>Levocarnitine</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q8WTS6</uniprot-id>
        <uniprot-id>Q9NVH6</uniprot-id>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P49189</uniprot-id>
        <uniprot-id>O75936</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000501</smpdb-id>
      <name>gamma-Glutamyltranspeptidase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB03088</drugbank-id>
          <name>Pidolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04701</drugbank-id>
          <name>S-Methyl glutathione</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q9H4Y5</uniprot-id>
        <uniprot-id>Q6P531</uniprot-id>
        <uniprot-id>P15144</uniprot-id>
        <uniprot-id>P55210</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>O14841</uniprot-id>
        <uniprot-id>O75223</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000507</smpdb-id>
      <name>L-Arginine:Glycine Amidinotransferase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03144</drugbank-id>
          <name>N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000535</smpdb-id>
      <name>Adenine Phosphoribosyltransferase Deficiency (APRT)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00173</drugbank-id>
          <name>Adenine</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>5-O-phosphono-alpha-D-ribofuranosyl diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB01700</drugbank-id>
          <name>AICA ribonucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02134</drugbank-id>
          <name>Xanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB02377</drugbank-id>
          <name>Guanine</name>
        </drug>
        <drug>
          <drugbank-id>DB02527</drugbank-id>
          <name>Cyclic adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02857</drugbank-id>
          <name>Guanosine</name>
        </drug>
        <drug>
          <drugbank-id>DB03101</drugbank-id>
          <name>Ribose-1-Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04076</drugbank-id>
          <name>Hypoxanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04335</drugbank-id>
          <name>Inosine</name>
        </drug>
        <drug>
          <drugbank-id>DB04457</drugbank-id>
          <name>2'-Deoxyguanosine-5'-Monophosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P50583</uniprot-id>
        <uniprot-id>O75414</uniprot-id>
        <uniprot-id>O75356</uniprot-id>
        <uniprot-id>Q5MY95</uniprot-id>
        <uniprot-id>Q16774</uniprot-id>
        <uniprot-id>P49902</uniprot-id>
        <uniprot-id>Q16854</uniprot-id>
        <uniprot-id>P07741</uniprot-id>
        <uniprot-id>P00491</uniprot-id>
        <uniprot-id>P00492</uniprot-id>
        <uniprot-id>Q9Y2T3</uniprot-id>
        <uniprot-id>Q9UKK9</uniprot-id>
        <uniprot-id>P21108</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P22102</uniprot-id>
        <uniprot-id>O15067</uniprot-id>
        <uniprot-id>P22234</uniprot-id>
        <uniprot-id>P30566</uniprot-id>
        <uniprot-id>P31939</uniprot-id>
        <uniprot-id>Q9BY32</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>P20839</uniprot-id>
        <uniprot-id>P36959</uniprot-id>
        <uniprot-id>P47989</uniprot-id>
        <uniprot-id>P30520</uniprot-id>
        <uniprot-id>P23109</uniprot-id>
        <uniprot-id>P00813</uniprot-id>
        <uniprot-id>P00568</uniprot-id>
        <uniprot-id>Q8NBU5</uniprot-id>
        <uniprot-id>Q08499</uniprot-id>
        <uniprot-id>Q96PN6</uniprot-id>
        <uniprot-id>P33402</uniprot-id>
        <uniprot-id>Q02153</uniprot-id>
        <uniprot-id>Q9Y233</uniprot-id>
        <uniprot-id>P10599</uniprot-id>
        <uniprot-id>P23921</uniprot-id>
        <uniprot-id>P31350</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000720</smpdb-id>
      <name>27-Hydroxylase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01956</drugbank-id>
          <name>Taurine</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02659</drugbank-id>
          <name>Cholic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03796</drugbank-id>
          <name>Palmitic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04348</drugbank-id>
          <name>Taurocholic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04540</drugbank-id>
          <name>Cholesterol</name>
        </drug>
        <drug>
          <drugbank-id>DB06777</drugbank-id>
          <name>Chenodeoxycholic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB08833</drugbank-id>
          <name>Taurochenodeoxycholic acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17516</uniprot-id>
        <uniprot-id>P51857</uniprot-id>
        <uniprot-id>Q02318</uniprot-id>
        <uniprot-id>Q9Y2P5</uniprot-id>
        <uniprot-id>Q9UHK6</uniprot-id>
        <uniprot-id>Q99424</uniprot-id>
        <uniprot-id>P51659</uniprot-id>
        <uniprot-id>P22307</uniprot-id>
        <uniprot-id>Q14032</uniprot-id>
        <uniprot-id>Q9H2F3</uniprot-id>
        <uniprot-id>Q9UNU6</uniprot-id>
        <uniprot-id>P22680</uniprot-id>
        <uniprot-id>P38571</uniprot-id>
        <uniprot-id>Q9Y6A2</uniprot-id>
        <uniprot-id>Q9NYL5</uniprot-id>
        <uniprot-id>O75881</uniprot-id>
        <uniprot-id>O95992</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0002313</smpdb-id>
      <name>Sarcosine Oncometabolite Pathway</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04401</drugbank-id>
          <name>Betaine aldehyde</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q8WWI5</uniprot-id>
        <uniprot-id>Q8IWA5</uniprot-id>
        <uniprot-id>Q8NE62</uniprot-id>
        <uniprot-id>P49419</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>Q99707</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
        <uniprot-id>Q14749</uniprot-id>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>Q9UI17</uniprot-id>
        <uniprot-id>Q9UL12</uniprot-id>
        <uniprot-id>P34897</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000033</smpdb-id>
      <name>Methionine Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01917</drugbank-id>
          <name>Putrescine</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02238</drugbank-id>
          <name>4-methylthio-2-oxobutanoic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03566</drugbank-id>
          <name>Spermidine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04193</drugbank-id>
          <name>L-Homoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P42898</uniprot-id>
        <uniprot-id>Q99707</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>P26358</uniprot-id>
        <uniprot-id>P17707</uniprot-id>
        <uniprot-id>P19623</uniprot-id>
        <uniprot-id>Q13126</uniprot-id>
        <uniprot-id>P23526</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P56192</uniprot-id>
        <uniprot-id>Q96DP5</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
        <uniprot-id>Q8NE62</uniprot-id>
        <uniprot-id>Q8IXL7</uniprot-id>
        <uniprot-id>Q9Y3D2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000035</smpdb-id>
      <name>Bile Acid Biosynthesis</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01956</drugbank-id>
          <name>Taurine</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02659</drugbank-id>
          <name>Cholic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03796</drugbank-id>
          <name>Palmitic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04348</drugbank-id>
          <name>Taurocholic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04540</drugbank-id>
          <name>Cholesterol</name>
        </drug>
        <drug>
          <drugbank-id>DB06777</drugbank-id>
          <name>Chenodeoxycholic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB08833</drugbank-id>
          <name>Taurochenodeoxycholic acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17516</uniprot-id>
        <uniprot-id>P51857</uniprot-id>
        <uniprot-id>Q02318</uniprot-id>
        <uniprot-id>Q9Y2P5</uniprot-id>
        <uniprot-id>Q9UHK6</uniprot-id>
        <uniprot-id>Q99424</uniprot-id>
        <uniprot-id>P51659</uniprot-id>
        <uniprot-id>P22307</uniprot-id>
        <uniprot-id>Q14032</uniprot-id>
        <uniprot-id>Q9H2F3</uniprot-id>
        <uniprot-id>Q9UNU6</uniprot-id>
        <uniprot-id>P22680</uniprot-id>
        <uniprot-id>P38571</uniprot-id>
        <uniprot-id>Q9Y6A2</uniprot-id>
        <uniprot-id>Q9NYL5</uniprot-id>
        <uniprot-id>O75881</uniprot-id>
        <uniprot-id>O95992</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000136</smpdb-id>
      <name>2-Hydroxyglutric Aciduria (D and L Form)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>5-O-phosphono-alpha-D-ribofuranosyl diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02530</drugbank-id>
          <name>gamma-Aminobutyric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>A8YXX4</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>P27708</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>Q6IA69</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>Q5JPH6</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q99259</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P51649</uniprot-id>
        <uniprot-id>P47897</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000144</smpdb-id>
      <name>Adenosine Deaminase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00173</drugbank-id>
          <name>Adenine</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>5-O-phosphono-alpha-D-ribofuranosyl diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB01700</drugbank-id>
          <name>AICA ribonucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02134</drugbank-id>
          <name>Xanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB02377</drugbank-id>
          <name>Guanine</name>
        </drug>
        <drug>
          <drugbank-id>DB02527</drugbank-id>
          <name>Cyclic adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02857</drugbank-id>
          <name>Guanosine</name>
        </drug>
        <drug>
          <drugbank-id>DB03101</drugbank-id>
          <name>Ribose-1-Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04076</drugbank-id>
          <name>Hypoxanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04335</drugbank-id>
          <name>Inosine</name>
        </drug>
        <drug>
          <drugbank-id>DB04457</drugbank-id>
          <name>2'-Deoxyguanosine-5'-Monophosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P50583</uniprot-id>
        <uniprot-id>O75414</uniprot-id>
        <uniprot-id>O75356</uniprot-id>
        <uniprot-id>Q5MY95</uniprot-id>
        <uniprot-id>Q16774</uniprot-id>
        <uniprot-id>P49902</uniprot-id>
        <uniprot-id>Q16854</uniprot-id>
        <uniprot-id>P07741</uniprot-id>
        <uniprot-id>P00491</uniprot-id>
        <uniprot-id>P00492</uniprot-id>
        <uniprot-id>Q9Y2T3</uniprot-id>
        <uniprot-id>Q9UKK9</uniprot-id>
        <uniprot-id>P21108</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P22102</uniprot-id>
        <uniprot-id>O15067</uniprot-id>
        <uniprot-id>P22234</uniprot-id>
        <uniprot-id>P30566</uniprot-id>
        <uniprot-id>P31939</uniprot-id>
        <uniprot-id>Q9BY32</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>P20839</uniprot-id>
        <uniprot-id>P36959</uniprot-id>
        <uniprot-id>P47989</uniprot-id>
        <uniprot-id>P30520</uniprot-id>
        <uniprot-id>P23109</uniprot-id>
        <uniprot-id>P00813</uniprot-id>
        <uniprot-id>P00568</uniprot-id>
        <uniprot-id>Q8NBU5</uniprot-id>
        <uniprot-id>Q08499</uniprot-id>
        <uniprot-id>Q96PN6</uniprot-id>
        <uniprot-id>P33402</uniprot-id>
        <uniprot-id>Q02153</uniprot-id>
        <uniprot-id>Q9Y233</uniprot-id>
        <uniprot-id>P10599</uniprot-id>
        <uniprot-id>P23921</uniprot-id>
        <uniprot-id>P31350</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000168</smpdb-id>
      <name>AICA-Ribosiduria</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00173</drugbank-id>
          <name>Adenine</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>5-O-phosphono-alpha-D-ribofuranosyl diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB01700</drugbank-id>
          <name>AICA ribonucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02134</drugbank-id>
          <name>Xanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB02377</drugbank-id>
          <name>Guanine</name>
        </drug>
        <drug>
          <drugbank-id>DB02527</drugbank-id>
          <name>Cyclic adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02857</drugbank-id>
          <name>Guanosine</name>
        </drug>
        <drug>
          <drugbank-id>DB03101</drugbank-id>
          <name>Ribose-1-Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04076</drugbank-id>
          <name>Hypoxanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04335</drugbank-id>
          <name>Inosine</name>
        </drug>
        <drug>
          <drugbank-id>DB04457</drugbank-id>
          <name>2'-Deoxyguanosine-5'-Monophosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P50583</uniprot-id>
        <uniprot-id>O75414</uniprot-id>
        <uniprot-id>O75356</uniprot-id>
        <uniprot-id>Q5MY95</uniprot-id>
        <uniprot-id>Q16774</uniprot-id>
        <uniprot-id>P49902</uniprot-id>
        <uniprot-id>Q16854</uniprot-id>
        <uniprot-id>P07741</uniprot-id>
        <uniprot-id>P00491</uniprot-id>
        <uniprot-id>P00492</uniprot-id>
        <uniprot-id>Q9Y2T3</uniprot-id>
        <uniprot-id>Q9UKK9</uniprot-id>
        <uniprot-id>P21108</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P22102</uniprot-id>
        <uniprot-id>O15067</uniprot-id>
        <uniprot-id>P22234</uniprot-id>
        <uniprot-id>P30566</uniprot-id>
        <uniprot-id>P31939</uniprot-id>
        <uniprot-id>Q9BY32</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>P20839</uniprot-id>
        <uniprot-id>P36959</uniprot-id>
        <uniprot-id>P47989</uniprot-id>
        <uniprot-id>P30520</uniprot-id>
        <uniprot-id>P23109</uniprot-id>
        <uniprot-id>P00813</uniprot-id>
        <uniprot-id>P00568</uniprot-id>
        <uniprot-id>Q8NBU5</uniprot-id>
        <uniprot-id>Q08499</uniprot-id>
        <uniprot-id>Q96PN6</uniprot-id>
        <uniprot-id>P33402</uniprot-id>
        <uniprot-id>Q02153</uniprot-id>
        <uniprot-id>Q9Y233</uniprot-id>
        <uniprot-id>P10599</uniprot-id>
        <uniprot-id>P23921</uniprot-id>
        <uniprot-id>P31350</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000183</smpdb-id>
      <name>gamma-Glutamyltransferase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB03088</drugbank-id>
          <name>Pidolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04701</drugbank-id>
          <name>S-Methyl glutathione</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q9H4Y5</uniprot-id>
        <uniprot-id>Q6P531</uniprot-id>
        <uniprot-id>P15144</uniprot-id>
        <uniprot-id>P55210</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>O14841</uniprot-id>
        <uniprot-id>O75223</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000203</smpdb-id>
      <name>Molybdenum Cofactor Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00173</drugbank-id>
          <name>Adenine</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>5-O-phosphono-alpha-D-ribofuranosyl diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB01700</drugbank-id>
          <name>AICA ribonucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02134</drugbank-id>
          <name>Xanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB02377</drugbank-id>
          <name>Guanine</name>
        </drug>
        <drug>
          <drugbank-id>DB02527</drugbank-id>
          <name>Cyclic adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02857</drugbank-id>
          <name>Guanosine</name>
        </drug>
        <drug>
          <drugbank-id>DB03101</drugbank-id>
          <name>Ribose-1-Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04076</drugbank-id>
          <name>Hypoxanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04335</drugbank-id>
          <name>Inosine</name>
        </drug>
        <drug>
          <drugbank-id>DB04457</drugbank-id>
          <name>2'-Deoxyguanosine-5'-Monophosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P50583</uniprot-id>
        <uniprot-id>O75414</uniprot-id>
        <uniprot-id>O75356</uniprot-id>
        <uniprot-id>Q5MY95</uniprot-id>
        <uniprot-id>Q16774</uniprot-id>
        <uniprot-id>P49902</uniprot-id>
        <uniprot-id>Q16854</uniprot-id>
        <uniprot-id>P07741</uniprot-id>
        <uniprot-id>P00491</uniprot-id>
        <uniprot-id>P00492</uniprot-id>
        <uniprot-id>Q9Y2T3</uniprot-id>
        <uniprot-id>Q9UKK9</uniprot-id>
        <uniprot-id>P21108</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P22102</uniprot-id>
        <uniprot-id>O15067</uniprot-id>
        <uniprot-id>P22234</uniprot-id>
        <uniprot-id>P30566</uniprot-id>
        <uniprot-id>P31939</uniprot-id>
        <uniprot-id>Q9BY32</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>P20839</uniprot-id>
        <uniprot-id>P36959</uniprot-id>
        <uniprot-id>P47989</uniprot-id>
        <uniprot-id>P30520</uniprot-id>
        <uniprot-id>P23109</uniprot-id>
        <uniprot-id>P00813</uniprot-id>
        <uniprot-id>P00568</uniprot-id>
        <uniprot-id>Q8NBU5</uniprot-id>
        <uniprot-id>Q08499</uniprot-id>
        <uniprot-id>Q96PN6</uniprot-id>
        <uniprot-id>P33402</uniprot-id>
        <uniprot-id>Q02153</uniprot-id>
        <uniprot-id>Q9Y233</uniprot-id>
        <uniprot-id>P10599</uniprot-id>
        <uniprot-id>P23921</uniprot-id>
        <uniprot-id>P31350</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000207</smpdb-id>
      <name>Prolidase Deficiency (PD)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03144</drugbank-id>
          <name>N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Flavin mononucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
  </pathways>
  <reactions>
    <reaction>
      <sequence>1</sequence>
      <left-element>
        <drugbank-id>DB00145</drugbank-id>
        <name>Glycine</name>
      </left-element>
      <right-element>
        <drugbank-id>DB01828</drugbank-id>
        <name>Methylamine</name>
      </right-element>
      <enzymes>
        <enzyme>
          <drugbank-id>BE0000618</drugbank-id>
          <name>Glycine dehydrogenase [decarboxylating], mitochondrial</name>
          <uniprot-id>P23378</uniprot-id>
        </enzyme>
        <enzyme>
          <drugbank-id>BE0002302</drugbank-id>
          <name>Glycine cleavage system H protein, mitochondrial</name>
          <uniprot-id>P23434</uniprot-id>
        </enzyme>
      </enzymes>
    </reaction>
    <reaction>
      <sequence>2</sequence>
      <left-element>
        <drugbank-id>DB01828</drugbank-id>
        <name>Methylamine</name>
      </left-element>
      <right-element>
        <drugbank-id>DBMET03082</drugbank-id>
        <name>Dihydrolipoamide</name>
      </right-element>
      <enzymes>
        <enzyme>
          <drugbank-id>BE0000010</drugbank-id>
          <name>Aminomethyltransferase, mitochondrial</name>
          <uniprot-id>P48728</uniprot-id>
        </enzyme>
        <enzyme>
          <drugbank-id>BE0002302</drugbank-id>
          <name>Glycine cleavage system H protein, mitochondrial</name>
          <uniprot-id>P23434</uniprot-id>
        </enzyme>
      </enzymes>
    </reaction>
    <reaction>
      <sequence>3</sequence>
      <left-element>
        <drugbank-id>DBMET03082</drugbank-id>
        <name>Dihydrolipoamide</name>
      </left-element>
      <right-element>
        <drugbank-id>DB00166</drugbank-id>
        <name>Lipoic acid</name>
      </right-element>
      <enzymes>
        <enzyme>
          <drugbank-id>BE0000737</drugbank-id>
          <name>Dihydrolipoyl dehydrogenase, mitochondrial</name>
          <uniprot-id>P09622</uniprot-id>
        </enzyme>
        <enzyme>
          <drugbank-id>BE0002302</drugbank-id>
          <name>Glycine cleavage system H protein, mitochondrial</name>
          <uniprot-id>P23434</uniprot-id>
        </enzyme>
      </enzymes>
    </reaction>
  </reactions>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target position="1">
      <id>BE0000518</id>
      <name>2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A13818</ref-id>
            <pubmed-id>17146529</pubmed-id>
            <citation>Bashir Q, Rashid N, Akhtar M: Mechanism and substrate stereochemistry of 2-amino-3-oxobutyrate CoA ligase: implications for 5-aminolevulinate synthase and related enzymes. Chem Commun (Camb). 2006 Dec 28;(48):5065-7. Epub 2006 Oct 13.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O75600" source="Swiss-Prot">
        <name>2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial</name>
        <general-function>Pyridoxal phosphate binding</general-function>
        <specific-function/>
        <gene-name>GCAT</gene-name>
        <locus>22q13.1</locus>
        <cellular-location>Mitochondrion</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>8.11</theoretical-pi>
        <molecular-weight>45284.6</molecular-weight>
        <chromosome-location>22</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:4188</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GCAT</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF077740</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>3342906</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>O75600</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>KBL_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.3.1.29</synonym>
          <synonym>AKB ligase</synonym>
          <synonym>Aminoacetone synthase</synonym>
          <synonym>Glycine acetyltransferase</synonym>
          <synonym>KBL</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001034|2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial
MWPGNAWRAALFWVPRGRRAQSALAQLRGILEGELEGIRGAGTWKSERVITSRQGPHIRV
DGVSGGILNFCANNYLGLSSHPEVIQAGLQALEEFGAGLSSVRFICGTQSIHKNLEAKIA
RFHQREDAILYPSCYDANAGLFEALLTPEDAVLSDELNHASIIDGIRLCKAHKYRYRHLD
MADLEAKLQEAQKHRLRLVATDGAFSMDGDIAPLQEICCLASRYGALVFMDECHATGFLG
PTGRGTDELLGVMDQVTIINSTLGKALGGASGGYTTGPGPLVSLLRQRARPYLFSNSLPP
AVVGCASKALDLLMGSNTIVQSMAAKTQRFRSKMEAAGFTISGASHPICPVMLGDARLAS
RMADDMLKRGIFVIGFSYPVVPKGKARIRVQISAVHSEEDIDRCVEAFVEVGRLHGALP</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010365|2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial (GCAT)
ATGTGGCCTGGGAACGCCTGGCGCGCCGCACTCTTCTGGGTGCCCCGCGGCCGCCGCGCA
CAGTCAGCGCTGGCCCAGCTGCGTGGCATTCTGGAGGGGGAGCTGGAAGGCATCCGCGGA
GCTGGCACTTGGAAGAGTGAGCGGGTCATCACGTCCCGTCAGGGGCCGCACATCCGCGTG
GACGGCGTCTCCGGAGGGCCTGGCACTGTCATCTTTCCAGGCCTGCCCTTGCCCCACCTG
AGCTGCTGTATCCATCTCCTCTCCTTCACCTCAGGAATCCTTAACTTCTGTGCCAACAAC
TACCTGGGCCTGAGCAGCCACCCTGAGGTGATCCAGGCAGGTCTGCAGGCTCTGGAGGAG
TTTGGAGCTGGCCTCAGCTCTGTCCGCTTTATCTGTGGAACCCAGAGCATCCACAAGAAT
CTAGAAGCAAAAATAGCCCGCTTCCACCAGCGGGAGGATGCCATCCTCTATCCCAGCTGT
TATGACGCCAACGCCGGCCTCTTTGAGGCCCTGCTGACCCCAGAGGACGCAGTCCTGTCG
GACGAGCTGAACCATGCCTCCATCATCGACGGCATCCGGCTGTGCAAGGCCCACAAGTAC
CGCTATCGCCACCTGGACATGGCCGACCTAGAAGCCAAGCTGCAGGAGGCCCAGAAGCAT
CGGCTGCGCCTGGTGGCCACTGATGGGGCCTTTTCCATGGATGGCGACATCGCACCCCTG
CAGGAGATCTGCTGCCTCGCCTCTAGATATGGTGCCCTGGTCTTCATGGATGAATGCCAT
GCCACTGGCTTCCTGGGGCCCACAGGACGGGGCACAGATGAGCTGCTGGGTGTGATGGAC
CAGGTCACCATCATCAACTCCACCCTGGGGAAGGCCCTGGGTGGAGCATCAGGGGGCTAC
ACGACAGGGCCTGGGCCCCTGGTGTCCCTGCTGCGGCAGCGCGCCCGGCCATACCTCTTC
TCCAACAGTCTGCCACCTGCTGTCGTTGGCTGCGCCTCCAAGGCCCTAGATCTGCTGATG
GGGAGTAACACCATTGTCCAGTCTATGGCTGCCAAGACCCAGAGGTTCCGTAGTAAGATG
GAAGCTGCTGGCTTCACTATCTCGGGAGCCAGTCACCCCATCTGCCCTGTGATGCTGGGT
GATGCCCGGCTGGCCTCTCGCATGGCGGATGACATGCTGAAGAGAGGCATCTTTGTCATC
GGGTTCAGCTACCCCGTGGTCCCCAAGGGCAAGGCCCGGATCCGGGTACAGATCTCAGCA
GTGCATAGCGAGGAAGACATTGACCGCTGCGTGGAGGCCTTCGTGGAAGTGGGGCGACTG
CACGGGGCACTGCCCTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00155</identifier>
            <name>Aminotran_1_2</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine C-acetyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>pyridoxal phosphate binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular amino acid metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>L-threonine catabolic process to glycine</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="2">
      <id>BE0000409</id>
      <name>5-aminolevulinate synthase, nonspecific, mitochondrial</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A13358</ref-id>
            <pubmed-id>17469798</pubmed-id>
            <citation>Turbeville TD, Zhang J, Hunter GA, Ferreira GC: Histidine 282 in 5-aminolevulinate synthase affects substrate binding and catalysis. Biochemistry. 2007 May 22;46(20):5972-81. Epub 2007 May 1.</citation>
          </article>
          <article>
            <ref-id>A13819</ref-id>
            <pubmed-id>17578005</pubmed-id>
            <citation>He XM, Zhou J, Cheng Y, Fan J: [Purification and production of the extracellular 5-aminolevulinate from recombiniant Escherichia coli expressing yeast ALAS]. Sheng Wu Gong Cheng Xue Bao. 2007 May;23(3):520-4.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P13196" source="Swiss-Prot">
        <name>5-aminolevulinate synthase, nonspecific, mitochondrial</name>
        <general-function>Pyridoxal phosphate binding</general-function>
        <specific-function/>
        <gene-name>ALAS1</gene-name>
        <locus>3p21.1</locus>
        <cellular-location>Mitochondrion matrix</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>8.57</theoretical-pi>
        <molecular-weight>70580.325</molecular-weight>
        <chromosome-location>3</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:396</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>ALAS1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>X56351</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>28583</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P13196</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>HEM1_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.3.1.37</synonym>
          <synonym>5-aminolevulinic acid synthase 1</synonym>
          <synonym>ALAS-H</synonym>
          <synonym>ALAS3</synonym>
          <synonym>ALASH</synonym>
          <synonym>Delta-ALA synthase 1</synonym>
          <synonym>Delta-aminolevulinate synthase 1</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000815|5-aminolevulinate synthase, nonspecific, mitochondrial
MESVVRRCPFLSRVPQAFLQKAGKSLLFYAQNCPKMMEVGAKPAPRALSTAAVHYQQIKE
TPPASEKDKTAKAKVQQTPDGSQQSPDGTQLPSGHPLPATSQGTASKCPFLAAQMNQRGS
SVFCKASLELQEDVQEMNAVRKEVAETSAGPSVVSVKTDGGDPSGLLKNFQDIMQKQRPE
RVSHLLQDNLPKSVSTFQYDRFFEKKIDEKKNDHTYRVFKTVNRRAHIFPMADDYSDSLI
TKKQVSVWCSNDYLGMSRHPRVCGAVMDTLKQHGAGAGGTRNISGTSKFHVDLERELADL
HGKDAALLFSSCFVANDSTLFTLAKMMPGCEIYSDSGNHASMIQGIRNSRVPKYIFRHND
VSHLRELLQRSDPSVPKIVAFETVHSMDGAVCPLEELCDVAHEFGAITFVDEVHAVGLYG
ARGGGIGDRDGVMPKMDIISGTLGKAFGCVGGYIASTSSLIDTVRSYAAGFIFTTSLPPM
LLAGALESVRILKSAEGRVLRRQHQRNVKLMRQMLMDAGLPVVHCPSHIIPVRVADAAKN
TEVCDELMSRHNIYVQAINYPTVPRGEELLRIAPTPHHTPQMMNYFLENLLVTWKQVGLE
LKPHSSAECNFCRRPLHFEVMSEREKSYFSGLSKLVSAQA</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0018948|5-aminolevulinate synthase, nonspecific, mitochondrial (ALAS1)
ATGGAGAGTGTTGTTCGCCGCTGCCCATTCTTATCCCGAGTCCCCCAGGCCTTTCTGCAG
AAAGCAGGCAAATCTCTGTTGTTCTATGCCCAAAACTGCCCCAAGATGATGGAAGTTGGG
GCCAAGCCAGCCCCTCGGGCATTGTCCACTGCAGCAGTACACTACCAACAGATCAAAGAA
ACCCCTCCGGCCAGTGAGAAAGACAAAACTGCTAAGGCCAAGGTCCAACAGACTCCTGAT
GGATCCCAGCAGAGTCCAGATGGCACACAGCTTCCGTCTGGACACCCCTTGCCTGCCACA
AGCCAGGGCACTGCAAGCAAATGCCCTTTCCTGGCAGCACAGATGAATCAGAGAGGCAGC
AGTGTCTTCTGCAAAGCCAGTCTTGAGCTTCAGGAGGATGTGCAGGAAATGAATGCCGTG
AGGAAAGAGGTTGCTGAAACCTCAGCAGGCCCCAGTGTGGTTAGTGTGAAAACCGATGGA
GGGGATCCCAGTGGACTGCTGAAGAACTTCCAGGACATCATGCAAAAGCAAAGACCAGAA
AGAGTGTCTCATCTTCTTCAAGATAACTTGCCAAAATCTGTTTCCACTTTTCAGTATGAT
CGTTTCTTTGAGAAAAAAATTGATGAGAAAAAGAATGACCACACCTATCGAGTTTTTAAA
ACTGTGAACCGGCGAGCACACATCTTCCCCATGGCAGATGACTATTCAGACTCCCTCATC
ACCAAAAAGCAAGTGTCAGTCTGGTGCAGTAATGACTACCTAGGAATGAGTCGCCACCCA
CGGGTGTGTGGGGCAGTTATGGACACTTTGAAACAACATGGTGCTGGGGCAGGTGGTACT
AGAAATATTTCTGGAACTAGTAAATTCCATGTGGACTTAGAGCGGGAGCTGGCAGACCTC
CATGGGAAAGATGCCGCACTCTTGTTTTCCTCGTGCTTTGTGGCCAATGACTCAACCCTC
TTCACCCTGGCTAAGATGATGCCAGGCTGTGAGATTTACTCTGATTCTGGGAACCATGCC
TCCATGATCCAAGGGATTCGAAACAGCCGAGTGCCAAAGTACATCTTCCGCCACAATGAT
GTCAGCCACCTCAGAGAACTGCTGCAAAGATCTGACCCCTCAGTCCCCAAGATTGTGGCA
TTTGAAACTGTCCATTCAATGGATGGGGCGGTGTGCCCACTGGAAGAGCTGTGTGATGTG
GCCCATGAGTTTGGAGCAATCACCTTCGTGGATGAGGTCCACGCAGTGGGGCTTTATGGG
GCTCGAGGCGGAGGGATTGGGGATCGGGATGGAGTCATGCCAAAAATGGACATCATTTCT
GGAACACTTGGCAAAGCCTTTGGTTGTGTTGGAGGGTACATCGCCAGCACGAGTTCTCTG
ATTGACACCGTACGGTCCTATGCTGCTGGCTTCATCTTCACCACCTCTCTGCCACCCATG
CTGCTGGCTGGAGCCCTGGAGTCTGTGCGGATCCTGAAGAGCGCTGAGGGACGGGTGCTT
CGCCGCCAGCACCAGCGCAACGTCAAACTCATGAGACAGATGCTAATGGATGCCGGCCTC
CCTGTTGTCCACTGCCCCAGCCACATCATCCCTGTGCGGGTTGCAGATGCTGCTAAAAAC
ACAGAAGTCTGTGATGAACTAATGAGCAGACATAACATCTACGTGCAAGCAATCAATTAC
CCTACGGTGCCCCGGGGAGAAGAGCTCCTACGGATTGCCCCCACCCCTCACCACACACCC
CAGATGATGAACTACTTCCTTGAGAATCTGCTAGTCACATGGAAGCAAGTGGGGCTGGAA
CTGAAGCCTCATTCCTCAGCTGAGTGCAACTTCTGCAGGAGGCCACTGCATTTTGAAGTG
ATGAGTGAAAGAGAGAAGTCCTATTTCTCAGGCTTGAGCAAGTTGGTATCTGCTCAGGCC
TGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00155</identifier>
            <name>Aminotran_1_2</name>
          </pfam>
          <pfam>
            <identifier>PF09029</identifier>
            <name>Preseq_ALAS</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial matrix</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>5-aminolevulinate synthase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>pyridoxal phosphate binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular lipid metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>heme biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>mitochondrion organization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>organelle organization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>porphyrin-containing compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protoporphyrinogen IX biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="3">
      <id>BE0000898</id>
      <name>5-aminolevulinate synthase, erythroid-specific, mitochondrial</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A13820</ref-id>
            <pubmed-id>7883699</pubmed-id>
            <citation>Hungerer C, Troup B, Romling U, Jahn D: Regulation of the hemA gene during 5-aminolevulinic acid formation in Pseudomonas aeruginosa. J Bacteriol. 1995 Mar;177(6):1435-43.</citation>
          </article>
          <article>
            <ref-id>A9628</ref-id>
            <pubmed-id>12686158</pubmed-id>
            <citation>Shoolingin-Jordan PM, Al-Daihan S, Alexeev D, Baxter RL, Bottomley SS, Kahari ID, Roy I, Sarwar M, Sawyer L, Wang SF: 5-Aminolevulinic acid synthase: mechanism, mutations and medicine. Biochim Biophys Acta. 2003 Apr 11;1647(1-2):361-6.</citation>
          </article>
          <article>
            <ref-id>A13821</ref-id>
            <pubmed-id>8407861</pubmed-id>
            <citation>Munakata H, Yamagami T, Nagai T, Yamamoto M, Hayashi N: Purification and structure of rat erythroid-specific delta-aminolevulinate synthase. J Biochem. 1993 Jul;114(1):103-11.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P22557" source="Swiss-Prot">
        <name>5-aminolevulinate synthase, erythroid-specific, mitochondrial</name>
        <general-function>Pyridoxal phosphate binding</general-function>
        <specific-function/>
        <gene-name>ALAS2</gene-name>
        <locus>Xp11.21</locus>
        <cellular-location>Mitochondrion matrix</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>8.19</theoretical-pi>
        <molecular-weight>64632.86</molecular-weight>
        <chromosome-location>X</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:397</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>ALAS2</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>X56352</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>28586</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P22557</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>HEM0_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.3.1.37</synonym>
          <synonym>5-aminolevulinic acid synthase 2</synonym>
          <synonym>ALAS-E</synonym>
          <synonym>ALASE</synonym>
          <synonym>ASB</synonym>
          <synonym>Delta-ALA synthase 2</synonym>
          <synonym>Delta-aminolevulinate synthase 2</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001789|5-aminolevulinate synthase, erythroid-specific, mitochondrial
MVTAAMLLQCCPVLARGPTSLLGKVVKTHQFLFGIGRCPILATQGPNCSQIHLKATKAGG
DSPSWAKGHCPFMLSELQDGKSKIVQKAAPEVQEDVKAFKTDLPSSLVSVSLRKPFSGPQ
EQEQISGKVTHLIQNNMPGNYVFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQH
FSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGAGAGGTRNISGTSKFHVELE
QELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKF
VFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVH
AVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFT
TSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRV
GNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAW
TAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0016244|5-aminolevulinate synthase, erythroid-specific, mitochondrial (ALAS2)
ATGGTGACTGCAGCCATGCTGCTACAGTGCTGCCCAGTGCTTGCCCGGGGCCCCACAAGC
CTCCTAGGCAAGGTGGTTAAGACTCACCAGTTCCTGTTTGGTATTGGACGCTGTCCCATC
CTGGCTACCCAAGGACCAAACTGTTCTCAAATCCACCTTAAGGCAACAAAGGCTGGAGGA
GATTCTCCATCTTGGGCGAAGGGCCACTGTCCCTTCATGCTGTCGGAACTCCAGGATGGG
AAGAGCAAGATTGTGCAGAAGGCAGCCCCAGAAGTCCAGGAAGATGTGAAGGCTTTCAAG
ACAGATCTGCCTAGCTCCCTGGTCTCAGTCAGCCTAAGGAAGCCATTTTCCGGTCCCCAG
GAGCAGGAGCAGATCTCTGGGAAGGTCACACACCTGATTCAGAACAATATGCCTGGAAAC
TATGTCTTCAGTTATGACCAGTTTTTCAGGGACAAGATCATGGAGAAGAAACAGGATCAC
ACCTACCGTGTGTTCAAGACTGTGAACCGCTGGGCTGATGCATATCCCTTTGCCCAACAT
TTCTCTGAGGCATCTGTGGCCTCAAAGGATGTGTCCGTCTGGTGTAGTAATGATTACCTG
GGCATGAGCCGACACCCTCAGGTCTTGCAAGCCACACAGGAGACCCTGCAGCGTCATGGT
GCTGGAGCTGGTGGCACCCGCAACATCTCAGGCACCAGTAAGTTTCATGTGGAGCTTGAG
CAGGAGCTGGCTGAGCTGCACCAGAAGGACTCAGCCCTGCTCTTCTCCTCCTGCTTTGTT
GCCAATGACTCTACTCTCTTCACCTTGGCCAAGATCCTGCCAGGGTGCGAGATTTACTCA
GACGCAGGCAACCATGCTTCCATGATCCAAGGTATCCGTAACAGTGGAGCAGCCAAGTTT
GTCTTCAGGCACAATGACCCTGACCACCTAAAGAAACTTCTAGAGAAGTCTAACCCTAAG
ATACCCAAAATTGTGGCCTTTGAGACTGTCCACTCCATGGATGGTGCCATCTGTCCCCTC
GAGGAGTTGTGTGATGTGTCCCACCAGTATGGGGCCCTGACCTTCGTGGATGAGGTCCAT
GCTGTAGGACTGTATGGGTCCCGGGGCGCTGGGATTGGGGAGCGTGATGGAATTATGCAT
AAGATTGACATCATCTCTGGAACTCTTGGCAAGGCCTTTGGCTGTGTGGGCGGCTACATT
GCCAGCACCCGTGACTTGGTGGACATGGTGCGCTCCTATGCTGCAGGCTTCATCTTTACC
ACTTCTCTGCCCCCCATGGTGCTCTCTGGAGCTCTAGAATCTGTGCGGCTGCTCAAGGGA
GAGGAGGGCCAAGCCCTGAGGCGAGCCCACCAGCGCAATGTCAAGCACATGCGCCAGCTA
CTCATGGACAGGGGCCTTCCTGTCATCCCCTGCCCCAGCCACATCATCCCCATCCGGGTG
GGCAATGCAGCACTCAACAGCAAGCTCTGTGATCTCCTGCTCTCCAAGCATGGCATCTAT
GTGCAGGCCATCAACTACCCAACTGTCCCCCGGGGTGAAGAGCTCCTGCGCTTGGCACCC
TCCCCCCACCACAGCCCTCAGATGATGGAAGATTTTGTGGAGAAGCTGCTGCTGGCTTGG
ACTGCGGTGGGGCTGCCCCTCCAGGATGTGTCTGTGGCTGCCTGCAATTTCTGTCGCCGT
CCTGTACACTTTGAGCTCATGAGTGAGTGGGAACGTTCCTACTTCGGGAACATGGGGCCC
CAGTATGTCACCACCTATGCCTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00155</identifier>
            <name>Aminotran_1_2</name>
          </pfam>
          <pfam>
            <identifier>PF09029</identifier>
            <name>Preseq_ALAS</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial inner membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial matrix</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>5-aminolevulinate synthase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>coenzyme binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>pyridoxal phosphate binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular iron ion homeostasis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>erythrocyte differentiation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>heme biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>hemoglobin biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>oxygen homeostasis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>porphyrin-containing compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protoporphyrinogen IX biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to hypoxia</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="4">
      <id>BE0000998</id>
      <name>Glycine--tRNA ligase</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A13822</ref-id>
            <pubmed-id>17150752</pubmed-id>
            <citation>Okamoto K, Kuno A, Hasegawa T: Recognition sites of glycine tRNA for glycyl-tRNA synthetase from hyperthermophilic archaeon, Aeropyrum pernix K1. Nucleic Acids Symp Ser (Oxf). 2005;(49):299-300.</citation>
          </article>
          <article>
            <ref-id>A13823</ref-id>
            <pubmed-id>17433503</pubmed-id>
            <citation>Tsang SW, Vinters HV, Cummings JL, Wong PT, Chen CP, Lai MK: Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease. Neurobiol Aging. 2008 Oct;29(10):1524-32. Epub 2007 Apr 11.</citation>
          </article>
          <article>
            <ref-id>A13824</ref-id>
            <pubmed-id>16982409</pubmed-id>
            <citation>Scherer SS: Inherited neuropathies: new genes don't fit old models. Neuron. 2006 Sep 21;51(6):672-4.</citation>
          </article>
          <article>
            <ref-id>A13825</ref-id>
            <pubmed-id>17544401</pubmed-id>
            <citation>Cader MZ, Ren J, James PA, Bird LE, Talbot K, Stammers DK: Crystal structure of human wildtype and S581L-mutant glycyl-tRNA synthetase, an enzyme underlying distal spinal muscular atrophy. FEBS Lett. 2007 Jun 26;581(16):2959-64. Epub 2007 May 29.</citation>
          </article>
          <article>
            <ref-id>A13826</ref-id>
            <pubmed-id>17035524</pubmed-id>
            <citation>Antonellis A, Lee-Lin SQ, Wasterlain A, Leo P, Quezado M, Goldfarb LG, Myung K, Burgess S, Fischbeck KH, Green ED: Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons. J Neurosci. 2006 Oct 11;26(41):10397-406.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P41250" source="Swiss-Prot">
        <name>Glycine--tRNA ligase</name>
        <general-function>Protein dimerization activity</general-function>
        <specific-function>Catalyzes the attachment of glycine to tRNA(Gly). Is also able produce diadenosine tetraphosphate (Ap4A), a universal pleiotropic signaling molecule needed for cell regulation pathways, by direct condensation of 2 ATPs.</specific-function>
        <gene-name>GARS</gene-name>
        <locus>7p15</locus>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>7.04</theoretical-pi>
        <molecular-weight>83164.83</molecular-weight>
        <chromosome-location>7</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:4162</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GARS</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>D30658</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>1311463</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P41250</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>SYG_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>6.1.1.14</synonym>
          <synonym>AP-4-A synthetase</synonym>
          <synonym>Diadenosine tetraphosphate synthetase</synonym>
          <synonym>Glycyl-tRNA synthetase</synonym>
          <synonym>GlyRS</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037111|Glycine--tRNA ligase
MPSPRPVLLRGARAALLLLLPPRLLARPSLLLRRSLSAASCPPISLPAAASRSSMDGAGA
EEVLAPLRLAVRQQGDLVRKLKEDKAPQVDVDKAVAELKARKRVLEAKELALQPKDDIVD
RAKMEDTLKRRFFYDQAFAIYGGVSGLYDFGPVGCALKNNIIQTWRQHFIQEEQILEIDC
TMLTPEPVLKTSGHVDKFADFMVKDVKNGECFRADHLLKAHLQKLMSDKKCSVEKKSEME
SVLAQLDNYGQQELADLFVNYNVKSPITGNDLSPPVSFNLMFKTFIGPGGNMPGYLRPET
AQGIFLNFKRLLEFNQGKLPFAAAQIGNSFRNEISPRSGLIRVREFTMAEIEHFVDPSEK
DHPKFQNVADLHLYLYSAKAQVSGQSARKMRLGDAVEQGVINNTVLGYFIGRIYLYLTKV
GISPDKLRFRQHMENEMAHYACDCWDAESKTSYGWIEIVGCADRSCYDLSCHARATKVPL
VAEKPLKEPKTVNVVQFEPSKGAIGKAYKKDAKLVMEYLAICDECYITEMEMLLNEKGEF
TIETEGKTFQLTKDMINVKRFQKTLYVEEVVPNVIEPSFGLGRIMYTVFEHTFHVREGDE
QRTFFSFPAVVAPFKCSVLPLSQNQEFMPFVKELSEALTRHGVSHKVDDSSGSIGRRYAR
TDEIGVAFGVTIDFDTVNKTPHTATLRDRDSMRQIRAEISELPSIVQDLANGNITWADVE
ARYPLFEGQETGKKETIEE</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010698|Glycine--tRNA ligase (GARS)
ATGCCCTCTCCGCGTCCAGTGCTGCTTAGAGGTGCTCGCGCCGCTCTGCTGCTGCTGCTG
CCGCCCCGGCTCTTAGCCCGACCCTCGCTCCTGCTCCGCCGGTCCCTCAGCGCGGCCTCC
TGCCCCCCGATCTCCTTGCCCGCCGCCGCCTCCCGGAGCAGCATGGACGGCGCGGGGGCT
GAGGAGGTGCTGGCACCTCTGAGGCTAGCAGTGCGCCAGCAGGGAGATCTTGTGCGAAAA
CTCAAAGAAGATAAAGCACCCCAAGTAGACGTAGACAAAGCAGTGGCTGAGCTCAAAGCC
CGCAAGAGGGTTCTGGAAGCAAAGGAGCTGGCGTTACAGCCCAAAGATGATATTGTAGAC
CGAGCAAAAATGGAAGATACCCTGAAGAGGAGGTTTTTCTATGATCAAGCTTTTGCTATT
TATGGAGGTGTTAGTGGTCTGTATGACTTTGGGCCAGTTGGCTGTGCTTTGAAGAACAAT
ATTATTCAGACCTGGAGGCAGCACTTTATCCAAGAGGAACAGATCCTGGAGATCGATTGC
ACCATGCTCACCCCTGAGCCAGTTTTAAAGACCTCTGGCCATGTAGACAAATTTGCTGAC
TTCATGGTGAAAGACGTAAAAAATGGAGAATGTTTTCGTGCTGACCATCTATTAAAAGCT
CATTTACAGAAATTGATGTCTGATAAGAAGTGTTCTGTCGAAAAGAAATCAGAAATGGAA
AGTGTTTTGGCCCAGCTTGATAACTATGGACAGCAAGAACTTGCGGATCTTTTTGTGAAC
TATAATGTAAAATCTCCCATTACTGGAAATGATCTATCCCCTCCAGTGTCTTTTAACTTA
ATGTTCAAGACTTTCATTGGGCCTGGAGGAAACATGCCTGGGTACTTGAGACCAGAAACT
GCACAGGGGATTTTCTTGAATTTCAAACGACTTTTGGAGTTCAACCAAGGAAAGTTGCCT
TTTGCTGCTGCCCAGATTGGAAATTCTTTTAGAAATGAGATCTCCCCTCGATCTGGACTG
ATCAGAGTCAGAGAATTCACAATGGCAGAAATTGAGCACTTTGTAGATCCCAGTGAGAAA
GACCACCCCAAGTTCCAGAATGTGGCAGACCTTCACCTTTATTTGTATTCAGCAAAAGCC
CAGGTCAGCGGACAGTCCGCTCGGAAAATGCGCCTGGGAGATGCTGTTGAACAGGGTGTG
ATTAATAACACAGTATTAGGCTATTTCATTGGCCGCATCTACCTCTACCTCACGAAGGTT
GGAATATCTCCAGATAAACTCCGCTTCCGGCAGCACATGGAGAATGAGATGGCCCATTAT
GCCTGTGACTGTTGGGATGCAGAATCCAAAACATCCTACGGTTGGATTGAGATTGTTGGA
TGTGCTGATCGTTCCTGTTATGACCTCTCCTGTCATGCACGAGCCACCAAAGTCCCACTT
GTAGCTGAGAAACCTCTGAAAGAACCCAAAACAGTCAATGTTGTTCAGTTTGAACCCAGT
AAGGGAGCAATTGGTAAGGCATATAAGAAGGATGCAAAACTGGTGATGGAGTATCTTGCC
ATTTGTGATGAGTGCTACATTACAGAAATGGAGATGCTGCTGAATGAGAAAGGGGAATTC
ACAATTGAAACTGAAGGGAAAACATTTCAGTTAACAAAAGACATGATCAATGTGAAGAGA
TTCCAGAAAACACTATATGTGGAAGAAGTTGTTCCGAATGTAATTGAACCTTCCTTCGGC
CTGGGTAGGATCATGTATACGGTATTTGAACATACATTCCATGTACGAGAAGGAGATGAA
CAGAGAACATTCTTCAGTTTCCCTGCTGTAGTTGCTCCATTCAAATGTTCCGTCCTCCCA
CTGAGCCAAAACCAGGAGTTCATGCCATTTGTCAAGGAATTATCGGAAGCCCTGACCAGG
CATGGAGTATCTCACAAAGTAGACGATTCCTCTGGGTCAATCGGAAGGCGCTATGCCAGG
ACTGATGAGATTGGCGTGGCTTTTGGTGTCACCATTGACTTTGACACAGTGAACAAGACC
CCCCACACTGCAACTCTGAGGGACCGTGACTCAATGCGGCAGATAAGAGCAGAGATCTCT
GAGCTGCCCAGCATAGTCCAAGACCTAGCCAATGGCAACATCACATGGGCTGATGTGGAG
GCCAGGTATCCTCTGTTTGAAGGGCAAGAGACTGGTAAAAAAGAGACAATCGAGGAATGA
</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00587</identifier>
            <name>tRNA-synt_2b</name>
          </pfam>
          <pfam>
            <identifier>PF03129</identifier>
            <name>HGTP_anticodon</name>
          </pfam>
          <pfam>
            <identifier>PF00458</identifier>
            <name>WHEP-TRS</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>axon</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial matrix</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>secretory granule</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine-tRNA ligase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>protein dimerization activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>diadenosine tetraphosphate biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>gene expression</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycyl-tRNA aminoacylation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tRNA aminoacylation for protein translation</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="5">
      <id>BE0000760</id>
      <name>Glutamate receptor ionotropic, NMDA 2A</name>
      <organism>Humans</organism>
      <actions>
        <action>antagonist</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A13827</ref-id>
            <pubmed-id>17360906</pubmed-id>
            <citation>Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, Wu DC, Lu J, Tymianski M, Craig AM, Wang YT: NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci. 2007 Mar 14;27(11):2846-57.</citation>
          </article>
          <article>
            <ref-id>A13828</ref-id>
            <pubmed-id>17403555</pubmed-id>
            <citation>Domingues A, Almeida S, da Cruz e Silva EF, Oliveira CR, Rego AC: Toxicity of beta-amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-D-aspartate receptor subunits. Neurochem Int. 2007 May;50(6):872-80. Epub 2007 Mar 7.</citation>
          </article>
          <article>
            <ref-id>A13829</ref-id>
            <pubmed-id>17513636</pubmed-id>
            <citation>Brosnan RJ, Yang L, Milutinovic PS, Zhao J, Laster MJ, Eger EI 2nd, Sonner JM: Ammonia has anesthetic properties. Anesth Analg. 2007 Jun;104(6):1430-3, table of contents.</citation>
          </article>
          <article>
            <ref-id>A13830</ref-id>
            <pubmed-id>17646495</pubmed-id>
            <citation>Milutinovic PS, Yang L, Cantor RS, Eger EI 2nd, Sonner JM: Anesthetic-like modulation of a gamma-aminobutyric acid type A, strychnine-sensitive glycine, and N-methyl-d-aspartate receptors by coreleased neurotransmitters. Anesth Analg. 2007 Aug;105(2):386-92.</citation>
          </article>
          <article>
            <ref-id>A13831</ref-id>
            <pubmed-id>17405869</pubmed-id>
            <citation>Gabra BH, Kessler FK, Ritter JK, Dewey WL, Smith FL: Decrease in N-methyl-D-aspartic acid receptor-NR2B subunit levels by intrathecal short-hairpin RNA blocks group I metabotropic glutamate receptor-mediated hyperalgesia. J Pharmacol Exp Ther. 2007 Jul;322(1):186-94. Epub 2007 Apr 3.</citation>
          </article>
          <article>
            <ref-id>A9</ref-id>
            <pubmed-id>11752352</pubmed-id>
            <citation>Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q12879" source="Swiss-Prot">
        <name>Glutamate receptor ionotropic, NMDA 2A</name>
        <general-function>Zinc ion binding</general-function>
        <specific-function>NMDA receptor subtype of glutamate-gated ion channels possesses high calcium permeability and voltage-dependent sensitivity to magnesium. Activation requires binding of agonist to both types of subunits.</specific-function>
        <gene-name>GRIN2A</gene-name>
        <locus>16p13.2</locus>
        <cellular-location>Cell membrane</cellular-location>
        <transmembrane-regions>556-576
634-654
817-837</transmembrane-regions>
        <signal-regions>1-22</signal-regions>
        <theoretical-pi>7.11</theoretical-pi>
        <molecular-weight>165281.215</molecular-weight>
        <chromosome-location>16</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:4585</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GRIN2A</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>U09002</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>558749</identifier>
          </external-identifier>
          <external-identifier>
            <resource>IUPHAR</resource>
            <identifier>456</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>456</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q12879</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>NMDE1_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>GluN2A</synonym>
          <synonym>Glutamate [NMDA] receptor subunit epsilon-1</synonym>
          <synonym>hNR2A</synonym>
          <synonym>N-methyl D-aspartate receptor subtype 2A</synonym>
          <synonym>NMDAR2A</synonym>
          <synonym>NR2A</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001516|Glutamate receptor ionotropic, NMDA 2A
MGRVGYWTLLVLPALLVWRGPAPSAAAEKGPPALNIAVMLGHSHDVTERELRTLWGPEQA
AGLPLDVNVVALLMNRTDPKSLITHVCDLMSGARIHGLVFGDDTDQEAVAQMLDFISSHT
FVPILGIHGGASMIMADKDPTSTFFQFGASIQQQATVMLKIMQDYDWHVFSLVTTIFPGY
REFISFVKTTVDNSFVGWDMQNVITLDTSFEDAKTQVQLKKIHSSVILLYCSKDEAVLIL
SEARSLGLTGYDFFWIVPSLVSGNTELIPKEFPSGLISVSYDDWDYSLEARVRDGIGILT
TAASSMLEKFSYIPEAKASCYGQMERPEVPMHTLHPFMVNVTWDGKDLSFTEEGYQVHPR
LVVIVLNKDREWEKVGKWENHTLSLRHAVWPRYKSFSDCEPDDNHLSIVTLEEAPFVIVE
DIDPLTETCVRNTVPCRKFVKINNSTNEGMNVKKCCKGFCIDILKKLSRTVKFTYDLYLV
TNGKHGKKVNNVWNGMIGEVVYQRAVMAVGSLTINEERSEVVDFSVPFVETGISVMVSRS
NGTVSPSAFLEPFSASVWVMMFVMLLIVSAIAVFVFEYFSPVGYNRNLAKGKAPHGPSFT
IGKAIWLLWGLVFNNSVPVQNPKGTTSKIMVSVWAFFAVIFLASYTANLAAFMIQEEFVD
QVTGLSDKKFQRPHDYSPPFRFGTVPNGSTERNIRNNYPYMHQYMTKFNQKGVEDALVSL
KTGKLDAFIYDAAVLNYKAGRDEGCKLVTIGSGYIFATTGYGIALQKGSPWKRQIDLALL
QFVGDGEMEELETLWLTGICHNEKNEVMSSQLDIDNMAGVFYMLAAAMALSLITFIWEHL
FYWKLRFCFTGVCSDRPGLLFSISRGIYSCIHGVHIEEKKKSPDFNLTGSQSNMLKLLRS
AKNISSMSNMNSSRMDSPKRAADFIQRGSLIMDMVSDKGNLMYSDNRSFQGKESIFGDNM
NELQTFVANRQKDNLNNYVFQGQHPLTLNESNPNTVEVAVSTESKANSRPRQLWKKSVDS
IRQDSLSQNPVSQRDEATAENRTHSLKSPRYLPEEMAHSDISETSNRATCHREPDNSKNH
KTKDNFKRSVASKYPKDCSEVERTYLKTKSSSPRDKIYTIDGEKEPGFHLDPPQFVENVT
LPENVDFPDPYQDPSENFRKGDSTLPMNRNPLHNEEGLSNNDQYKLYSKHFTLKDKGSPH
SETSERYRQNSTHCRSCLSNMPTYSGHFTMRSPFKCDACLRMGNLYDIDEDQMLQETGNP
ATGEQVYQQDWAQNNALQLQKNKLRISRQHSYDNIVDKPRELDLSRPSRSISLKDRERLL
EGNFYGSLFSVPSSKLSGKKSSLFPQGLEDSKRSKSLLPDHTSDNPFLHSHRDDQRLVIG
RCPSDPYKHSLPSQAVNDSYLRSSLRSTASYCSRDSRGHNDVYISEHVMPYAANKNNMYS
TPRVLNSCSNRRVYKKMPSIESDV</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0016199|Glutamate receptor ionotropic, NMDA 2A (GRIN2A)
ATGGGCAGAGTGGGCTATTGGACCCTGCTGGTGCTGCCGGCCCTTCTGGTCTGGCGCGGT
CCGGCGCCGAGCGCGGCGGCGGAGAAGGGTCCCCCCGCGCTAAATATTGCGGTGATGCTG
GGTCACAGCCACGACGTGACAGAGCGCGAACTTCGAACACTGTGGGGCCCCGAGCAGGCG
GCGGGGCTGCCCCTGGACGTGAACGTGGTAGCTCTGCTGATGAACCGCACCGACCCCAAG
AGCCTCATCACGCACGTGTGCGACCTCATGTCCGGGGCACGCATCCACGGCCTCGTGTTT
GGGGACGACACGGACCAGGAGGCCGTAGCCCAGATGCTGGATTTTATCTCCTCCCACACC
TTCGTCCCCATCTTGGGCATTCATGGGGGCGCATCTATGATCATGGCTGACAAGGATCCG
ACGTCTACCTTCTTCCAGTTTGGAGCGTCCATCCAGCAGCAAGCCACGGTCATGCTGAAG
ATCATGCAGGATTATGACTGGCATGTCTTCTCCCTGGTGACCACTATCTTCCCTGGCTAC
AGGGAATTCATCAGCTTCGTCAAGACCACAGTGGACAACAGCTTTGTGGGCTGGGACATG
CAGAATGTGATCACACTGGACACTTCCTTTGAGGATGCAAAGACACAAGTCCAGCTGAAG
AAGATCCACTCTTCTGTCATCTTGCTCTACTGTTCCAAAGACGAGGCTGTTCTCATTCTG
AGTGAGGCCCGCTCCCTTGGCCTCACCGGGTATGATTTCTTCTGGATTGTCCCCAGCTTG
GTCTCTGGGAACACGGAGCTCATCCCAAAAGAGTTTCCATCGGGACTCATTTCTGTCTCC
TACGATGACTGGGACTACAGCCTGGAGGCGAGAGTGAGGGACGGCATTGGCATCCTAACC
ACCGCTGCATCTTCTATGCTGGAGAAGTTCTCCTACATCCCCGAGGCCAAGGCCAGCTGC
TACGGGCAGATGGAGAGGCCAGAGGTCCCGATGCACACCTTGCACCCATTTATGGTCAAT
GTTACATGGGATGGCAAAGACTTATCCTTCACTGAGGAAGGCTACCAGGTGCACCCCAGG
CTGGTGGTGATTGTGCTGAACAAAGACCGGGAATGGGAAAAGGTGGGCAAGTGGGAGAAC
CATACGCTGAGCCTGAGGCACGCCGTGTGGCCCAGGTACAAGTCCTTCTCCGACTGTGAG
CCGGATGACAACCATCTCAGCATCGTCACCCTGGAGGAGGCCCCATTCGTCATCGTGGAA
GACATAGACCCCCTGACCGAGACGTGTGTGAGGAACACCGTGCCATGTCGGAAGTTCGTC
AAAATCAACAATTCAACCAATGAGGGGATGAATGTGAAGAAATGCTGCAAGGGGTTCTGC
ATTGATATTCTGAAGAAGCTTTCCAGAACTGTGAAGTTTACTTACGACCTCTATCTGGTG
ACCAATGGGAAGCATGGCAAGAAAGTTAACAATGTGTGGAATGGAATGATCGGTGAAGTG
GTCTATCAACGGGCAGTCATGGCAGTTGGCTCGCTCACCATCAATGAGGAACGTTCTGAA
GTGGTGGACTTCTCTGTGCCCTTTGTGGAAACGGGAATCAGTGTCATGGTTTCAAGAAGT
AATGGCACCGTCTCACCTTCTGCTTTTCTAGAACCATTCAGCGCCTCTGTCTGGGTGATG
ATGTTTGTGATGCTGCTCATTGTTTCTGCCATAGCTGTTTTTGTCTTTGAATACTTCAGC
CCTGTTGGATACAACAGAAACTTAGCCAAAGGGAAAGCACCCCATGGGCCTTCTTTTACA
ATTGGAAAAGCTATATGGCTTCTTTGGGGCCTGGTGTTCAATAACTCCGTGCCTGTCCAG
AATCCTAAAGGGACCACCAGCAAGATCATGGTATCTGTATGGGCCTTCTTCGCTGTCATA
TTCCTGGCTAGCTACACAGCCAATCTGGCTGCCTTCATGATCCAAGAGGAATTTGTGGAC
CAAGTGACCGGCCTCAGTGACAAAAAGTTTCAGAGACCTCATGACTATTCCCCACCTTTT
CGATTTGGGACAGTGCCTAATGGAAGCACGGAGAGAAACATTCGGAATAACTATCCCTAC
ATGCATCAGTACATGACCAAATTTAATCAGAAAGGAGTAGAGGACGCCTTGGTCAGCCTG
AAAACGGGGAAGCTGGACGCTTTCATCTACGATGCCGCAGTCTTGAATTACAAGGCTGGG
AGGGATGAAGGCTGCAAGCTGGTGACCATCGGGAGTGGGTACATCTTTGCCACCACCGGT
TATGGAATTGCCCTTCAGAAAGGCTCTCCTTGGAAGAGGCAGATCGACCTGGCCTTGCTT
CAGTTTGTGGGTGATGGTGAGATGGAGGAGCTGGAGACCCTGTGGCTCACTGGGATCTGC
CACAACGAGAAGAACGAGGTGATGAGCAGCCAGCTGGACATTGACAACATGGCGGGCGTA
TTCTACATGCTGGCTGCCGCCATGGCCCTTAGCCTCATCACCTTCATCTGGGAGCACCTC
TTCTACTGGAAGCTGCGCTTCTGTTTCACGGGCGTGTGCTCCGACCGGCCTGGGTTGCTC
TTCTCCATCAGCAGGGGCATCTACAGCTGCATTCATGGAGTGCACATTGAAGAAAAGAAG
AAGTCTCCAGACTTCAATCTGACGGGATCCCAGAGCAACATGTTAAAACTCCTCCGGTCA
GCCAAAAACATTTCCAGCATGTCCAACATGAACTCCTCAAGAATGGACTCACCCAAAAGA
GCTGCTGACTTCATCCAAAGAGGTTCCCTCATCATGGACATGGTTTCAGATAAGGGGAAT
TTGATGTACTCAGACAACAGGTCCTTTCAGGGGAAAGAGAGCATTTTTGGAGACAACATG
AACGAACTCCAAACATTTGTGGCCAACCGGCAGAAGGATAACCTCAATAACTATGTATTC
CAGGGACAACATCCTCTTACTCTCAATGAGTCCAACCCTAACACGGTGGAGGTGGCCGTG
AGCACAGAATCCAAAGCGAACTCTAGACCCCGGCAGCTGTGGAAGAAATCCGTGGATTCC
ATACGCCAGGATTCACTATCCCAGAATCCAGTCTCCCAGAGGGATGAGGCAACAGCAGAG
AATAGGACCCACTCCCTAAAGAGCCCTAGGTATCTTCCAGAAGAGATGGCCCACTCTGAC
ATTTCAGAAACGTCAAATCGGGCCACGTGCCACAGGGAACCTGACAACAGTAAGAACCAC
AAAACCAAGGACAACTTTAAAAGGTCAGTGGCCTCCAAATACCCCAAGGACTGTAGTGAG
GTCGAGCGCACCTACCTGAAAACCAAATCAAGCTCCCCTAGAGACAAGATCTACACTATA
GATGGTGAGAAGGAGCCTGGTTTCCACTTAGATCCACCCCAGTTTGTTGAAAATGTGACC
CTGCCCGAGAACGTGGACTTCCCGGACCCCTACCAGGATCCCAGTGAAAACTTCCGCAAG
GGGGACTCCACGCTGCCAATGAACCGGAACCCCTTGCATAATGAAGAGGGGCTTTCCAAC
AACGACCAGTATAAACTCTACTCCAAGCACTTCACCTTGAAAGACAAGGGTTCCCCGCAC
AGTGAGACCAGCGAGCGATACCGGCAGAACTCCACGCACTGCAGAAGCTGCCTTTCCAAC
ATGCCCACCTATTCAGGCCACTTCACCATGAGGTCCCCCTTCAAGTGCGATGCCTGCCTG
CGGATGGGGAACCTCTATGACATCGATGAAGACCAGATGCTTCAGGAGACAGGTAACCCA
GCCACCGGGGAGCAGGTCTACCAGCAGGACTGGGCACAGAACAATGCCCTTCAATTACAA
AAGAACAAGCTAAGGATTAGCCGTCAGCATTCCTACGATAACATTGTCGACAAACCTAGG
GAGCTAGACCTTAGCAGGCCCTCCCGGAGCATAAGCCTCAAGGACAGGGAACGGCTTCTG
GAGGGAAATTTTTACGGCAGCCTGTTTAGTGTCCCCTCAAGCAAACTCTCGGGGAAAAAA
AGCTCCCTTTTCCCCCAAGGTCTGGAGGACAGCAAGAGGAGCAAGTCTCTCTTGCCAGAC
CACACCTCCGATAACCCTTTCCTCCACTCCCACAGGGATGACCAACGCTTGGTTATTGGG
AGATGCCCCTCGGACCCTTACAAACACTCGTTGCCATCCCAGGCGGTGAATGACAGCTAT
CTTCGGTCGTCCTTGAGGTCAACGGCATCGTACTGTTCCAGGGACAGTCGGGGCCACAAT
GATGTGTATATTTCGGAGCATGTTATGCCTTATGCTGCAAATAAGAATAATATGTACTCT
ACCCCCAGGGTTTTAAATTCCTGCAGCAATAGACGCGTGTACAAGAAAATGCCTAGTATC
GAATCTGATGTTTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01094</identifier>
            <name>ANF_receptor</name>
          </pfam>
          <pfam>
            <identifier>PF00060</identifier>
            <name>Lig_chan</name>
          </pfam>
          <pfam>
            <identifier>PF10613</identifier>
            <name>Lig_chan-Glu_bd</name>
          </pfam>
          <pfam>
            <identifier>PF10565</identifier>
            <name>NMDAR2_C</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cell junction</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cell surface</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>dendrite</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>endoplasmic reticulum</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>neuronal postsynaptic density</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>NMDA selective glutamate receptor complex</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>postsynaptic membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>presynaptic membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>synaptic vesicle</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>terminal bouton</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>calcium channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>extracellular-glutamate-gated ion channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glutamate binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>neurotransmitter binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>NMDA glutamate receptor activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>voltage-gated cation channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>zinc ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>action potential</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>activation of MAPKK activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>axon guidance</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to amino acid stimulus</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to dsRNA</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to lipid</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to magnesium ion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to manganese ion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to zinc ion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cerebral cortex development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>directional locomotion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>dopamine metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>epidermal growth factor receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>excitatory postsynaptic potential</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>Fc-epsilon receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>fibroblast growth factor receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glutamate receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>hippocampus development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>innate immune response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>insulin receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ion transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ionotropic glutamate receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>learning or memory</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>long-term synaptic potentiation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>MAPK cascade</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>memory</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of protein catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>neurotrophin TRK receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of apoptotic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein localization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein tetramerization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>Ras protein signal transduction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of long-term neuronal synaptic plasticity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of sensory perception of pain</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to amphetamine</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to calcium ion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to carbohydrate</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to cocaine</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to drug</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to ethanol</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to fungicide</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to methylmercury</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to other organism</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to wounding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>rhythmic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>sensory perception of pain</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>serotonin metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>sleep</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small GTPase mediated signal transduction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>spinal cord development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>startle response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>synaptic transmission</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>synaptic transmission, glutamatergic</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>vascular endothelial growth factor receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>visual learning</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="6">
      <id>BE0002303</id>
      <name>Bile acid-CoA:amino acid N-acyltransferase</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A13832</ref-id>
            <pubmed-id>17379925</pubmed-id>
            <citation>Styles NA, Falany JL, Barnes S, Falany CN: Quantification and regulation of the subcellular distribution of bile acid coenzyme A:amino acid N-acyltransferase activity in rat liver. J Lipid Res. 2007 Jun;48(6):1305-15. Epub 2007 Mar 22.</citation>
          </article>
          <article>
            <ref-id>A13833</ref-id>
            <pubmed-id>17416343</pubmed-id>
            <citation>Visser WF, van Roermund CW, Ijlst L, Waterham HR, Wanders RJ: Demonstration of bile acid transport across the mammalian peroxisomal membrane. Biochem Biophys Res Commun. 2007 Jun 1;357(2):335-40. Epub 2007 Mar 26.</citation>
          </article>
          <article>
            <ref-id>A13834</ref-id>
            <pubmed-id>17256745</pubmed-id>
            <citation>Pellicoro A, van den Heuvel FA, Geuken M, Moshage H, Jansen PL, Faber KN: Human and rat bile acid-CoA:amino acid N-acyltransferase are liver-specific peroxisomal enzymes: implications for intracellular bile salt transport. Hepatology. 2007 Feb;45(2):340-8.</citation>
          </article>
          <article>
            <ref-id>A13835</ref-id>
            <pubmed-id>16931649</pubmed-id>
            <citation>Nakamura K, Morrison SF: Central efferent pathways mediating skin cooling-evoked sympathetic thermogenesis in brown adipose tissue. Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R127-36. Epub 2006 Aug 24.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q14032" source="Swiss-Prot">
        <name>Bile acid-CoA:amino acid N-acyltransferase</name>
        <general-function>Very long chain acyl-coa hydrolase activity</general-function>
        <specific-function>Involved in bile acid metabolism. In liver hepatocytes catalyzes the second step in the conjugation of C24 bile acids (choloneates) to glycine and taurine before excretion into bile canaliculi. The major components of bile are cholic acid and chenodeoxycholic acid. In a first step the bile acids are converted to an acyl-CoA thioester, either in peroxisomes (primary bile acids deriving from the cholesterol pathway), or cytoplasmic at the endoplasmic reticulum (secondary bile acids). May catalyze the conjugation of primary or secondary bile acids, or both. The conjugation increases the detergent properties of bile acids in the intestine, which facilitates lipid and fat-soluble vitamin absorption. In turn, bile acids are deconjugated by bacteria in the intestine and are recycled back to the liver for reconjugation (secondary bile acids). May also act as an acyl-CoA thioesterase that regulates intracellular levels of free fatty acids. In vitro, catalyzes the hydrolysis of long- and very long-chain saturated acyl-CoAs to the free fatty acid and coenzyme A (CoASH), and conjugates glycine to these acyl-CoAs.</specific-function>
        <gene-name>BAAT</gene-name>
        <locus>9q22.3</locus>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>7.0</theoretical-pi>
        <molecular-weight>46298.865</molecular-weight>
        <chromosome-location>9</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:932</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>BAAT</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>L34081</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>532505</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q14032</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>BAAT_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.3.1.65</synonym>
          <synonym>BACAT</synonym>
          <synonym>Glycine N-choloyltransferase</synonym>
          <synonym>Long-chain fatty-acyl-CoA hydrolase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0019265|Bile acid-CoA:amino acid N-acyltransferase
MIQLTATPVSALVDEPVHIRATGLIPFQMVSFQASLEDENGDMFYSQAHYRANEFGEVDL
NHASSLGGDYMGVHPMGLFWSLKPEKLLTRLLKRDVMNRPFQVQVKLYDLELIVNNKVAS
APKASLTLERWYVAPGVTRIKVREGRLRGALFLPPGEGLFPGVIDLFGGLGGLLEFRASL
LASRGFASLALAYHNYEDLPRKPEVTDLEYFEEAANFLLRHPKVFGSGVGVVSVCQGVQI
GLSMAIYLKQVTATVLINGTNFPFGIPQVYHGQIHQPLPHSAQLISTNALGLLELYRTFE
TTQVGASQYLFPIEEAQGQFLFIVGEGDKTINSKAHAEQAIGQLKRHGKNNWTLLSYPGA
GHLIEPPYSPLCCASTTHDLRLHWGGEVIPHAAAQEHAWKEIQRFLRKHLIPDVTSQL</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0019266|Bile acid-CoA:amino acid N-acyltransferase (BAAT)
ATGATCCAGTTGACAGCTACCCCTGTGAGTGCACTTGTTGATGAGCCAGTGCATATCCGA
GCTACAGGCCTGATTCCCTTTCAGATGGTGAGTTTTCAGGCATCACTGGAAGATGAAAAC
GGAGACATGTTTTATTCTCAAGCCCACTATAGGGCCAATGAATTCGGTGAGGTGGACCTG
AATCATGCTTCTTCACTTGGAGGGGATTATATGGGAGTCCACCCCATGGGTCTCTTCTGG
TCTCTGAAACCTGAAAAGCTATTAACAAGACTGTTGAAAAGAGATGTGATGAATAGGCCT
TTCCAGGTCCAAGTAAAACTTTATGACTTAGAGTTAATAGTGAACAATAAAGTTGCCAGT
GCTCCAAAGGCCAGCCTGACTTTGGAGAGGTGGTATGTGGCACCTGGTGTCACACGAATT
AAGGTTCGAGAAGGCCGCCTTCGAGGAGCTCTCTTTCTCCCTCCAGGAGAGGGTCTCTTC
CCAGGGGTAATTGATTTGTTTGGTGGTTTGGGTGGGCTGCTTGAATTTCGGGCCAGCCTC
CTAGCCAGTCGTGGCTTCGCCTCCTTGGCCTTGGCTTACCATAACTATGAAGACCTGCCC
CGCAAACCAGAAGTAACAGATTTGGAATATTTTGAGGAGGCTGCCAACTTTCTCCTGAGA
CATCCAAAGGTCTTTGGCTCAGGCGTTGGGGTAGTCTCTGTATGTCAAGGAGTACAGATT
GGACTATCTATGGCTATTTACCTAAAGCAAGTCACAGCCACGGTACTTATTAATGGGACC
AACTTTCCTTTTGGCATTCCACAGGTATATCATGGTCAGATCCATCAGCCCCTTCCCCAT
TCTGCACAATTAATATCCACCAATGCCTTGGGGTTACTAGAGCTCTATCGCACTTTTGAG
ACAACTCAAGTTGGGGCCAGTCAATATTTGTTTCCTATTGAAGAGGCCCAGGGGCAATTC
CTCTTCATTGTAGGAGAAGGTGATAAGACTATCAACAGCAAAGCACACGCTGAACAAGCC
ATAGGACAGCTGAAGAGACATGGGAAGAACAACTGGACCCTGCTATCTTACCCTGGGGCA
GGCCACCTGATAGAACCTCCCTATTCTCCTCTGTGCTGTGCCTCAACGACCCACGATTTG
AGGTTACACTGGGGAGGAGAGGTGATCCCACACGCAGCTGCACAGGAACATGCTTGGAAG
GAGATCCAGAGATTTCTCAGGAAGCACCTCATTCCAGATGTGACCAGTCAACTCTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF08840</identifier>
            <name>BAAT_C</name>
          </pfam>
          <pfam>
            <identifier>PF04775</identifier>
            <name>Bile_Hydr_Trans</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>peroxisomal matrix</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>peroxisome</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>carboxylic ester hydrolase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine N-choloyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>long-chain acyl-CoA hydrolase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>medium-chain acyl-CoA hydrolase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>N-acyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>palmitoyl-CoA hydrolase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>receptor binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>very long chain acyl-CoA hydrolase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>acyl-CoA metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>bile acid and bile salt transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>bile acid biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>bile acid conjugation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>bile acid metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>fatty acid metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>liver development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>organ regeneration</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>taurine metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="7">
      <id>BE0002304</id>
      <name>N-arachidonyl glycine receptor</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A192447</ref-id>
            <pubmed-id>20136843</pubmed-id>
            <citation>Parmar N, Ho WS: N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels. Br J Pharmacol. 2010 Jun;160(3):594-603. doi: 10.1111/j.1476-5381.2009.00622.x. Epub 2010 Feb 5.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q14330" source="Swiss-Prot">
        <name>N-arachidonyl glycine receptor</name>
        <general-function>G-protein coupled receptor activity</general-function>
        <specific-function>Receptor for N-arachidonyl glycine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase. May contribute to regulation of the immune system.</specific-function>
        <gene-name>GPR18</gene-name>
        <locus>13q32</locus>
        <cellular-location>Cell membrane</cellular-location>
        <transmembrane-regions>27-47
57-77
96-116
139-159
192-212
233-253
269-289</transmembrane-regions>
        <signal-regions/>
        <theoretical-pi>9.56</theoretical-pi>
        <molecular-weight>38133.27</molecular-weight>
        <chromosome-location>13</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:4472</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GPR18</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>L42324</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>1066731</identifier>
          </external-identifier>
          <external-identifier>
            <resource>IUPHAR</resource>
            <identifier>89</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>89</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q14330</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GPR18_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>G-protein coupled receptor 18</synonym>
          <synonym>GPCRW</synonym>
          <synonym>NAGly receptor</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004524|N-arachidonyl glycine receptor
MITLNNQDQPVPFNSSHPDEYKIAALVFYSCIFIIGLFVNITALWVFSCTTKKRTTVTIY
MMNVALVDLIFIMTLPFRMFYYAKDEWPFGEYFCQILGALTVFYPSIALWLLAFISADRY
MAIVQPKYAKELKNTCKAVLACVGVWIMTLTTTTPLLLLYKDPDKDSTPATCLKISDIIY
LKAVNVLNLTRLTFFFLIPLFIMIGCYLVIIHNLLHGRTSKLKPKVKEKSIRIIITLLVQ
VLVCFMPFHICFAFLMLGTGENSYNPWGAFTTFLMNLSTCLDVILYYIVSKQFQARVISV
MLYRNYLRSMRRKSFRSGSLRSLSNINSEML</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0011660|N-arachidonyl glycine receptor (GPR18)
ATGATCACCCTGAACAATCAAGATCAACCTGTCCCTTTTAACAGCTCACATCCAGATGAA
TACAAAATTGCAGCCCTTGTCTTCTATAGCTGTATCTTCATAATTGGATTATTTGTTAAC
ATCACTGCATTATGGGTTTTCAGTTGTACCACCAAGAAGAGAACCACGGTAACCATCTAT
ATGATGAATGTGGCATTAGTGGACTTGATATTTATAATGACTTTACCCTTTCGAATGTTT
TATTATGCAAAAGATGAATGGCCATTTGGAGAGTACTTCTGCCAGATTCTTGGAGCTCTC
ACAGTGTTTTACCCAAGCATTGCTTTATGGCTTCTTGCCTTTATTAGTGCTGACAGATAC
ATGGCCATTGTACAGCCGAAGTACGCCAAAGAACTTAAAAACACGTGCAAAGCCGTGCTG
GCGTGTGTGGGAGTCTGGATAATGACCCTGACCACGACCACCCCTCTGCTACTGCTCTAT
AAAGACCCAGATAAAGACTCCACTCCCGCCACCTGCCTCAAGATTTCTGACATCATCTAT
CTAAAAGCTGTGAACGTGCTGAACCTCACTCGACTGACATTTTTTTTCTTGATTCCTTTG
TTCATCATGATTGGGTGCTACTTGGTCATTATTCATAATCTCCTTCACGGCAGGACGTCT
AAGCTGAAACCCAAAGTCAAGGAGAAGTCCATAAGGATCATCATCACGCTGCTGGTGCAG
GTGCTCGTCTGCTTTATGCCCTTCCACATCTGTTTCGCTTTCCTGATGCTGGGAACGGGG
GAGAACAGTTACAATCCCTGGGGAGCCTTTACCACCTTCCTCATGAACCTCAGCACGTGT
CTGGATGTGATTCTCTACTACATCGTTTCAAAACAATTTCAGGCTCGAGTCATTAGTGTC
ATGCTATACCGTAATTACCTTCGAAGCATGCGCAGAAAAAGTTTCCGATCTGGTAGTCTA
CGGTCACTAAGCAATATAAACAGTGAAATGTTATGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00001</identifier>
            <name>7tm_1</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>integral component of membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>G-protein coupled receptor activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>G-protein coupled receptor signaling pathway</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="8">
      <id>BE0000185</id>
      <name>Glutathione synthetase</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A4171</ref-id>
            <pubmed-id>17452339</pubmed-id>
            <citation>Herrera K, Cahoon RE, Kumaran S, Jez J: Reaction mechanism of glutathione synthetase from Arabidopsis thaliana: site-directed mutagenesis of active site residues. J Biol Chem. 2007 Jun 8;282(23):17157-65. Epub 2007 Apr 22.</citation>
          </article>
          <article>
            <ref-id>A4172</ref-id>
            <pubmed-id>16996193</pubmed-id>
            <citation>Ducruix C, Junot C, Fievet JB, Villiers F, Ezan E, Bourguignon J: New insights into the regulation of phytochelatin biosynthesis in A. thaliana cells from metabolite profiling analyses. Biochimie. 2006 Nov;88(11):1733-42. Epub 2006 Sep 7.</citation>
          </article>
          <article>
            <ref-id>A4173</ref-id>
            <pubmed-id>17397529</pubmed-id>
            <citation>Ristoff E, Larsson A: Inborn errors in the metabolism of glutathione. Orphanet J Rare Dis. 2007 Mar 30;2:16.</citation>
          </article>
          <article>
            <ref-id>A4174</ref-id>
            <pubmed-id>17124497</pubmed-id>
            <citation>Pai CH, Chiang BY, Ko TP, Chou CC, Chong CM, Yen FJ, Chen S, Coward JK, Wang AH, Lin CH: Dual binding sites for translocation catalysis by Escherichia coli glutathionylspermidine synthetase. EMBO J. 2006 Dec 13;25(24):5970-82. Epub 2006 Nov 23.</citation>
          </article>
          <article>
            <ref-id>A4175</ref-id>
            <pubmed-id>17401648</pubmed-id>
            <citation>Janaky R, Dohovics R, Saransaari P, Oja SS: Modulation of [3H]dopamine release by glutathione in mouse striatal slices. Neurochem Res. 2007 Aug;32(8):1357-64. Epub 2007 Mar 31.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P48637" source="Swiss-Prot">
        <name>Glutathione synthetase</name>
        <general-function>Protein homodimerization activity</general-function>
        <specific-function/>
        <gene-name>GSS</gene-name>
        <locus>20q11.2</locus>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.73</theoretical-pi>
        <molecular-weight>52384.325</molecular-weight>
        <chromosome-location>20</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:4624</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GSS</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>L42531</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>886284</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P48637</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GSHB_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>6.3.2.3</synonym>
          <synonym>Glutathione synthase</synonym>
          <synonym>GSH synthetase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000369|Glutathione synthetase
MATNWGSLLQDKQQLEELARQAVDRALAEGVLLRTSQEPTSSEVVSYAPFTLFPSLVPSA
LLEQAYAVQMDFNLLVDAVSQNAAFLEQTLSSTIKQDDFTARLFDIHKQVLKEGIAQTVF
LGLNRSDYMFQRSADGSPALKQIEINTISASFGGLASRTPAVHRHVLSVLSKTKEAGKIL
SNNPSKGLALGIAKAWELYGSPNALVLLIAQEKERNIFDQRAIENELLARNIHVIRRTFE
DISEKGSLDQDRRLFVDGQEIAVVYFRDGYMPRQYSLQNWEARLLLERSHAAKCPDIATQ
LAGTKKVQQELSRPGMLEMLLPGQPEAVARLRATFAGLYSLDVGEEGDQAIAEALAAPSR
FVLKPQREGGGNNLYGEEMVQALKQLKDSEERASYILMEKIEPEPFENCLLRPGSPARVV
QCISELGIFGVYVRQEKTLVMNKHVGHLLRTKAIEHADGGVAAGVAVLDNPYPV</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0016029|Glutathione synthetase (GSS)
ATGGCCACCAACTGGGGGAGCCTCTTGCAGGATAAACAGCAGCTAGAGGAGCTGGCACGG
CAGGCCGTGGACCGGGCCCTGGCTGAGGGAGTATTGCTGAGGACCTCACAGGAGCCCACT
TCCTCGGAGGTGGTGAGCTATGCCCCATTCACGCTCTTCCCCTCACTGGTCCCCAGTGCC
CTGCTGGAGCAAGCCTATGCTGTGCAGATGGACTTCAACCTGCTAGTGGATGCTGTCAGC
CAGAACGCTGCCTTCCTGGAGCAAACTCTTTCCAGCACCATCAAACAGGATGACTTTACC
GCTCGTCTCTTTGACATCCACAAGCAAGTCCTAAAAGAGGGCATTGCCCAGACTGTGTTC
CTGGGCCTGAATCGCTCAGACTACATGTTCCAGCGCAGCGCAGATGGCTCCCCAGCCCTG
AAACAGATCGAAATCAACACCATCTCTGCCAGCTTTGGGGGCCTGGCCTCCCGGACCCCA
GCTGTGCACCGACATGTTCTCAGTGTCCTGAGTAAGACCAAAGAAGCTGGCAAGATCCTC
TCTAATAATCCCAGCAAGGGACTGGCCCTGGGAATTGCCAAAGCCTGGGAGCTCTACGGC
TCACCCAATGCTCTGGTGCTACTGATTGCTCAAGAGAAGGAAAGAAACATATTTGACCAG
CGTGCCATAGAGAATGAGCTACTGGCCAGGAACATCCATGTGATCCGACGAACATTTGAA
GATATCTCTGAAAAGGGGTCTCTGGACCAAGACCGAAGGCTGTTTGTGGATGGCCAGGAA
ATTGCTGTGGTTTACTTCCGGGATGGCTACATGCCTCGTCAGTACAGTCTACAGAATTGG
GAAGCACGTCTACTGCTGGAGAGGTCACATGCTGCCAAGTGCCCAGACATTGCCACCCAG
CTGGCTGGGACTAAGAAGGTGCAGCAGGAGCTAAGCAGGCCGGGCATGCTGGAGATGTTG
CTCCCTGGCCAGCCTGAGGCTGTGGCCCGCCTCCGCGCCACCTTTGCTGGCCTCTACTCA
CTGGATGTGGGTGAAGAAGGGGACCAGGCCATCGCCGAGGCCCTTGCTGCCCCTAGCCGG
TTTGTGCTAAAGCCCCAGAGAGAGGGTGGAGGTAACAACCTATATGGGGAGGAAATGGTA
CAGGCCCTGAAACAGCTGAAGGACAGTGAGGAGAGGGCCTCCTACATCCTCATGGAGAAG
ATCGAACCTGAGCCTTTTGAGAATTGCCTGCTACGGCCTGGCAGCCCTGCCCGAGTGGTC
CAGTGCATTTCAGAGCTGGGCATCTTTGGGGTCTATGTCAGGCAGGAAAAGACACTCGTG
ATGAACAAGCACGTGGGGCATCTACTTCGAACCAAAGCCATCGAGCATGCAGATGGTGGT
GTGGCAGCGGGAGTGGCAGTCCTGGACAACCCATACCCTGTGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF03917</identifier>
            <name>GSH_synth_ATP</name>
          </pfam>
          <pfam>
            <identifier>PF03199</identifier>
            <name>GSH_synthase</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glutathione binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glutathione synthase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>magnesium ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>protein homodimerization activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>aging</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular amino acid metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glutathione biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glutathione derivative biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>nervous system development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to amino acid</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to cadmium ion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to nutrient levels</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to oxidative stress</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to tumor necrosis factor</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>xenobiotic metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="9">
      <id>BE0000454</id>
      <name>Glutamate receptor ionotropic, NMDA 2C</name>
      <organism>Humans</organism>
      <actions>
        <action>agonist</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A13836</ref-id>
            <pubmed-id>8955518</pubmed-id>
            <citation>Widdowson PS, Gyte AJ, Upton R, Wyatt I: Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors. Brain Res. 1996 Nov 4;738(2):236-42.</citation>
          </article>
          <article>
            <ref-id>A13837</ref-id>
            <pubmed-id>9073168</pubmed-id>
            <citation>Al-Ghoul WM, Meeker RB, Greenwood RS: Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in vasopressin and oxytocin neuroendocrine cells. Brain Res Mol Brain Res. 1997 Mar;44(2):262-72.</citation>
          </article>
          <article>
            <ref-id>A13838</ref-id>
            <pubmed-id>11861317</pubmed-id>
            <citation>Malayev A, Gibbs TT, Farb DH: Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids. Br J Pharmacol. 2002 Feb;135(4):901-9.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q14957" source="Swiss-Prot">
        <name>Glutamate receptor ionotropic, NMDA 2C</name>
        <general-function>Nmda glutamate receptor activity</general-function>
        <specific-function>NMDA receptor subtype of glutamate-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium. Mediated by glycine.</specific-function>
        <gene-name>GRIN2C</gene-name>
        <locus>17q25</locus>
        <cellular-location>Cell membrane</cellular-location>
        <transmembrane-regions>554-574
627-647
815-835</transmembrane-regions>
        <signal-regions>1-19</signal-regions>
        <theoretical-pi>8.61</theoretical-pi>
        <molecular-weight>134207.77</molecular-weight>
        <chromosome-location>17</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:4587</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GRIN2C</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>L76224</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>1196449</identifier>
          </external-identifier>
          <external-identifier>
            <resource>IUPHAR</resource>
            <identifier>458</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q14957</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>NMDE3_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>GluN2C</synonym>
          <synonym>Glutamate [NMDA] receptor subunit epsilon-3</synonym>
          <synonym>N-methyl D-aspartate receptor subtype 2C</synonym>
          <synonym>NMDAR2C</synonym>
          <synonym>NR2C</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010317|Glutamate receptor ionotropic, NMDA 2C
MGGALGPALLLTSLFGAWAGLGPGQGEQGMTVAVVFSSSGPPQAQFRARLTPQSFLDLPL
EIQPLTVGVNTTNPSSLLTQICGLLGAAHVHGIVFEDNVDTEAVAQILDFISSQTHVPIL
SISGGSAVVLTPKEPGSAFLQLGVSLEQQLQVLFKVLEEYDWSAFAVITSLHPGHALFLE
GVRAVADASHVSWRLLDVVTLELGPGGPRARTQRLLRQLDAPVFVAYCSREEAEVLFAEA
AQAGLVGPGHVWLVPNLALGSTDAPPATFPVGLISVVTESWRLSLRQKVRDGVAILALGA
HSYWRQHGTLPAPAGDCRVHPGPVSPAREAFYRHLLNVTWEGRDFSFSPGGYLVQPTMVV
IALNRHRLWEMVGRWEHGVLYMKYPVWPRYSASLQPVVDSRHLTVATLEERPFVIVESPD
PGTGGCVPNTVPCRRQSNHTFSSGDVAPYTKLCCKGFCIDILKKLARVVKFSYDLYLVTN
GKHGKRVRGVWNGMIGEVYYKRADMAIGSLTINEERSEIVDFSVPFVETGISVMVARSNG
TVSPSAFLEPYSPAVWVMMFVMCLTVVAITVFMFEYFSPVSYNQNLTRGKKSGGPAFTIG
KSVWLLWALVFNNSVPIENPRGTTSKIMVLVWAFFAVIFLASYTANLAAFMIQEQYIDTV
SGLSDKKFQRPQDQYPPFRFGTVPNGSTERNIRSNYRDMHTHMVKFNQRSVEDALTSLKM
GKLDAFIYDAAVLNYMAGKDEGCKLVTIGSGKVFATTGYGIAMQKDSHWKRAIDLALLQF
LGDGETQKLETVWLSGICQNEKNEVMSSKLDIDNMAGVFYMLLVAMGLALLVFAWEHLVY
WKLRHSVPNSSQLDFLLAFSRGIYSCFSGVQSLASPPRQASPDLTASSAQASVLKMLQAA
RDMVTTAGVSSSLDRATRTIENWGGGRRAPPPSPCPTPRSGPSPCLPTPDPPPEPSPTGW
GPPDGGRAALVRRAPQPPGRPPTPGPPLSDVSRVSRRPAWEARWPVRTGHCGRHLSASER
PLSPARCHYSSFPRADRSGRPFLPLFPELEDLPLLGPEQLARREALLHAAWARGSRPRHA
SLPSSVAEAFARPSSLPAGCTGPACARPDGHSACRRLAQAQSMCLPIYREACQEGEQAGA
PAWQHRQHVCLHAHAHLPFCWGAVCPHLPPCASHGSWLSGAWGPLGHRGRTLGLGTGYRD
SGGLDEISRVARGTQGFPGPCTWRRISSLESEV</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010318|Glutamate receptor ionotropic, NMDA 2C (GRIN2C)
ATGGGTGGGGCCCTGGGGCCGGCCCTGTTGCTCACCTCGCTCTTCGGTGCCTGGGCAGGG
CTGGGTCCGGGGCAGGGCGAGCAGGGCATGACGGTGGCCGTGGTGTTTAGCAGCTCAGGG
CCGCCCCAGGCCCAGTTCCGTGCCCGCCTCACCCCCCAGAGCTTCCTGGACCTACCCCTG
GAGATCCAGCCGCTCACAGTTGGGGTCAACACCACCAACCCCAGCAGCCTCCTCACCCAG
ATCTGCGGCCTCCTGGGTGCTGCCCACGTCCACGGCATTGTCTTTGAGGACAACGTGGAC
ACCGAGGCGGTGGCCCAGATCCTTGACTTCATCTCCTCCCAGACCCATGTGCCCATCCTC
AGCATCAGCGGAGGCTCTGCTGTGGTCCTCACCCCCAAGGAGCCGGGCTCCGCCTTCCTG
CAGCTGGGCGTGTCCCTGGAGCAGCAGCTGCAGGTGCTGTTCAAGGTGCTGGAAGAGTAC
GACTGGAGCGCCTTCGCCGTCATCACCAGCCTGCACCCGGGCCACGCGCTCTTCCTGGAG
GGCGTGCGCGCCGTCGCCGACGCCAGCCACGTGAGTTGGCGGCTGCTGGACGTGGTCACG
CTGGAGCTGGGCCCGGGAGGGCCGCGCGCGCGCACGCAGCGCCTGCTGCGCCAGCTCGAC
GCGCCCGTGTTTGTGGCCTACTGCTCGCGCGAGGAGGCCGAGGTGCTCTTCGCCGAGGCG
GCGCAGGCCGGTCTGGTGGGGCCCGGCCACGTGTGGCTGGTGCCCAACCTGGCGCTGGGC
AGCACCGATGCGCCCCCCGCCACCTTCCCCGTGGGCCTCATCAGCGTCGTCACCGAGAGC
TGGCGCCTCAGCCTGCGCCAGAAGGTGCGCGACGGCGTGGCCATTCTGGCCCTGGGCGCC
CACAGCTACTGGCGCCAGCATGGAACCCTGCCAGCCCCGGCCGGGGACTGCCGTGTTCAC
CCTGGGCCCGTCAGCCCTGCCCGGGAGGCCTTCTACAGGCACCTACTGAATGTCACCTGG
GAGGGCCGAGACTTCTCCTTCAGCCCTGGTGGGTACCTGGTCCAGCCCACCATGGTGGTG
ATCGCCCTCAACCGGCACCGCCTCTGGGAGATGGTGGGGCGCTGGGAGCATGGCGTCCTA
TACATGAAGTACCCCGTGTGGCCTCGCTACAGTGCCTCTCTGCAGCCTGTGGTGGACAGT
CGGCACCTGACGGTGGCCACGCTGGAAGAGCGGCCCTTTGTCATCGTGGAGAGCCCTGAC
CCTGGCACAGGAGGCTGTGTCCCCAACACCGTGCCCTGCCGCAGGCAGAGCAACCACACC
TTCAGCAGCGGGGACGTGGCCCCCTACACCAAGCTCTGCTGTAAGGGATTCTGCATCGAC
ATCCTCAAGAAGCTGGCCAGAGTGGTCAAATTCTCCTACGACCTGTACCTGGTGACCAAC
GGCAAGCATGGCAAGCGGGTGCGCGGCGTATGGAACGGCATGATTGGGGAGGTGTACTAC
AAGCGGGCAGACATGGCCATCGGCTCCCTCACCATCAATGAGGAACGCTCCGAGATCGTA
GACTTCTCTGTACCCTTTGTGGAGACGGGCATCAGTGTGATGGTGGCTCGCAGCAATGGC
ACCGTCTCCCCCTCGGCCTTCTTGGAGCCATATAGCCCTGCAGTGTGGGTGATGATGTTT
GTCATGTGCCTCACTGTGGTGGCCATCACCGTCTTCATGTTCGAGTACTTCAGCCCTGTC
AGCTACAACCAGAACCTCACCAGAGGCAAGAAGTCCGGGGGCCCAGCTTTCACTATCGGC
AAGTCCGTGTGGCTGCTGTGGGCGCTGGTCTTCAACAACTCAGTGCCCATCGAGAACCCG
CGGGGCACCACCAGCAAGATCATGGTTCTGGTCTGGGCCTTCTTTGCTGTCATCTTCCTC
GCCAGCTACACGGCCAACCTGGCCGCCTTCATGATCCAAGAGCAATACATCGACACTGTG
TCGGGCCTCAGTGACAAGAAGTTTCAGCGGCCTCAAGATCAGTACCCACCTTTCCGCTTC
GGCACGGTGCCCAACGGCAGCACGGAGCGGAACATCCGCAGTAACTACCGTGACATGCAC
ACCCACATGGTCAAGTTCAACCAGCGCTCGGTGGAGGACGCGCTCACCAGCCTCAAGATG
GGGAAGCTGGATGCCTTCATCTATGATGCTGCTGTCCTCAACTACATGGCAGGCAAGGAC
GAGGGCTGCAAGCTGGTCACCATTGGGTCTGGCAAGGTCTTTGCTACCACTGGCTACGGC
ATCGCCATGCAGAAGGACTCCCACTGGAAGCGGGCCATAGACCTGGCGCTCTTGCAGTTC
CTGGGGGACGGAGAGACACAGAAACTGGAGACAGTGTGGCTCTCAGGGATCTGCCAGAAT
GAGAAGAACGAGGTGATGAGCAGCAAGCTGGACATCGACAACATGGCAGGCGTCTTCTAC
ATGCTGCTGGTGGCCATGGGGCTGGCCCTGCTGGTCTTCGCCTGGGAGCACCTGGTCTAC
TGGAAGCTGCGCCACTCGGTGCCCAACTCATCCCAGCTGGACTTCCTGCTGGCTTTCAGC
AGGGGCATCTACAGCTGCTTCAGCGGGGTGCAGAGCCTCGCCAGCCCACCGCGGCAGGCC
AGCCCGGACCTCACGGCCAGCTCGGCCCAGGCCAGCGTGCTCAAGATGCTGCAGGCAGCC
CGCGACATGGTGACCACGGCGGGCGTAAGCAGCTCCCTGGACCGCGCCACTCGCACCATC
GAGAATTGGGGTGGCGGCCGCCGTGCGCCCCCACCGTCCCCCTGCCCGACCCCGCGGTCT
GGCCCCAGCCCATGCCTGCCCACCCCCGACCCGCCCCCAGAGCCGAGCCCCACGGGCTGG
GGACCGCCAGACGGGGGTCGCGCGGCGCTTGTGCGCAGGGCTCCGCAGCCCCCGGGCCGC
CCCCCGACGCCGGGGCCGCCCCTGTCCGACGTCTCCCGAGTGTCGCGCCGCCCAGCCTGG
GAGGCGCGGTGGCCGGTGCGGACCGGGCACTGCGGGAGGCACCTCTCGGCCTCCGAGCGG
CCCCTGTCGCCCGCGCGCTGTCACTACAGCTCCTTTCCTCGAGCCGACCGATCCGGCCGC
CCCTTCCTCCCGCTCTTCCCGGAGCTGGAGGACCTGCCGCTGCTCGGTCCGGAGCAGCTG
GCCCGGCGGGAGGCCCTGCTGCACGCGGCCTGGGCCCGGGGCTCGCGCCCGCGTCACGCT
TCCCTGCCCAGCTCCGTGGCCGAGGCCTTCGCTCGGCCCAGCTCGCTGCCCGCTGGGTGC
ACCGGCCCCGCCTGCGCCCGCCCCGACGGCCACTCGGCCTGCAGGCGCTTGGCGCAGGCG
CAGTCGATGTGCTTGCCGATCTACCGGGAGGCCTGCCAGGAGGGCGAGCAGGCAGGGGCC
CCCGCCTGGCAGCACAGACAGCACGTCTGCCTGCACGCCCACGCCCACCTGCCATTTTGC
TGGGGGGCTGTCTGTCCTCACCTTCCACCCTGTGCCAGCCACGGCTCCTGGCTCTCCGGG
GCCTGGGGGCCTCTGGGGCACAGGGGCAGGACTCTGGGGCTGGGCACAGGCTACAGAGAC
AGTGGGGGACTGGACGAGATCAGCAGGGTAGCCCGTGGGACGCAAGGCTTCCCGGGACCC
TGCACCTGGAGACGGATCTCCAGTCTGGAGTCAGAAGTGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01094</identifier>
            <name>ANF_receptor</name>
          </pfam>
          <pfam>
            <identifier>PF00060</identifier>
            <name>Lig_chan</name>
          </pfam>
          <pfam>
            <identifier>PF10613</identifier>
            <name>Lig_chan-Glu_bd</name>
          </pfam>
          <pfam>
            <identifier>PF10565</identifier>
            <name>NMDAR2_C</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cell junction</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>dendrite</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>intracellular</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>NMDA selective glutamate receptor complex</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>postsynaptic density</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>postsynaptic membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>cation channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>extracellular-glutamate-gated ion channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>NMDA glutamate receptor activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>activation of MAPKK activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>axon guidance</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>directional locomotion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>epidermal growth factor receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>excitatory postsynaptic potential</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>Fc-epsilon receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>fibroblast growth factor receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glutamate receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>innate immune response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>insulin receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ion transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ionotropic glutamate receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>MAPK cascade</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of protein catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>neuromuscular process controlling balance</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>neurotrophin TRK receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein localization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>Ras protein signal transduction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to wounding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small GTPase mediated signal transduction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>synaptic transmission</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>synaptic transmission, glutamatergic</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>vascular endothelial growth factor receptor signaling pathway</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="10">
      <id>BE0002154</id>
      <name>Serine hydroxymethyltransferase</name>
      <organism>Humans</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A13839</ref-id>
            <pubmed-id>17905752</pubmed-id>
            <citation>Bouwman RA, Musters RJ, van Beek-Harmsen BJ, de Lange JJ, Lamberts RR, Loer SA, Boer C: Sevoflurane-induced cardioprotection depends on PKC-alpha activation via production of reactive oxygen species. Br J Anaesth. 2007 Nov;99(5):639-45. Epub 2007 Sep 27.</citation>
          </article>
          <article>
            <ref-id>A9911</ref-id>
            <pubmed-id>17664250</pubmed-id>
            <citation>Chang WN, Tsai JN, Chen BH, Huang HS, Fu TF: Serine hydroxymethyltransferase isoforms are differentially inhibited by leucovorin: characterization and comparison of recombinant zebrafish serine hydroxymethyltransferases. Drug Metab Dispos. 2007 Nov;35(11):2127-37. doi: 10.1124/dmd.107.016840. Epub 2007 Jul 30.</citation>
          </article>
          <article>
            <ref-id>A13840</ref-id>
            <pubmed-id>17567465</pubmed-id>
            <citation>Kon K, Ikejima K, Okumura K, Aoyama T, Arai K, Takei Y, Lemasters JJ, Sato N: Role of apoptosis in acetaminophen hepatotoxicity. J Gastroenterol Hepatol. 2007 Jun;22 Suppl 1:S49-52.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q53ET4" source="TrEMBL">
        <name>Serine hydroxymethyltransferase</name>
        <general-function>Pyridoxal phosphate binding</general-function>
        <specific-function>Interconversion of serine and glycine.</specific-function>
        <gene-name/>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>8.53</theoretical-pi>
        <molecular-weight>55973.345</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AK223555</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>62898842</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q53ET4</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>Q53ET4_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.1.2.1</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011561|Serine hydroxymethyltransferase
MLYFSLFWAARPLQRCGQLVRMAIRAQHSNAAQTQTGEANRGWTGQESLSDSDPEMWELL
QREKDRQCRGLELIASENFCSRAALEALGSCLNNKYSEGYPGKRYYGGAEVVDEIELLCQ
RRALEAFDLDPAQWGVNVQPYSGSPANLAVYTALLQPHDRIMGLDLPDGGHLTHGYMSDV
KRISATSIFFESMPYKLNPKTGLIDYNQLALTARLFRPRLIIAGTSAYARLIDYARMREV
CDEVKAHLLADMAHISGLVAAKVIPSPFKHADIVTTTTHKTLRGARSGLIFYRKGVKAVD
PKTGREIPYTFEDRINFAVFPSLQGGPHNHAIAAVAVALKQACTPMFREYSLQVLKNARA
MADALLERGYSLVSGGTDNHLVLVDLRPKGLDGARAERVLELVSITANKNTCPGDRSAIT
PGGLRLGAPALTSRQFHEDDFRRVVDFIDEGVNIGLEVKSKTAKLQDFKSFLLKDSETSQ
RLANLRQRVEQFARAFPMPGFDEH</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0004225|1515 bp
ATGCTGTACTTCTCTTTGTTTTGGGCGGCTCGGCCTCTGCAGAGATGTGGGCAGCTGGTC
AGGATGGCCATTCGGGCTCAGCACAGCAACGCAGCCCAGACTCAGACTGGGGAAGCAAAC
AGGGGCTGGACAGGCCAGGAGAGCCTGTCGGACAGTGATCCTGAGATGTGGGAGTTGCTG
CAGAGGGAGAAGGACAGGCAGTGTCGTGGCCTGGAGCTCATTGCCTCAGAGAACTTCTGC
AGCCGAGCTGCGCTGGAGGCCCTGGGGTCCTGTCTGAACAACAAGTACTCGGAGGGTTAT
CCTGGCAAGAGATACTATGGGGGAGCAGAGGTGGTGGATGAAATTGAGCTGCTGTGCCAG
CGCCGGGCCTTGGAAGCCTTTGACCTGGATCCTGCACAGTGGGGAGTCAATGTCCAGCCC
TACTCCGGGTCCCCAGCCAACCTGGCCGTCTACACAGCCCTTCTGCAACCTCACGACCGG
ATCATGGGGCTGGACCTGCCCGATGGGGGCCATCTCACCCACGGCTACATGTCTGACGTC
AAGCGGATATCAGCCACGTCCATCTTCTTCGAGTCTATGCCCTATAAGCTCAACCCCAAA
ACTGGCCTCATTGACTACAACCAGCTGGCACTGACTGCTCGACTTTTCCGGCCACGGCTC
ATCATAGCTGGCACCAGCGCCTATGCTCGCCTCATTGACTACGCCCGCATGAGAGAGGTG
TGTGATGAAGTCAAAGCACACCTGCTGGCAGACATGGCCCACATCAGTGGCCTGGTGGCT
GCCAAGGTGATTCCCTCGCCTTTCAAGCACGCGGACATCGTCACCACCACTACTCACAAG
ACTCTTCGAGGGGCCAGGTCAGGGCTCATCTTCTACCGGAAAGGGGTGAAGGCTGTGGAC
CCCAAGACTGGCCGGGAGATCCCTTACACATTTGAGGACCGAATCAACTTTGCCGTGTTC
CCATCCCTGCAGGGGGGCCCCCACAATCATGCCATTGCTGCAGTAGCTGTGGCCCTAAAG
CAGGCCTGCACCCCCATGTTCCGGGAGTACTCCCTGCAGGTTCTGAAGAATGCTCGGGCC
ATGGCAGATGCCCTGCTAGAGCGAGGCTACTCACTGGTATCAGGTGGTACTGACAACCAC
CTGGTGCTGGTGGACCTGCGGCCCAAGGGCCTGGATGGAGCTCGGGCTGAGCGGGTGCTA
GAGCTTGTATCCATCACTGCCAACAAGAACACCTGTCCTGGAGACCGAAGTGCCATCACA
CCGGGCGGCCTGCGGCTTGGGGCCCCAGCCTTAACTTCTCGACAGTTCCATGAGGATGAC
TTCCGGAGAGTTGTGGACTTTATAGATGAAGGGGTCAACATTGGCTTAGAGGTGAAGAGC
AAGACTGCCAAGCTCCAGGATTTCAAATCCTTCCTGCTTAAGGACTCAGAAACAAGTCAG
CGTCTGGCCAACCTCAGGCAACGGGTGGAGCAGTTTGCCAGGGCCTTCCCCATGCCTGGT
TTTGATGAGCATTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00464</identifier>
            <name>SHMT</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>glycine hydroxymethyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>methyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>pyridoxal phosphate binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>L-serine metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tetrahydrofolate interconversion</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="11">
      <id>BE0002305</id>
      <name>Glycine N-acyltransferase</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A13841</ref-id>
            <pubmed-id>17146584</pubmed-id>
            <citation>Narasipura SD, Ren P, Dyavaiah M, Auger I, Chaturvedi V, Chaturvedi S: An efficient method for homologous gene reconstitution in Cryptococcus gattii using URA5 auxotrophic marker. Mycopathologia. 2006 Dec;162(6):401-9.</citation>
          </article>
          <article>
            <ref-id>A13842</ref-id>
            <pubmed-id>17143481</pubmed-id>
            <citation>Zhou CX, Gao Y: Frequent genetic alterations and reduced expression of the Axin1 gene in oral squamous cell carcinoma: involvement in tumor progression and metastasis. Oncol Rep. 2007 Jan;17(1):73-9.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q6IB77" source="Swiss-Prot">
        <name>Glycine N-acyltransferase</name>
        <general-function>Transferase activity, transferring acyl groups</general-function>
        <specific-function>Mitochondrial acyltransferase which transfers an acyl group to the N-terminus of glycine and glutamine, although much less efficiently. Can conjugate numerous substrates to form a variety of N-acylglycines, with a preference for benzoyl-CoA over phenylacetyl-CoA as acyl donors. Thereby detoxify xenobiotics, such as benzoic acid or salicylic acid, and endogenous organic acids, such as isovaleric acid.</specific-function>
        <gene-name>GLYAT</gene-name>
        <locus>11q12.1</locus>
        <cellular-location>Mitochondrion</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>8.28</theoretical-pi>
        <molecular-weight>33923.995</molecular-weight>
        <chromosome-location>11</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:13734</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GLYAT</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF023466</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>2554941</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q6IB77</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GLYAT_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.3.1.13</synonym>
          <synonym>AAc</synonym>
          <synonym>ACGNAT</synonym>
          <synonym>Acyl-CoA:glycine N-acyltransferase</synonym>
          <synonym>Aralkyl acyl-CoA N-acyltransferase</synonym>
          <synonym>Aralkyl acyl-CoA:amino acid N-acyltransferase</synonym>
          <synonym>Benzoyl-coenzyme A:glycine N-acyltransferase</synonym>
          <synonym>CAT</synonym>
          <synonym>GAT</synonym>
          <synonym>Glycine N-benzoyltransferase</synonym>
          <synonym>HRP-1(CLP)</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037188|Glycine N-acyltransferase
MMLPLQGAQMLQMLEKSLRKSLPASLKVYGTVFHINHGNPFNLKAVVDKWPDFNTVVVCP
QEQDMTDDLDHYTNTYQIYSKDPQNCQEFLGSPELINWKQHLQIQSSQPSLNEAIQNLAA
IKSFKVKQTQRILYMAAETAKELTPFLLKSKILSPNGGKPKAINQEMFKLSSMDVTHAHL
VNKFWHFGGNERSQRFIERCIQTFPTCCLLGPEGTPVCWDLMDQTGEMRMAGTLPEYRLH
GLVTYVIYSHAQKLGKLGFPVYSHVDYSNEAMQKMSYTLQHVPIPRSWNQWNCVPL</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0011661|Glycine N-acyltransferase (GLYAT)
ATGATGTTACCATTGCAAGGTGCCCAGATGCTGCAGATGCTGGAGAAATCCTTGAGGAAG
AGCCTCCCAGCATCCTTAAAGGTTTATGGAACTGTCTTTCACATAAACCATGGAAATCCA
TTCAATCTGAAGGCTGTGGTGGACAAGTGGCCTGATTTTAATACAGTGGTTGTCTGCCCT
CAGGAGCAGGATATGACAGATGACCTTGATCACTATACCAATACTTACCAAATCTACTCC
AAAGATCCCCAAAACTGTCAGGAATTCCTTGGATCACCAGAACTCATCAACTGGAAACAG
CATTTACAGATTCAAAGTTCACAGCCTAGCCTGAATGAGGCTATACAAAATCTTGCAGCC
ATTAAGTCCTTCAAAGTCAAACAAACACAACGCATTCTCTATATGGCAGCTGAAACAGCC
AAGGAACTGACTCCTTTCCTGCTGAAATCAAAGATTTTATCTCCCAATGGTGGCAAACCC
AAGGCCATGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF08444</identifier>
            <name>Gly_acyl_tr_C</name>
          </pfam>
          <pfam>
            <identifier>PF06021</identifier>
            <name>Gly_acyl_tr_N</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial matrix</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine N-acyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine N-benzoyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transferase activity, transferring acyl groups</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>acyl-CoA metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>monocarboxylic acid metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to toxic substance</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>xenobiotic metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="12">
      <id>BE0000292</id>
      <name>Serine hydroxymethyltransferase, mitochondrial</name>
      <organism>Humans</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A9909</ref-id>
            <pubmed-id>17142057</pubmed-id>
            <citation>Vatsyayan R, Roy U: Molecular cloning and biochemical characterization of Leishmania donovani serine hydroxymethyltransferase. Protein Expr Purif. 2007 Apr;52(2):433-40. Epub 2006 Oct 26.</citation>
          </article>
          <article>
            <ref-id>A9910</ref-id>
            <pubmed-id>17355947</pubmed-id>
            <citation>Rajinikanth M, Harding SA, Tsai CJ: The glycine decarboxylase complex multienzyme family in Populus. J Exp Bot. 2007;58(7):1761-70. Epub 2007 Mar 12.</citation>
          </article>
          <article>
            <ref-id>A9913</ref-id>
            <pubmed-id>16876889</pubmed-id>
            <citation>Gagnon D, Foucher A, Girard I, Ouellette M: Stage specific gene expression and cellular localization of two isoforms of the serine hydroxymethyltransferase in the protozoan parasite Leishmania. Mol Biochem Parasitol. 2006 Nov;150(1):63-71. Epub 2006 Jul 13.</citation>
          </article>
          <article>
            <ref-id>A13846</ref-id>
            <pubmed-id>16980404</pubmed-id>
            <citation>Mukherjee M, Sievers SA, Brown MT, Johnson PJ: Identification and biochemical characterization of serine hydroxymethyl transferase in the hydrogenosome of Trichomonas vaginalis. Eukaryot Cell. 2006 Dec;5(12):2072-8. Epub 2006 Sep 15.</citation>
          </article>
          <article>
            <ref-id>A9911</ref-id>
            <pubmed-id>17664250</pubmed-id>
            <citation>Chang WN, Tsai JN, Chen BH, Huang HS, Fu TF: Serine hydroxymethyltransferase isoforms are differentially inhibited by leucovorin: characterization and comparison of recombinant zebrafish serine hydroxymethyltransferases. Drug Metab Dispos. 2007 Nov;35(11):2127-37. doi: 10.1124/dmd.107.016840. Epub 2007 Jul 30.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P34897" source="Swiss-Prot">
        <name>Serine hydroxymethyltransferase, mitochondrial</name>
        <general-function>Pyridoxal phosphate binding</general-function>
        <specific-function>Contributes to the de novo mitochondrial thymidylate biosynthesis pathway. Required to prevent uracil accumulation in mtDNA. Interconversion of serine and glycine. Associates with mitochondrial DNA.</specific-function>
        <gene-name>SHMT2</gene-name>
        <locus>12q12-q14</locus>
        <cellular-location>Mitochondrion</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>8.67</theoretical-pi>
        <molecular-weight>55992.385</molecular-weight>
        <chromosome-location>12</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:10852</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>SHMT2</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>U23143</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>746436</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P34897</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GLYM_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.1.2.1</synonym>
          <synonym>Glycine hydroxymethyltransferase</synonym>
          <synonym>Serine methylase</synonym>
          <synonym>SHMT</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000581|Serine hydroxymethyltransferase, mitochondrial
MLYFSLFWAARPLQRCGQLVRMAIRAQHSNAAQTQTGEANRGWTGQESLSDSDPEMWELL
QREKDRQCRGLELIASENFCSRAALEALGSCLNNKYSEGYPGKRYYGGAEVVDEIELLCQ
RRALEAFDLDPAQWGVNVQPYSGSPANLAVYTALLQPHDRIMGLDLPDGGHLTHGYMSDV
KRISATSIFFESMPYKLNPKTGLIDYNQLALTARLFRPRLIIAGTSAYARLIDYARMREV
CDEVKAHLLADMAHISGLVAAKVIPSPFKHADIVTTTTHKTLRGARSGLIFYRKGVKAVD
PKTGREIPYTFEDRINFAVFPSLQGGPHNHAIAAVAVALKQACTPMFREYSLQVLKNARA
MADALLERGYSLVSGGTDNHLVLVDLRPKGLDGARAERVLELVSITANKNTCPGDRSAIT
PGGLRLGAPALTSRQFREDDFRRVVDFIDEGVNIGLEVKSKTAKLQDFKSFLLKDSETSQ
RLANLRQRVEQFARAFPMPGFDEH</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0018939|Serine hydroxymethyltransferase, mitochondrial (SHMT2)
ATGCTGTACTTCTCTTTGTTTTGGGCGGCTCGGCCTCTGCAGAGATGTGGGCAGCTGGTC
AGGATGGCCATTCGGGCTCAGCACAGCAACGCAGCCCAGACTCAGACTGGGGAAGCAAAC
AGGGGCTGGACAGGCCAGGAGAGCCTGTCGGACAGTGATCCTGAGATGTGGGAGTTGCTG
CAGAGGGAGAAGGACAGGCAGTGTCGTGGCCTGGAGCTCATTGCCTCAGAGAACTTCTGC
AGCCGAGCTGCGCTGGAGGCCCTGGGGTCCTGTCTGAACAACAAGTACTCGGAGGGTTAT
CCTGGCAAGAGATACTATGGGGGAGCAGAGGTGGTGGATGAAATTGAGCTGCTGTGCCAG
CGCCGGGCCTTGGAAGCCTTTGACCTGGATCCTGCACAGTGGGGAGTCAATGTCCAGCCC
TACTCCGGGTCCCCAGCCAACCTGGCCGTCTACACAGCCCTTCTGCAACCTCACGACCGG
ATCATGGGGCTGGACCTGCCCGATGGGGGCCATCTCACCCACGGCTACATGTCTGACGTC
AAGCGGATATCAGCCACGTCCATCTTCTTCGAGTCTATGCCCTATAAGCTCAACCTGGCA
CTGACTGCTCGACTTTTCCGGCCACGGCTCATCATAGCTGGCACCAGCGCCTATGCTCGC
CTCATTGACTACGCCCGCATGAGAGAGGTGTGTGATGAAGTCAAAGCACACCTGCTGGCA
GACATGGCCCACATCAGTGGCCTGGTGGCTGCCAAGGTGATTCCCTCGCCTTTCAAGCAC
GCGGACATCGTCACCACCACTACTCACAAGACTCTTCGAGGGGCCAGGTCAGGGCTCATC
TTCTACCGGAAAGGGGTGAAGGCTGTGGACCCCAAGACTGGCCGGGAGATCCCTTACACA
TTTGAGGACCGAATCAACTTTGCCGTGTTCCCATCCCTGCAGGGGGGCCCCCACAATCAT
GCCATTGCTGCAGTAGCTGTGGCCCTAAAGCAGGCCTGCACCCCCATGTTCCGGGAGTAC
TCCCTGCAGGTTCTGAAGAATGCTCGGGCCATGGCAGATGCCCTGCTAGAGCGAGGCTAC
TCACTGGTATCAGGTGGTACTGACAACCACCTGGTGCTGGTGGACCTGCGGCCCAAGGGC
CTGGATGGAGCTCGGGCTGAGCGGGTGCTAGAGCTTGTATCCATCACTGCCAACAAGAAC
ACCTGTCCTGGAGACCGAAGTGCCATCACACCGGGCGGCCTGCGGCTTGGGGCCCCAGCC
TTAACTTCTCGACAGTTCCGTGAGGATGACTTCCGGAGAGTTGTGGACTTTATAGATGAA
GGGGTCAACATTGGCTTAGAGGTGAAGAGCAAGACTGCCAAGCTCCAGGATTTCAAATCC
TTCCTGCTTAAGGACTCAGAAACAAGTCAGCGTCTGGCCAACCTCAGGCAACGGGTGGAG
CAGTTTGCCAGGGCCTTCCCCATGCCTGGTTTTGATGAGCATTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00464</identifier>
            <name>SHMT</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>microtubule cytoskeleton</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial inner membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial intermembrane space</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial matrix</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial nucleoid</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>amino acid binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>chromatin binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine hydroxymethyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>L-allo-threonine aldolase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>pyridoxal phosphate binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>folic acid metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine biosynthetic process from serine</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>L-serine biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>one-carbon metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein homotetramerization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tetrahydrofolate interconversion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>vitamin metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>water-soluble vitamin metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="13">
      <id>BE0002306</id>
      <name>Glycine N-acyltransferase-like protein 2</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A161545</ref-id>
            <pubmed-id>20305126</pubmed-id>
            <citation>Waluk DP, Schultz N, Hunt MC: Identification of glycine N-acyltransferase-like 2 (GLYATL2) as a transferase that produces N-acyl glycines in humans. FASEB J. 2010 Aug;24(8):2795-803. doi: 10.1096/fj.09-148551. Epub 2010 Mar 19.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q8WU03" source="Swiss-Prot">
        <name>Glycine N-acyltransferase-like protein 2</name>
        <general-function>Glycine n-acyltransferase activity</general-function>
        <specific-function>Mitochondrial acyltransferase which transfers the acyl group to the N-terminus of glycine. Conjugates numerous substrates, such as arachidonoyl-CoA and saturated medium and long-chain acyl-CoAs ranging from chain-length C8:0-CoA to C18:0-CoA, to form a variety of N-acylglycines. Shows a preference for monounsaturated fatty acid oleoyl-CoA (C18:1-CoA) as an acyl donor. Does not exhibit any activity toward C22:6-CoA and chenodeoxycholoyl-CoA, nor toward serine or alanine.</specific-function>
        <gene-name>GLYATL2</gene-name>
        <locus>11q12.1</locus>
        <cellular-location>Endoplasmic reticulum</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.67</theoretical-pi>
        <molecular-weight>34277.055</molecular-weight>
        <chromosome-location>11</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:24178</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GLYATL2</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF426250</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>29243559</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q8WU03</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GLYL2_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.3.1.13</synonym>
          <synonym>Acyl-CoA:glycine N-acyltransferase-like protein 2</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016748|Glycine N-acyltransferase-like protein 2
MLVLHNSQKLQILYKSLEKSIPESIKVYGAIFNIKDKNPFNMEVLVDAWPDYQIVITRPQ
KQEMKDDQDHYTNTYHIFTKAPDKLEEVLSYSNVISWEQTLQIQGCQEGLDEAIRKVATS
KSVQVDYMKTILFIPELPKKHKTSSNDKMELFEVDDDNKEGNFSNMFLDASHAGLVNEHW
AFGKNERSLKYIERCLQDFLGFGVLGPEGQLVSWIVMEQSCELRMGYTVPKYRHQGNMLQ
IGYHLEKYLSQKEIPFYFHVADNNEKSLQALNNLGFKICPCGWHQWKCTPKKYC</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0016749|Glycine N-acyltransferase-like protein 2 (GLYATL2)
ATGCTTGTGCTTCATAACTCTCAGAAGCTGCAGATTCTGTATAAATCCTTAGAAAAGAGC
ATCCCTGAATCCATAAAGGTATATGGCGCCATTTTCAACATAAAAGATAAAAACCCTTTC
AACATGGAGGTGCTGGTAGATGCCTGGCCAGATTACCAGATCGTCATTACCCGGCCTCAG
AAACAGGAGATGAAAGATGACCAGGATCATTATACCAACACTTACCACATCTTCACCAAA
GCTCCTGACAAATTAGAGGAAGTCCTGTCATACTCCAATGTAATCAGCTGGGAGCAAACT
TTGCAGATCCAAGGTTGCCAAGAGGGCTTGGATGAAGCAATAAGAAAGGTTGCAACTTCA
AAATCAGTGCAGGTAGATTACATGAAAACCATCCTCTTTATACCGGAATTACCAAAGAAA
CACAAGACCTCAAGTAATGACAAGATGGAGTTATTTGAAGTGGATGATGATAACAAGGAA
GGAAACTTTTCAAACATGTTCTTAGATGCTTCACATGCAGGTCTTGTGAATGAACACTGG
GCCTTTGGGAAAAATGAGAGGAGCTTGAAATATATTGAACGCTGCCTCCAGGATTTTCTA
GGATTTGGTGTGCTGGGTCCAGAGGGCCAGCTTGTCTCTTGGATTGTGATGGAACAGTCC
TGTGAGTTGAGAATGGGTTATACTGTCCCCAAATACAGACACCAAGGCAACATGTTGCAA
ATTGGTTATCATCTTGAAAAGTATCTTTCTCAGAAAGAAATCCCATTTTATTTCCATGTG
GCAGATAATAATGAGAAAAGCCTACAGGCACTGAACAATTTGGGGTTTAAGATTTGTCCT
TGTGGCTGGCATCAGTGGAAATGCACCCCCAAGAAATATTGTTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF08444</identifier>
            <name>Gly_acyl_tr_C</name>
          </pfam>
          <pfam>
            <identifier>PF06021</identifier>
            <name>Gly_acyl_tr_N</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>endoplasmic reticulum</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine N-acyltransferase activity</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="14">
      <id>BE0002307</id>
      <name>Glycine N-acyltransferase-like protein 1</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A101692</ref-id>
            <pubmed-id>22475485</pubmed-id>
            <citation>Matsuo M, Terai K, Kameda N, Matsumoto A, Kurokawa Y, Funase Y, Nishikawa K, Sugaya N, Hiruta N, Kishimoto T: Designation of enzyme activity of glycine-N-acyltransferase family genes and depression of glycine-N-acyltransferase in human hepatocellular carcinoma. Biochem Biophys Res Commun. 2012 Apr 20;420(4):901-6. doi: 10.1016/j.bbrc.2012.03.099. Epub 2012 Mar 27.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q969I3" source="Swiss-Prot">
        <name>Glycine N-acyltransferase-like protein 1</name>
        <general-function>Glycine n-acyltransferase activity</general-function>
        <specific-function>Acyltransferase which transfers an acyl group to the N-terminus of glutamine. Can use phenylacetyl-CoA as an acyl donor.</specific-function>
        <gene-name>GLYATL1</gene-name>
        <locus>11q12.1</locus>
        <cellular-location>Mitochondrion</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.86</theoretical-pi>
        <molecular-weight>35100.895</molecular-weight>
        <chromosome-location>11</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:30519</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GLYATL1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>DQ084381</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>71384826</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q969I3</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GLYL1_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.3.1.68</synonym>
          <synonym>Acyl-CoA:glycine N-acyltransferase-like protein 1</synonym>
          <synonym>Glutamine N-acyltransferase</synonym>
          <synonym>GNAT</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004530|Glycine N-acyltransferase-like protein 1
MILLNNSHKLLALYKSLARSIPESLKVYGSVYHINHGNPFNMEVLVDSWPEYQMVIIRPQ
KQEMTDDMDSYTNVYRMFSKEPQKSEEVLKNCEIVNWKQRLQIQGLQESLGEGIRVATFS
KSVKVEHSRALLLVTEDILKLNASSKSKLGSWAETGHPDDEFESETPNFKYAQLDVSYSG
LVNDNWKRGKNERSLHYIKRCIEDLPAACMLGPEGVPVSWVTMDPSCEVGMAYSMEKYRR
TGNMARVMVRYMKYLRQKNIPFYISVLEENEDSRRFVGQFGFFEASCEWHQWTCYPQNLV
PF</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0019264|Glycine N-acyltransferase-like protein 1 (GLYATL1)
ATGATCCTACTGAATAACTCCCATAAGCTGCTGGCCCTATACAAATCCTTGGCCAGGAGC
ATCCCTGAGTCCCTGAAGGTGTATGGCTCTGTGTATCACATCAATCACGGGAACCCCTTC
AACATGGAGGTGCTGGTGGATTCCTGGCCTGAATATCAGATGGTTATTATCCGGCCTCAA
AAGCAGGAGATGACTGATGACATGGATTCATACACAAACGTATATCGTATGTTCTCCAAA
GAGCCTCAAAAATCAGAAGAAGTTTTGAAAAATTGTGAGATCGTAAACTGGAAACAGAGA
CTCCAAATCCAAGGTCTTCAAGAAAGTTTAGGTGAGGGGATAAGAGTGGCTACATTTTCA
AAGTCAGTGAAAGTAGAGCATTCGAGAGCACTCCTCTTGGTTACGGAAGATATTCTGAAG
CTCAATGCCTCCAGTAAAAGCAAGCTTGGAAGCTGGGCTGAGACAGGCCACCCAGATGAT
GAATTTGAAAGTGAAACTCCCAACTTTAAGTATGCCCAGCTGGATGTCTCTTATTCTGGG
CTGGTAAATGACAACTGGAAGCGAGGGAAGAATGAGAGGAGCCTGCATTACATCAAGCGC
TGCATAGAAGACCTGCCAGCAGCCTGTATGCTCGGCCCAGAGGGAGTCCCGGTCTCATGG
GTAACCATGGACCCTTCTTGTGAAGTAGGAATGGCCTACAGCATGGAAAAATACCGAAGG
ACAGGCAACATGGCACGAGTGATGGTGCGATACATGAAATATCTGCGTCAGAAGAATATT
CCATTTTACATCTCTGTGTTGGAAGAAAATGAAGACTCCCGCAGATTTGTGGGGCAGTTT
GGTTTCTTTGAGGCCTCCTGTGAGTGGCACCAATGGACTTGCTACCCACAGAATCTAGTT
CCATTTTAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF08444</identifier>
            <name>Gly_acyl_tr_C</name>
          </pfam>
          <pfam>
            <identifier>PF06021</identifier>
            <name>Gly_acyl_tr_N</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glutamine N-acyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine N-acyltransferase activity</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="15">
      <id>BE0000102</id>
      <name>Alanine--glyoxylate aminotransferase 2, mitochondrial</name>
      <organism>Humans</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A13847</ref-id>
            <pubmed-id>15240345</pubmed-id>
            <citation>Baker PR, Cramer SD, Kennedy M, Assimos DG, Holmes RP: Glycolate and glyoxylate metabolism in HepG2 cells. Am J Physiol Cell Physiol. 2004 Nov;287(5):C1359-65. Epub 2004 Jul 7.</citation>
          </article>
          <article>
            <ref-id>A6728</ref-id>
            <pubmed-id>6703688</pubmed-id>
            <citation>Takada Y, Mori T, Noguchi T: The effect of vitamin B6 deficiency on alanine: glyoxylate aminotransferase isoenzymes in rat liver. Arch Biochem Biophys. 1984 Feb 15;229(1):1-6.</citation>
          </article>
          <article>
            <ref-id>A9920</ref-id>
            <pubmed-id>16970975</pubmed-id>
            <citation>Dutta U, Cohenford MA, Guha M, Dain JA: Non-enzymatic interactions of glyoxylate with lysine, arginine, and glucosamine: a study of advanced non-enzymatic glycation like compounds. Bioorg Chem. 2007 Feb;35(1):11-24. Epub 2006 Sep 12.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9BYV1" source="Swiss-Prot">
        <name>Alanine--glyoxylate aminotransferase 2, mitochondrial</name>
        <general-function>Pyridoxal phosphate binding</general-function>
        <specific-function>Can metabolize asymmetric dimethylarginine (ADMA) via transamination to alpha-keto-delta-(NN-dimethylguanidino) valeric acid (DMGV). ADMA is a potent inhibitor of nitric-oxide (NO) synthase, and this activity provides mechanism through which the kidney regulates blood pressure.</specific-function>
        <gene-name>AGXT2</gene-name>
        <locus>5p13</locus>
        <cellular-location>Mitochondrion</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>7.91</theoretical-pi>
        <molecular-weight>57155.905</molecular-weight>
        <chromosome-location>5</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:14412</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>AGXT2</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AJ292204</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>12406973</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9BYV1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>AGT2_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>(R)-3-amino-2-methylpropionate--pyruvate transaminase</synonym>
          <synonym>2.6.1.44</synonym>
          <synonym>AGT 2</synonym>
          <synonym>AGT2</synonym>
          <synonym>Beta-ALAAT II</synonym>
          <synonym>Beta-alanine-pyruvate aminotransferase</synonym>
          <synonym>D-AIBAT</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000204|Alanine--glyoxylate aminotransferase 2, mitochondrial
MTLIWRHLLRPLCLVTSAPRILEMHPFLSLGTSRTSVTKLSLHTKPRMPPCDFMPERYQS
LGYNRVLEIHKEHLSPVVTAYFQKPLLLHQGHMEWLFDAEGSRYLDFFSGIVTVSVGHCH
PKVNAVAQKQLGRLWHTSTVFFHPPMHEYAEKLAALLPEPLKVIFLVNSGSEANELAMLM
ARAHSNNIDIISFRGAYHGCSPYTLGLTNVGTYKMELPGGTGCQPTMCPDVFRGPWGGSH
CRDSPVQTIRKCSCAPDCCQAKDQYIEQFKDTLSTSVAKSIAGFFAEPIQGVNGVVQYPK
GFLKEAFELVRARGGVCIADEVQTGFGRLGSHFWGFQTHDVLPDIVTMAKGIGNGFPMAA
VITTPEIAKSLAKCLQHFNTFGGNPMACAIGSAVLEVIKEENLQENSQEVGTYMLLKFAK
LRDEFEIVGDVRGKGLMIGIEMVQDKISCRPLPREEVNQIHEDCKHMGLLVGRGSIFSQT
FRIAPSMCITKPEVDFAVEVFRSALTQHMERRAK</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0016012|Alanine--glyoxylate aminotransferase 2, mitochondrial (AGXT2)
ATGACTCTAATCTGGAGACATTTGCTGAGACCCTTGTGCCTGGTCACTTCCGCTCCCAGG
ATCCTTGAGATGCATCCTTTCCTGAGCCTAGGTACTTCCCGGACATCAGTAACCAAGCTC
AGTCTTCATACAAAGCCCAGAATGCCTCCATGTGACTTCATGCCTGAAAGATACCAGTCC
CTTGGCTACAACCGTGTCCTGGAAATCCACAAGGAACATCTTTCTCCTGTGGTGACGGCA
TATTTCCAGAAACCCCTGCTGCTCCACCAGGGGCACATGGAGTGGCTCTTTGATGCTGAA
GGAAGCAGATACCTGGATTTCTTTTCCGGGATTGTTACTGTCAGTGTTGGCCATTGCCAC
CCAAAGGTGAATGCAGTGGCACAAAAGCAGCTCGGCCGCCTGTGGCATACAAGCACCGTC
TTCTTCCACCCTCCAATGCATGAATATGCAGAGAAGCTTGCCGCACTTCTTCCTGAGCCT
CTTAAGGTCATTTTCTTGGTGAACAGTGGCTCAGAAGCCAATGAGCTGGCCATGCTGATG
GCCAGGGCGCACTCAAACAACATAGACATCATTTCTTTCAGAGGAGCCTACCATGGATGC
AGTCCTTACACACTTGGCTTGACAAACGTAGGGACCTACAAGATGGAACTCCCTGGTGGG
ACAGGTTGCCAACCAACAATGTGTCCAGATGTTTTTCGTGGCCCTTGGGGAGGAAGCCAC
TGTCGAGATTCTCCAGTGCAAACAATCAGGAAGTGCAGCTGTGCACCAGACTGCTGCCAA
GCTAAAGATCAGTATATTGAGCAATTCAAAGATACGCTGAGCACATCTGTGGCCAAGTCA
ATTGCTGGATTTTTCGCAGAACCTATTCAAGGTGTGAATGGAGTTGTCCAGTACCCAAAG
GGGTTTCTAAAGGAAGCCTTTGAGCTGGTGCGAGCAAGGGGAGGCGTGTGCATTGCAGAT
GAAGTGATTAAAGAAGAAAATCTACAGGAAAACAGTCAAGAAGTTGGGACCTACATGTTA
CTAAAGTTTGCTAAGCTGCGGGATGAATTTGAAATTGTTGGAGACGTCCGAGGCAAAGGT
CTCATGATAGGCATAGAAATGGTGCAGGATAAGATAAGCTGTCGGCCTCTTCCCCGTGAA
GAAGTAAATCAGATCCATGAGGACTGCAAGCACATGGGACTCCTCGTTGGCAGAGGCAGC
ATTTTTTCTCAGACATTTCGCATTGCGCCCTCAATGTGCATCACTAAACCAGAAGTTGAT
TTTGCAGTAGAAGTATTTCGTTCTGCCTTAACCCAACACATGGAAAGAAGAGCTAAGTAA
</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00202</identifier>
            <name>Aminotran_3</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial matrix</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>(R)-3-amino-2-methylpropionate-pyruvate transaminase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>alanine-glyoxylate transaminase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>beta-alanine-pyruvate transaminase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>identical protein binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>pyridoxal phosphate binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular nitrogen compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine biosynthetic process, by transamination of glyoxylate</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glyoxylate catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glyoxylate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>L-alanine catabolic process, by transamination</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>nucleobase-containing small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of nitric oxide biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>pyrimidine nucleobase metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>pyrimidine nucleoside catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="16">
      <id>BE0002309</id>
      <name>Peroxisomal sarcosine oxidase</name>
      <organism>Humans</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A192450</ref-id>
            <pubmed-id>14766747</pubmed-id>
            <citation>Goyer A, Johnson TL, Olsen LJ, Collakova E, Shachar-Hill Y, Rhodes D, Hanson AD: Characterization and metabolic function of a peroxisomal sarcosine and pipecolate oxidase from Arabidopsis. J Biol Chem. 2004 Apr 23;279(17):16947-53. doi: 10.1074/jbc.M400071200. Epub 2004 Feb 6.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9P0Z9" source="Swiss-Prot">
        <name>Peroxisomal sarcosine oxidase</name>
        <general-function>Sarcosine oxidase activity</general-function>
        <specific-function>Metabolizes sarcosine, L-pipecolic acid and L-proline.</specific-function>
        <gene-name>PIPOX</gene-name>
        <locus>17q11.2</locus>
        <cellular-location>Peroxisome</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>8.54</theoretical-pi>
        <molecular-weight>44065.515</molecular-weight>
        <chromosome-location>17</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:17804</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>PIPOX</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF134593</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>7157903</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9P0Z9</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>SOX_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1.5.3.1</synonym>
          <synonym>L-pipecolate oxidase</synonym>
          <synonym>L-pipecolic acid oxidase</synonym>
          <synonym>LPIPOX</synonym>
          <synonym>PSO</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011662|Peroxisomal sarcosine oxidase
MAAQKDLWDAIVIGAGIQGCFTAYHLAKHRKRILLLEQFFLPHSRGSSHGQSRIIRKAYL
EDFYTRMMHECYQIWAQLEHEAGTQLHRQTGLLLLGMKENQELKTIQANLSRQRVEHQCL
SSEELKQRFPNIRLPRGEVGLLDNSGGVIYAYKALRALQDAIRQLGGIVRDGEKVVEINP
GLLVTVKTTSRSYQAKSLVITAGPWTNQLLRPLGIEMPLQTLRINVCYWREMVPGSYGVS
QAFPCFLWLGLCPHHIYGLPTGEYPGLMKVSYHHGNHADPEERDCPTARTDIGDVQILSS
FVRDHLPDLKPEPAVIESCMYTNTPDEQFILDRHPKYDNIVIGAGFSGHGFKLAPVVGKI
LYELSMKLTPSYDLAPFRISRFPSLGKAHL</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0011663|Peroxisomal sarcosine oxidase (PIPOX)
ATGGCGGCTCAGAAAGATCTCTGGGACGCCATTGTGATTGGGGCGGGGATCCAGGGCTGC
TTCACTGCATACCACCTGGCCAAACACAGGAAGAGGATCCTCCTGCTGGAGCAGTTCTTT
CTACCACACTCCCGAGGAAGCTCCCATGGACAAAGCCGGATAATCCGAAAGGCGTACCTG
GAAGACTTTTACACCCGGATGATGCATGAGTGCTATCAGATATGGGCCCAGCTGGAGCAC
GAGGCTGGAACCCAATTGCACAGGCAGACTGGATTACTGCTGCTGGGAATGAAAGAGAAT
CAAGAATTAAAGACAATCCAGGCCAATCTGTCGAGGCAGAGGGTAGAACACCAGTGTCTT
TCATCTGAGGAACTGAAGCAACGTTTCCCAAATATTCGGTTGCCCAGGGGAGAAGTGGGG
CTCTTGGACAATTCCGGAGGAGTTATCTATGCATATAAGGCCCTCAGAGCCCTGCAGGAT
GCAATTCGACAGCTAGGAGGCATAGTGCGTGACGGAGAGAAGGTGGTGGAGATAAACCCA
GGGCTACTGGTCACGGTGAAAACCACCTCCAGGAGCTACCAAGCTAAGAGCTTGGTCATC
ACAGCAGGTCCTTGGACCAACCAGCTCCTCCGTCCCCTGGGCATTGAGATGCCTCTCCAG
ACCCTGCGGATCAACGTGTGTTACTGGCGAGAGATGGTTCCTGGGAGCTATGGTGTGTCC
CAGGCCTTTCCGTGCTTCCTGTGGCTGGGCTTGTGTCCCCACCACATCTACGGACTGCCC
ACAGGAGAGTACCCAGGGCTGATGAAGGTCAGCTATCACCACGGCAACCACGCAGACCCT
GAGGAGCGGGACTGCCCCACAGCACGCACAGACATCGGAGACGTCCAGATCCTGAGCAGC
TTTGTCAGAGATCACTTACCTGATCTGAAGCCCGAGCCTGCTGTCATTGAGAGCTGCATG
TACACGAATACCCCTGATGAGCAGTTCATTCTCGATCGCCACCCAAAGTATGACAACATT
GTCATTGGTGCTGGATTCTCTGGGCACGGGTTCAAGCTGGCCCCTGTGGTGGGGAAGATC
CTGTATGAATTAAGCATGAAATTAACACCATCTTATGACTTGGCACCTTTTCGAATCAGC
CGTTTCCCAAGCCTGGGCAAAGCCCACCTTTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01266</identifier>
            <name>DAO</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>peroxisomal matrix</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>peroxisome</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>L-pipecolate oxidase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>receptor binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>sarcosine oxidase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular nitrogen compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>L-lysine catabolic process to acetyl-CoA via L-pipecolate</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>lysine catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>oxidation-reduction process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tetrahydrofolate metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="17">
      <id>BE0000534</id>
      <name>Glutamate receptor ionotropic, NMDA 3B</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A6182</ref-id>
            <pubmed-id>17502428</pubmed-id>
            <citation>Smothers CT, Woodward JJ: Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-D-aspartate NR1 and NR3 subunits. J Pharmacol Exp Ther. 2007 Aug;322(2):739-48. Epub 2007 May 14.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O60391" source="Swiss-Prot">
        <name>Glutamate receptor ionotropic, NMDA 3B</name>
        <general-function>Nmda glutamate receptor activity</general-function>
        <specific-function>NMDA receptor subtype of glutamate-gated ion channels with reduced single-channel conductance, low calcium permeability and low voltage-dependent sensitivity to magnesium. Mediated by glycine.</specific-function>
        <gene-name>GRIN3B</gene-name>
        <locus>19p13.3</locus>
        <cellular-location>Cell membrane</cellular-location>
        <transmembrane-regions>565-585
649-669
831-851</transmembrane-regions>
        <signal-regions>1-22</signal-regions>
        <theoretical-pi>9.5</theoretical-pi>
        <molecular-weight>112990.98</molecular-weight>
        <chromosome-location>19</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:16768</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GRIN3B</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AC004528</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>3025446</identifier>
          </external-identifier>
          <external-identifier>
            <resource>IUPHAR</resource>
            <identifier>461</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>O60391</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>NMD3B_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>GluN3B</synonym>
          <synonym>N-methyl-D-aspartate receptor subtype 3B</synonym>
          <synonym>NMDAR3B</synonym>
          <synonym>NR3B</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001066|Glutamate receptor ionotropic, NMDA 3B
MEFVRALWLGLALALGPGSAGGHPQPCGVLARLGGSVRLGALLPRAPLARARARAALARA
ALAPRLPHNLSLELVVAAPPARDPASLTRGLCQALVPPGVAALLAFPEARPELLQLHFLA
AATETPVLSLLRREARAPLGAPNPFHLQLHWASPLETLLDVLVAVLQAHAWEDVGLALCR
TQDPGGLVALWTSRAGRPPQLVLDLSRRDTGDAGLRARLAPMAAPVGGEAPVPAAVLLGC
DIARARRVLEAVPPGPHWLLGTPLPPKALPTAGLPPGLLALGEVARPPLEAAIHDIVQLV
ARALGSAAQVQPKRALLPAPVNCGDLQPAGPESPGRFLARFLANTSFQGRTGPVWVTGSS
QVHMSRHFKVWSLRRDPRGAPAWATVGSWRDGQLDLEPGGASARPPPPQGAQVWPKLRVV
TLLEHPFVFARDPDEDGQCPAGQLCLDPGTNDSATLDALFAALANGSAPRALRKCCYGYC
IDLLERLAEDTPFDFELYLVGDGKYGALRDGRWTGLVGDLLAGRAHMAVTSFSINSARSQ
VVDFTSPFFSTSLGIMVRARDTASPIGAFMWPLHWSTWLGVFAALHLTALFLTVYEWRSP
YGLTPRGRNRSTVFSYSSALNLCYAILFRRTVSSKTPKCPTGRLLMNLWAIFCLLVLSSY
TANLAAVMVGDKTFEELSGIHDPKLHHPAQGFRFGTVWESSAEAYIKKSFPDMHAHMRRH
SAPTTPRGVAMLTSDPPKLNAFIMDKSLLDYEVSIDADCKLLTVGKPFAIEGYGIGLPQN
SPLTSNLSEFISRYKSSGFIDLLHDKWYKMVPCGKRVFAVTETLQMSIYHFAGLFVLLCL
GLGSALLSSLGEHAFFRLALPRIRKGSRLQYWLHTSQKIHRALNTEPPEGSKEETAEAEP
SGPEVEQQQQQQDQPTAPEGWKRARRAVDKERRVRFLLEPAVVVAPEADAEAEAAPREGP
VWLCSYGRPPAARPTGAPQPGELQELERRIEVARERLRQALVRRGQLLAQLGDSARHRPR
RLLQARAAPAEAPPHSGRPGSQE</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0016125|Glutamate receptor ionotropic, NMDA 3B (GRIN3B)
ATGGAGTTTGTGCGGGCGCTGTGGCTGGGCCTGGCGCTGGCGCTGGGGCCGGGGTCCGCG
GGGGGCCACCCTCAGCCGTGCGGCGTCCTGGCGCGCCTCGGGGGCTCCGTGCGCCTGGGC
GCCCTCCTGCCCCGCGCGCCTCTCGCCCGCGCCCGCGCCCGCGCCGCCCTGGCCCGGGCC
GCCCTGGCGCCGCGGCTGCCGCACAACCTGAGCTTGGAGCTGGTGGTCGCCGCGCCCCCC
GCCCGCGACCCCGCCTCGCTGACCCGCGGCCTGTGCCAGGCGCTGGTGCCTCCGGGCGTG
GCGGCCCTGCTCGCCTTTCCCGAGGCTCGGCCCGAGCTGCTGCAGCTGCACTTCCTGGCG
GCGGCCACCGAGACCCCCGTGCTCAGCCTGCTGCGGCGGGAGGCGCGCGCGCCCCTCGGA
GCCCCGAACCCATTCCACCTGCAGCTGCACTGGGCCAGCCCCCTGGAGACGCTGCTGGAT
GTGCTGGTGGCGGTGCTGCAGGCGCACGCCTGGGAAGACGTCGGCCTGGCCCTGTGCCGC
ACTCAGGACCCCGGCGGCCTGGTGGCCCTCTGGACAAGCCGGGCTGGCCGGCCCCCACAG
CTGGTCCTGGACCTAAGCCGGCGGGACACGGGAGATGCAGGACTGCGGGCACGCCTGGCC
CCGATGGCGGCGCCAGTGGGGGGTGAAGCACCGGTACCCGCGGCGGTCCTCCTCGGCTGT
GACATCGCCCGTGCCCGTCGGGTGCTGGAGGCCGTACCTCCCGGCCCCCACTGGCTGTTG
GGGACACCACTGCCGCCCAAGGCCCTGCCCACCGCGGGGCTGCCACCAGGGCTGCTGGCG
CTGGGCGAGGTGGCACGACCCCCGCTGGAGGCCGCCATCCATGACATTGTGCAACTGGTG
GCCCGGGCGCTGGGCAGTGCGGCCCAGGTGCAGCCGAAGCGAGCCCTCCTCCCCGCCCCG
GTCAACTGCGGGGACCTGCAGCCGGCCGGGCCCGAGTCCCCGGGGCGCTTCTTGGCACGG
TTCCTGGCCAACACGTCCTTCCAGGGCCGCACGGGCCCCGTGTGGGTGACAGGCAGCTCC
CAGGTACACATGTCTCGGCACTTTAAGGTGTGGAGCCTTCGCCGGGACCCACGGGGCGCC
CCGGCCTGGGCCACGGTGGGCAGCTGGCGGGACGGCCAGCTGGACTTGGAACCGGGAGGT
GCCTCTGCACGGCCCCCGCCCCCACAGGGTGCCCAGGTCTGGCCCAAGCTGCGTGTGGTA
ACGCTGTTGGAACACCCATTTGTGTTTGCCCGTGATCCAGACGAAGACGGGCAGTGCCCA
GCGGGGCAGCTGTGCCTGGACCCTGGCACCAACGACTCGGCCACCCTGGACGCACTGTTC
GCCGCGCTGGCCAACGGCTCAGCGCCCCGTGCCCTGCGCAAGTGCTGCTACGGCTACTGC
ATTGACCTGCTGGAGCGGCTGGCGGAGGACACGCCCTTCGACTTCGAGCTGTACCTCGTG
GGTGACGGCAAGTACGGCGCCCTGCGGGACGGCCGCTGGACCGGCCTGGTCGGGGACCTG
CTGGCCGGCCGGGCCCACATGGCGGTCACCAGCTTCAGTATCAACTCCGCCCGCTCACAG
GTGGTGGACTTCACCAGCCCCTTCTTCTCCACCAGCCTGGGCATCATGGTGCGGGCACGG
GACACGGCCTCACCCATCGGTGCCTTTATGTGGCCCCTGCACTGGTCCACGTGGCTGGGC
GTCTTTGCGGCCCTGCACCTCACCGCGCTCTTCCTCACCGTGTACGAGTGGCGTAGCCCC
TACGGCCTCACGCCACGTGGCCGCAACCGCAGCACCGTCTTCTCCTACTCCTCAGCCCTC
AACCTGTGCTACGCCATCCTCTTCAGACGCACCGTGTCCAGCAAGACGCCCAAGTGCCCC
ACGGGCCGCCTGCTCATGAACCTCTGGGCCATCTTCTGCCTGCTGGTGCTGTCCAGCTAC
ACGGCCAACCTGGCTGCCGTCATGGTCGGGGACAAGACCTTCGAGGAGCTGTCGGGGATC
CACGACCCCAAGCTGCACCACCCGGCGCAGGGCTTCCGCTTCGGCACCGTGTGGGAGAGC
AGCGCCGAGGCGTACATCAAGAAGAGCTTCCCCGACATGCACGCACACATGCGGCGCCAC
AGCGCGCCCACCACGCCCCGCGGCGTCGCCATGCTCACGAGCGACCCCCCCAAGCTCAAC
GCCTTCATCATGGACAAGTCGCTCCTGGACTACGAGGTCTCCATCGACGCCGACTGCAAA
CTGCTGACCGTGGGAAAGCCCTTCGCCATTGAGGGCTATGGGATCGGACTGCCCCAGAAC
TCGCCGCTCACCTCCAACCTGTCCGAGTTCATCAGCCGCTACAAGTCCTCCGGCTTCATC
GACCTGCTCCACGACAAGTGGTACAAGATGGTGCCTTGCGGCAAGCGGGTCTTTGCGGTT
ACAGAGACCCTGCAGATGAGCATCTACCACTTCGCGGGCCTCTTCGTGTTGCTGTGCCTG
GGCCTGGGCAGCGCTCTGCTCAGCTCGCTGGGCGAGCACGCCTTCTTCCGCCTGGCGCTG
CCGCGCATCCGCAAGGGGAGCAGGCTGCAGTACTGGCTGCACACCAGCCAGAAAATCCAC
CGCGCCCTCAACACGGAGCCACCAGAGGGGTCGAAGGAGGAGACGGCAGAGGCGGAGCCC
AGCGGCCCCGAGGTGGAGCAGCAGCAGCAGCAGCAGGACCAGCCAACGGCTCCGGAGGGC
TGGAAACGGGCGCGCCGGGCCGTGGACAAGGAGCGCCGCGTGCGCTTCCTGCTGGAGCCC
GCCGTGGTTGTGGCACCCGAAGCGGACGCGGAGGCGGAGGCTGCGCCGCGAGAGGGCCCC
GTCTGGCTGTGCTCCTACGGCCGCCCGCCCGCCGCAAGGCCCACGGGGGCCCCCCAGCCC
GGGGAGCTGCAGGAGCTGGAGCGCCGCATCGAAGTCGCGCGTGAGCGGCTCCGCCAGGCC
CTGGTGCGGCGCGGCCAGCTCCTGGCACAGCTCGGGGACAGCGCACGTCACCGGCCTCGG
CGCTTGCTTCAGGCCAGAGCGGCCCCCGCGGAGGCCCCACCACACTCTGGCCGACCGGGG
AGCCAGGAATGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00060</identifier>
            <name>Lig_chan</name>
          </pfam>
          <pfam>
            <identifier>PF10613</identifier>
            <name>Lig_chan-Glu_bd</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cell junction</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>dendrite</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>neuronal cell body</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>NMDA selective glutamate receptor complex</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>postsynaptic membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>calcium channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>cation channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>extracellular-glutamate-gated ion channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>neurotransmitter binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>neurotransmitter receptor activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>NMDA glutamate receptor activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ion transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ionotropic glutamate receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein insertion into membrane</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of calcium ion transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>synaptic transmission, glutamatergic</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="18">
      <id>BE0000433</id>
      <name>Glycine receptor subunit alpha-1</name>
      <organism>Humans</organism>
      <actions>
        <action>ligand</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A9899</ref-id>
            <pubmed-id>17154252</pubmed-id>
            <citation>Heinze L, Harvey RJ, Haverkamp S, Wassle H: Diversity of glycine receptors in the mouse retina: localization of the alpha4 subunit. J Comp Neurol. 2007 Feb 1;500(4):693-707.</citation>
          </article>
          <article>
            <ref-id>A9900</ref-id>
            <pubmed-id>16884688</pubmed-id>
            <citation>Eulenburg V, Becker K, Gomeza J, Schmitt B, Becker CM, Betz H: Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia. Biochem Biophys Res Commun. 2006 Sep 22;348(2):400-5. Epub 2006 Jul 26.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P23415" source="Swiss-Prot">
        <name>Glycine receptor subunit alpha-1</name>
        <general-function>Transmitter-gated ion channel activity</general-function>
        <specific-function>The glycine receptor is a neurotransmitter-gated ion channel. Binding of glycine to its receptor increases the chloride conductance and thus produces hyperpolarization (inhibition of neuronal firing).</specific-function>
        <gene-name>GLRA1</gene-name>
        <locus>5q32</locus>
        <cellular-location>Cell junction</cellular-location>
        <transmembrane-regions>248-274
281-298
313-336
429-446</transmembrane-regions>
        <signal-regions>1-28</signal-regions>
        <theoretical-pi>9.04</theoretical-pi>
        <molecular-weight>52623.35</molecular-weight>
        <chromosome-location>5</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:4326</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GLRA1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>X52009</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>31851</identifier>
          </external-identifier>
          <external-identifier>
            <resource>IUPHAR</resource>
            <identifier>423</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>423</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P23415</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GLRA1_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>Glycine receptor 48 kDa subunit</synonym>
          <synonym>Glycine receptor strychnine-binding subunit</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000863|Glycine receptor subunit alpha-1
MYSFNTLRLYLWETIVFFSLAASKEAEAARSAPKPMSPSDFLDKLMGRTSGYDARIRPNF
KGPPVNVSCNIFINSFGSIAETTMDYRVNIFLRQQWNDPRLAYNEYPDDSLDLDPSMLDS
IWKPDLFFANEKGAHFHEITTDNKLLRISRNGNVLYSIRITLTLACPMDLKNFPMDVQTC
IMQLESFGYTMNDLIFEWQEQGAVQVADGLTLPQFILKEEKDLRYCTKHYNTGKFTCIEA
RFHLERQMGYYLIQMYIPSLLIVILSWISFWINMDAAPARVGLGITTVLTMTTQSSGSRA
SLPKVSYVKAIDIWMAVCLLFVFSALLEYAAVNFVSRQHKELLRFRRKRRHHKSPMLNLF
QEDEAGEGRFNFSAYGMGPACLQAKDGISVKGANNSNTTNPPPAPSKSPEEMRKLFIQRA
KKIDKISRIGFPMAFLIFNMFYWIIYKIVRREDVHNQ</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0016090|Glycine receptor subunit alpha-1 (GLRA1)
ATGTACAGCTTCAATACTCTTCGACTCTACCTTTGGGAGACCATTGTATTCTTCAGCCTT
GCTGCTTCTAAGGAGGCTGAAGCTGCTCGCTCCGCACCCAAGCCTATGTCACCCTCGGAT
TTCCTGGATAAGCTAATGGGGAGAACCTCCGGATATGATGCCAGGATCAGGCCCAATTTT
AAAGGTCCCCCAGTGAACGTGAGCTGCAACATTTTCATCAACAGCTTTGGTTCCATTGCT
GAGACAACCATGGACTATAGGGTCAACATCTTCCTGCGGCAGCAATGGAACGACCCCCGC
CTGGCCTATAATGAATACCCTGACGACTCTCTGGACCTGGACCCATCCATGCTGGACTCC
ATCTGGAAACCTGACCTGTTCTTTGCCAACGAGAAGGGGGCCCACTTCCATGAGATCACC
ACAGACAACAAATTGCTAAGGATCTCCCGGAATGGGAATGTCCTCTACAGCATCAGAATC
ACCCTGACACTGGCCTGCCCCATGGACTTGAAGAATTTCCCCATGGATGTCCAGACATGT
ATCATGCAACTGGAAAGCTTTGGATATACGATGAATGACCTCATCTTTGAGTGGCAGGAA
CAGGGAGCCGTGCAGGTAGCAGATGGACTAACTCTGCCCCAGTTTATCTTGAAGGAAGAG
AAGGACTTGAGATACTGCACCAAGCACTACAACACAGGTAAATTCACCTGCATTGAGGCC
CGGTTCCACCTGGAGCGGCAGATGGGTTACTACCTGATTCAGATGTATATTCCCAGCCTG
CTCATTGTCATCCTCTCATGGATCTCCTTCTGGATCAACATGGATGCTGCACCTGCTCGT
GTGGGCCTAGGCATCACCACTGTGCTCACCATGACCACCCAGAGCTCCGGCTCTCGAGCA
TCTCTGCCCAAGGTGTCCTATGTGAAAGCCATTGACATTTGGATGGCAGTTTGCCTGCTC
TTTGTGTTCTCAGCCCTATTAGAATATGCTGCCGTTAACTTTGTGTCTCGGCAACATAAG
GAGCTGCTCCGATTCAGGAGGAAGCGGAGACATCACAAGGAGGATGAAGCTGGAGAAGGC
CGCTTTAACTTCTCTGCCTATGGGATGGGCCCAGCCTGTCTACAGGCCAAGGATGGCATC
TCAGTCAAGGGCGCCAACAACAGTAACACCACCAACCCCCCTCCTGCACCATCTAAGTCC
CCAGAGGAGATGCGAAAACTCTTCATCCAGAGGGCCAAGAAGATCGACAAAATATCCCGC
ATTGGCTTCCCCATGGCCTTCCTCATTTTCAACATGTTCTACTGGATCATCTACAAGATT
GTCCGTAGAGAGGACGTCCACAACCAGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF02931</identifier>
            <name>Neur_chan_LBD</name>
          </pfam>
          <pfam>
            <identifier>PF02932</identifier>
            <name>Neur_chan_memb</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cell junction</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>chloride channel complex</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>external side of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>inhibitory synapse</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>intracellular membrane-bounded organelle</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>neuron projection</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>postsynaptic membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>synapse</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>extracellular-glycine-gated chloride channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>taurine binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transmitter-gated ion channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>acrosome reaction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>action potential</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>adult walking behavior</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>chloride transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>chloride transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>inhibitory postsynaptic potential</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ion transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ion transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>muscle contraction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of transmission of nerve impulse</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>neuromuscular process controlling posture</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>neuropeptide signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of acrosome reaction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of membrane potential</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of respiratory gaseous exchange by neurological system process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to amino acid</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>righting reflex</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>startle response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>synaptic transmission, glycinergic</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>visual perception</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="19">
      <id>BE0000316</id>
      <name>Serine--pyruvate aminotransferase</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A9901</ref-id>
            <pubmed-id>16899523</pubmed-id>
            <citation>Ricoult C, Echeverria LO, Cliquet JB, Limami AM: Characterization of alanine aminotransferase (AlaAT) multigene family and hypoxic response in young seedlings of the model legume Medicago truncatula. J Exp Bot. 2006;57(12):3079-89. Epub 2006 Aug 9.</citation>
          </article>
          <article>
            <ref-id>A9902</ref-id>
            <pubmed-id>16990263</pubmed-id>
            <citation>Han Q, Robinson H, Gao YG, Vogelaar N, Wilson SR, Rizzi M, Li J: Crystal structures of Aedes aegypti alanine glyoxylate aminotransferase. J Biol Chem. 2006 Dec 1;281(48):37175-82. Epub 2006 Sep 21.</citation>
          </article>
          <article>
            <ref-id>A9903</ref-id>
            <pubmed-id>17616291</pubmed-id>
            <citation>Lu TC, Ko YZ, Huang HW, Hung YC, Lin YC, Peng WH: Analgesic and anti-inflammatory activities of aqueous extract from Glycine tomentella root in mice. J Ethnopharmacol. 2007 Aug 15;113(1):142-8. Epub 2007 May 31.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P21549" source="Swiss-Prot">
        <name>Serine--pyruvate aminotransferase</name>
        <general-function>Transaminase activity</general-function>
        <specific-function/>
        <gene-name>AGXT</gene-name>
        <locus>2q36-q37</locus>
        <cellular-location>Peroxisome</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>8.55</theoretical-pi>
        <molecular-weight>43009.535</molecular-weight>
        <chromosome-location>2</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:341</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>AGXT</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>X56092</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>36582</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P21549</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>SPYA_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.6.1.51</synonym>
          <synonym>AGT</synonym>
          <synonym>AGT1</synonym>
          <synonym>Alanine--glyoxylate aminotransferase</synonym>
          <synonym>SPAT</synonym>
          <synonym>SPT</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010080|Serine--pyruvate aminotransferase
MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEI
KEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIG
ARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLL
LVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSF
YLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHG
RLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLR
IGLLGCNATRENVDRVTEALRAALQHCPKKKL</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010081|Serine--pyruvate aminotransferase (AGXT)
ATGGCCTCTCACAAGCTGCTGGTGACCCCCCCCAAGGCCCTGCTCAAGCCCCTCTCCATC
CCCAACCAGCTCCTGCTGGGGCCTGGTCCTTCCAACCTGCCTCCTCGCATCATGGCAGCC
GGGGGGCTGCAGATGATCGGGTCCATGAGCAAGGATATGTACCAGATCATGGACGAGATC
AAGGAAGGCATCCAGTACGTGTTCCAGACCAGGAACCCACTCACACTGGTCATCTCTGGC
TCGGGACACTGTGCCCTGGAGGCCGCCCTGGTCAATGTGCTGGAGCCTGGGGACTCCTTC
CTGGTTGGGGCCAATGGCATTTGGGGGCAGCGAGCCGTGGACATCGGGGAGCGCATAGGA
GCCCGAGTGCACCCGATGACCAAGGACCCTGGAGGCCACTACACACTGCAGGAGGTGGAG
GAGGGCCTGGCCCAGCACAAGCCAGTGCTGCTGTTCTTAACCCACGGGGAGTCGTCCACC
GGCGTGCTGCAGCCCCTTGATGGCTTCGGGGAACTCTGCCACAGGTACAAGTGCCTGCTC
CTGGTGGATTCGGTGGCATCCCTGGGCGGGACCCCCCTTTACATGGACCGGCAAGGCATC
GACATCCTGTACTCGGGCTCCCAGAAGGCCCTGAACGCCCCTCCAGGGACCTCGCTCATC
TCCTTCAGTGACAAGGCCAAAAAGAAGATGTACTCCCGCAAGACGAAGCCCTTCTCCTTC
TACCTGGACATCAAGTGGCTGGCCAACTTCTGGGGCTGTGACGACCAGCCCAGGATGTAC
CATCACACAATCCCCGTCATCAGCCTGTACAGCCTGAGAGAGAGCCTGGCCCTCATTGCG
GAACAGGGCCTGGAGAACAGCTGGCGCCAGCACCGCGAGGCCGCGGCGTATCTGCATGGG
CGCCTGCAGGCACTGGGGCTGCAGCTCTTCGTGAAGGACCCGGCGCTCCGGCTTCCCACA
GTCACCACTGTGGCTGTACCCGCTGGCTATGACTGGAGAGACATCGTCAGCTACGTCATA
GACCACTTCGACATTGAGATCATGGGTGGCCTTGGGCCCTCCACGGGGAAGGTGCTGCGG
ATCGGCCTGCTGGGCTGCAATGCCACCCGCGAGAATGTGGACCGCGTGACGGAGGCCCTG
AGGGCGGCCCTGCAGCACTGCCCCAAGAAGAAGCTGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00266</identifier>
            <name>Aminotran_5</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial matrix</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>peroxisomal matrix</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>peroxisome</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>alanine-glyoxylate transaminase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>amino acid binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>protein homodimerization activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>protein self-association</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>pyridoxal phosphate binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>receptor binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>serine-pyruvate transaminase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transaminase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular nitrogen compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine biosynthetic process, by transamination of glyoxylate</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glyoxylate catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glyoxylate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>L-alanine catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>L-cysteine catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>Notch signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>oxalic acid secretion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>proteasomal protein catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>pyruvate biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to cAMP</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to glucocorticoid</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="20">
      <id>BE0000055</id>
      <name>Glycine receptor subunit beta</name>
      <organism>Humans</organism>
      <actions>
        <action>ligand</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A9900</ref-id>
            <pubmed-id>16884688</pubmed-id>
            <citation>Eulenburg V, Becker K, Gomeza J, Schmitt B, Becker CM, Betz H: Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia. Biochem Biophys Res Commun. 2006 Sep 22;348(2):400-5. Epub 2006 Jul 26.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P48167" source="Swiss-Prot">
        <name>Glycine receptor subunit beta</name>
        <general-function>Glycine binding</general-function>
        <specific-function>The glycine receptor is a neurotransmitter-gated ion channel. Binding of glycine to its receptor increases the chloride conductance and thus produces hyperpolarization (inhibition of neuronal firing).</specific-function>
        <gene-name>GLRB</gene-name>
        <locus>4q31.3</locus>
        <cellular-location>Cell junction</cellular-location>
        <transmembrane-regions>266-290
299-316
331-354
479-496</transmembrane-regions>
        <signal-regions>1-22</signal-regions>
        <theoretical-pi>9.11</theoretical-pi>
        <molecular-weight>56121.62</molecular-weight>
        <chromosome-location>4</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:4329</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GLRB</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>U33267</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>992687</identifier>
          </external-identifier>
          <external-identifier>
            <resource>IUPHAR</resource>
            <identifier>427</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>427</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P48167</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GLRB_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>Glycine receptor 58 kDa subunit</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000110|Glycine receptor subunit beta
MKFLLTTAFLILISLWVEEAYSKEKSSKKGKGKKKQYLCPSQQSAEDLARVPANSTSNIL
NRLLVSYDPRIRPNFKGIPVDVVVNIFINSFGSIQETTMDYRVNIFLRQKWNDPRLKLPS
DFRGSDALTVDPTMYKCLWKPDLFFANEKSANFHDVTQENILLFIFRDGDVLVSMRLSIT
LSCPLDLTLFPMDTQRCKMQLESFGYTTDDLRFIWQSGDPVQLEKIALPQFDIKKEDIEY
GNCTKYYKGTGYYTCVEVIFTLRRQVGFYMMGVYAPTLLIVVLSWLSFWINPDASAARVP
LGIFSVLSLASECTTLAAELPKVSYVKALDVWLIACLLFGFASLVEYAVVQVMLNNPKRV
EAEKARIAKAEQADGKGGNVAKKNTVNGTGTPVHISTLQVGETRCKKVCTSKSDLRSNDF
SIVGSLPRDFELSNYDCYGKPIEVNNGLGKSQAKNNKKPPPAKPVIPTAAKRIDLYARAL
FPFCFLFFNVIYWSIYL</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0020445|Glycine receptor subunit beta (GLRB)
ATGAAGTTTTTATTGACAACTGCCTTTTTAATTTTAATTTCCTTGTGGGTGGAAGAAGCC
TATTCTAAGGAAAAGTCTTCAAAGAAAGGGAAGGGGAAAAAGAAGCAGTATCTATGCCCA
TCTCAGCAGTCAGCAGAGGACCTTGCCCGAGTACCTGCCAACTCCACTAGCAATATCTTG
AACAGGTTATTGGTCAGTTATGATCCCAGGATAAGACCAAACTTCAAAGGCATTCCTGTT
GATGTAGTAGTCAACATTTTTATTAACAGTTTTGGATCCATTCAAGAAACAACAATGGAC
TATAGAGTTAACATCTTCCTGAGACAAAAATGGAATGACCCCAGGCTGAAGCTCCCCAGT
GATTTTAGGGGTTCAGATGCACTGACAGTGGATCCAACAATGTACAAGTGTTTATGGAAA
CCTGATTTATTTTTTGCAAATGAAAAAAGTGCCAATTTTCATGATGTGACCCAGGAAAAC
ATCCTCCTCTTTATTTTTCGTGATGGAGATGTCCTTGTCAGCATGAGGTTATCTATTACT
CTTTCATGCCCTTTGGACTTGACATTGTTTCCCATGGATACACAACGTTGCAAGATGCAA
CTGGAGAGCTTTGGTTACACAACTGATGATTTACGATTTATCTGGCAGTCAGGAGATCCT
GTGCAATTAGAAAAAATTGCCTTGCCTCAATTTGATATCAAAAAGGAAGATATTGAATAT
GGTAACTGTACAAAATACTATAAAGGCACGGGCTACTACACATGCGTGGAAGTCATCTTC
ACCCTGAGGAGGCAGGTCGGCTTTTACATGATGGGGGTCTACGCCCCAACCCTGCTCATT
GTTGTTCTCTCCTGGCTTTCCTTCTGGATCAACCCGGACGCGAGTGCTGCCAGAGTGCCC
CTGGGTATCTTCTCAGTCCTCAGCTTGGCCTCTGAGTGCACAACCCTTGCCGCTGAGCTT
CCCAAAGTTTCCTATGTGAAGGCTCTTGATGTTTGGCTTATTGCTTGCCTTCTCTTTGGG
TTTGCTTCCCTGGTGGAGTATGCAGTTGTCCAGGTGATGCTGAACAACCCCAAAAGGGTT
GAAGCTGAAAAAGCCAGAATTGCTAAGGCTGAGCAAGCAGATGGAAAAGGTGGAAATGTG
GCTAAAAAGAATACTGTGAATGGAACAGGGACTCCTGTTCATATTAGCACTTTGCAGGTT
GGTGAGACCAGATGCAAAAAAGTTTGTACTTCTAAGTCTGATCTGAGATCTAATGACTTC
AGCATTGTTGGAAGCTTACCAAGAGATTTTGAACTATCCAATTATGACTGCTATGGAAAA
CCCATTGAAGTTAACAACGGACTTGGGAAATCTCAGGCTAAGAACAACAAGAAGCCTCCC
CCTGCGAAACCTGTTATTCCAACAGCAGCAAAGCGAATTGATCTTTATGCAAGAGCATTG
TTTCCTTTCTGCTTCTTGTTCTTCAATGTTATATATTGGTCTATATATTTATGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF02931</identifier>
            <name>Neur_chan_LBD</name>
          </pfam>
          <pfam>
            <identifier>PF02932</identifier>
            <name>Neur_chan_memb</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cell junction</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>chloride channel complex</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>neuron projection</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>postsynaptic membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>synapse</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>drug binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>extracellular-glycine-gated chloride channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>extracellular-glycine-gated ion channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>acrosome reaction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>adult walking behavior</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>chloride transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>gamma-aminobutyric acid receptor clustering</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ion transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ion transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>nervous system development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>neuropeptide signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein heterooligomerization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of membrane potential</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to amino acid</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>righting reflex</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>startle response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>synaptic transmission</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>synaptic transmission, glycinergic</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>visual perception</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="21">
      <id>BE0000331</id>
      <name>Serine hydroxymethyltransferase, cytosolic</name>
      <organism>Humans</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A9909</ref-id>
            <pubmed-id>17142057</pubmed-id>
            <citation>Vatsyayan R, Roy U: Molecular cloning and biochemical characterization of Leishmania donovani serine hydroxymethyltransferase. Protein Expr Purif. 2007 Apr;52(2):433-40. Epub 2006 Oct 26.</citation>
          </article>
          <article>
            <ref-id>A9910</ref-id>
            <pubmed-id>17355947</pubmed-id>
            <citation>Rajinikanth M, Harding SA, Tsai CJ: The glycine decarboxylase complex multienzyme family in Populus. J Exp Bot. 2007;58(7):1761-70. Epub 2007 Mar 12.</citation>
          </article>
          <article>
            <ref-id>A9911</ref-id>
            <pubmed-id>17664250</pubmed-id>
            <citation>Chang WN, Tsai JN, Chen BH, Huang HS, Fu TF: Serine hydroxymethyltransferase isoforms are differentially inhibited by leucovorin: characterization and comparison of recombinant zebrafish serine hydroxymethyltransferases. Drug Metab Dispos. 2007 Nov;35(11):2127-37. doi: 10.1124/dmd.107.016840. Epub 2007 Jul 30.</citation>
          </article>
          <article>
            <ref-id>A9912</ref-id>
            <pubmed-id>17150100</pubmed-id>
            <citation>Nijhout HF, Reed MC, Lam SL, Shane B, Gregory JF 3rd, Ulrich CM: In silico experimentation with a model of hepatic mitochondrial folate metabolism. Theor Biol Med Model. 2006 Dec 6;3:40.</citation>
          </article>
          <article>
            <ref-id>A9913</ref-id>
            <pubmed-id>16876889</pubmed-id>
            <citation>Gagnon D, Foucher A, Girard I, Ouellette M: Stage specific gene expression and cellular localization of two isoforms of the serine hydroxymethyltransferase in the protozoan parasite Leishmania. Mol Biochem Parasitol. 2006 Nov;150(1):63-71. Epub 2006 Jul 13.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P34896" source="Swiss-Prot">
        <name>Serine hydroxymethyltransferase, cytosolic</name>
        <general-function>Serine binding</general-function>
        <specific-function>Interconversion of serine and glycine.</specific-function>
        <gene-name>SHMT1</gene-name>
        <locus>17p11.2</locus>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>7.77</theoretical-pi>
        <molecular-weight>53082.18</molecular-weight>
        <chromosome-location>17</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:10850</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>SHMT1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>L11931</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>307422</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P34896</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GLYC_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.1.2.1</synonym>
          <synonym>Glycine hydroxymethyltransferase</synonym>
          <synonym>Serine methylase</synonym>
          <synonym>SHMT</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000659|Serine hydroxymethyltransferase, cytosolic
MTMPVNGAHKDADLWSSHDKMLAQPLKDSDVEVYNIIKKESNRQRVGLELIASENFASRA
VLEALGSCLNNKYSEGYPGQRYYGGTEFIDELETLCQKRALQAYKLDPQCWGVNVQPYSG
SPANFAVYTALVEPHGRIMGLDLPDGGHLTHGFMTDKKKISATSIFFESMPYKVNPDTGY
INYDQLEENARLFHPKLIIAGTSCYSRNLEYARLRKIADENGAYLMADMAHISGLVAAGV
VPSPFEHCHVVTTTTHKTLRGCRAGMIFYRKGVKSVDPKTGKEILYNLESLINSAVFPGL
QGGPHNHAIAGVAVALKQAMTLEFKVYQHQVVANCRALSEALTELGYKIVTGGSDNHLIL
VDLRSKGTDGGRAEKVLEACSIACNKNTCPGDRSALRPSGLRLGTPALTSRGLLEKDFQK
VAHFIHRGIELTLQIQSDTGVRATLKEFKERLAGDKYQAAVQALREEVESFASLFPLPGL
PDF</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010091|Serine hydroxymethyltransferase, cytosolic (SHMT1)
ATGGGCCTGGACCTTCCGGATGGGGGCCACCTGACCCATGGGTTCATGACAGACAAGAAG
AAAATCTCTGCCACGTCCATCTTCTTTGAATCTATGCCCTACAAGGTGAACCCAGATACT
GGCTACATCAACTATGACCAGCTGGAGGAGAACGCACGCCTCTTCCACCCGAAGCTGATC
ATCGCAGGAACCAGCTGCTACTCCCGAAACCTGGAATATGCCCGGCTACGGAAGATTGCA
GATGAGAACGGGGCGTATCTCATGGCGGACATGGCTCACATCAGCGGGCTGGTGGCGGCT
GGCGTGGTGCCCTCCCCATTTGAACACTGCCATGTGGTGACCACCACCACTCACAAGACC
CTGCGAGGCTGCCGAGCTGGCATGATCTTCTACAGGAAAGGAGTGAAAAGTGTGGATCCC
AAGACTGGCAAAGAGATTCTGTACAACCTGGAGTCTCTTATCAATTCTGCTGTGTTCCCT
GGCCTGCAGGGAGGTCCCCACAACCACGCCATTGCTGGGGTTGCTGTGGCACTGAAGCAA
GCTATGACTCTGGAATTTAAAGTTTATCAACACCAGGTGGTGGCCAACTGCAGGGCTCTG
TCTGAGGCCCTGACGGAGCTGGGCTACAAAATAGTCACAGGTGGTTCTGACAACCATTTG
ATCCTTGTGGATCTCCGTTCCAAAGGCACAGATGGTGGAAGGGCTGAGAAGGTGCTAGAA
GCCTGTTCTATTGCCTGCAACAAGAACACCTGTCCAGGTGACAGAAGCGCTCTGCGGCCC
AGTGGACTGCGGCTGGGGACCCCAGCACTGACGTCCCGTGGACTTTTGGAAAAAGACTTC
CAAAAAGTAGCCCACTTTATTCACAGAGGGATAGAGCTGACCCTGCAGATCCAGAGCGAC
ACTGGTGTCAGAGCCACCCTGAAAGAGTTCAAGGAGAGACTGGCAGGGGATAAGTACCAG
GCGGCCGTGCAGGCTCTCCGGGAGGAGGTTGAGAGCTTCGCCTCTCTCTTCCCTCTGCCT
GGCCTGCCTGACTTCTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00464</identifier>
            <name>SHMT</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine hydroxymethyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>L-allo-threonine aldolase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>protein homodimerization activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>pyridoxal phosphate binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>serine binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>branched-chain amino acid catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>carnitine biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular nitrogen compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to tetrahydrofolate</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>dTMP biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>folic acid metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine biosynthetic process from serine</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>L-serine catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein homotetramerization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein tetramerization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>purine nucleobase biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tetrahydrofolate interconversion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>vitamin metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>water-soluble vitamin metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="22">
      <id>BE0000414</id>
      <name>Glycine receptor subunit alpha-3</name>
      <organism>Humans</organism>
      <actions>
        <action>ligand</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A9899</ref-id>
            <pubmed-id>17154252</pubmed-id>
            <citation>Heinze L, Harvey RJ, Haverkamp S, Wassle H: Diversity of glycine receptors in the mouse retina: localization of the alpha4 subunit. J Comp Neurol. 2007 Feb 1;500(4):693-707.</citation>
          </article>
          <article>
            <ref-id>A9914</ref-id>
            <pubmed-id>17550639</pubmed-id>
            <citation>Majumdar S, Heinze L, Haverkamp S, Ivanova E, Wassle H: Glycine receptors of A-type ganglion cells of the mouse retina. Vis Neurosci. 2007 Jul-Aug;24(4):471-87. Epub 2007 May 29.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O75311" source="Swiss-Prot">
        <name>Glycine receptor subunit alpha-3</name>
        <general-function>Transmitter-gated ion channel activity</general-function>
        <specific-function>The glycine receptor is a neurotransmitter-gated ion channel. Binding of glycine to its receptor increases the chloride conductance and thus produces hyperpolarization (inhibition of neuronal firing).</specific-function>
        <gene-name>GLRA3</gene-name>
        <locus>4q33-q34</locus>
        <cellular-location>Cell junction</cellular-location>
        <transmembrane-regions>253-279
286-303
315-341
434-451</transmembrane-regions>
        <signal-regions>1-33</signal-regions>
        <theoretical-pi>8.51</theoretical-pi>
        <molecular-weight>53799.775</molecular-weight>
        <chromosome-location>4</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:4328</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GLRA3</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF017724</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>3342792</identifier>
          </external-identifier>
          <external-identifier>
            <resource>IUPHAR</resource>
            <identifier>425</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>425</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>O75311</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GLRA3_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>Glycine receptor subunit alpha-3 precursor</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000825|Glycine receptor subunit alpha-3
MAHVRHFRTLVSGFYFWEAALLLSLVATKETDSARSRSAPMSPSDFLDKLMGRTSGYDAR
IRPNFKGPPVNVTCNIFINSFGSIAETTMDYRVNIFLRQKWNDPRLAYSEYPDDSLDLDP
SMLDSIWKPDLFFANEKGANFHEVTTDNKLLRIFKNGNVLYSIRLTLTLSCPMDLKNFPM
DVQTCIMQLESFGYTMNDLIFEWQDEAPVQVAEGLTLPQFLLKEEKDLRYCTKHYNTGKF
TCIEVRFHLERQMGYYLIQMYIPSLLIVILSWVSFWINMDAAPARVALGITTVLTMTTQS
SGSRASLPKVSYVKAIDIWMAVCLLFVFSALLEYAAVNFVSRQHKELLRFRRKRKNKTEA
FALEKFYRFSDMDDEVRESRFSFTAYGMGPCLQAKDGMTPKGPNHPVQVMPKSPDEMRKV
FIDRAKKIDTISRACFPLAFLIFNIFYWVIYKILRHEDIHQQQD</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010287|Glycine receptor subunit alpha-3 (GLRA3)
ATGGCCCACGTGAGACACTTTCGGACATTAGTTTCGGGATTTTACTTCTGGGAAGCAGCA
CTGTTACTCAGTTTGGTTGCCACAAAGGAAACAGACAGTGCAAGATCTCGAAGTGCTCCA
ATGTCACCTTCTGATTTTCTGGATAAATTAATGGGCAGGACATCAGGATATGATGCAAGA
ATCAGACCCAATTTTAAAGGCCCTCCAGTTAATGTCACATGCAACATATTCATCAACAGC
TTTGGCTCTATCGCAGAGACGACCATGGATTACAGAGTGAATATCTTTCTTCGTCAGAAA
TGGAATGATCCCCGCCTCGCGTACAGTGAATATCCTGACGACTCTTTAGACCTCGACCCC
TCCATGTTGGACTCCATTTGGAAACCTGATTTGTTCTTTGCCAATGAAAAGGGTGCCAAC
TTTCATGAAGTCACTACAGACAACAAATTGCTAAGAATTTTCAAAAATGGAAATGTTCTT
TATTCAATAAGATTAACATTAACACTTTCCTGTCCAATGGATCTCAAGAATTTTCCCATG
GATGTACAAACATGTATAATGCAACTGGAAAGCTTTGGGTACACAATGAATGATCTCATT
TTTGAATGGCAAGATGAGGCACCCGTACAAGTGGCAGAAGGACTCACTTTGCCCCAGTTT
CTGTTGAAAGAAGAAAAAGATTTACGATACTGCACTAAACATTACAATACAGGAAAGTTT
ACGTGTATAGAAGTGCGATTCCATCTGGAGCGACAAATGGGATACTATCTGATCCAGATG
TACATTCCCAGTCTCCTGATTGTTATTCTATCCTGGGTTTCATTCTGGATCAACATGGAT
GCAGCACCGGCCAGGGTAGCTCTGGGGATAACCACTGTGCTAACGATGACTACACAGAGT
TCAGGATCACGAGCTTCCTTGCCAAAAGTTTCATATGTCAAAGCTATTGATATTTGGATG
GCAGTATGCCTCCTTTTTGTGTTTTCAGCACTTCTGGAGTATGCAGCTGTAAATTTTGTA
TCAAGACAACACAAAGAACTTCTGAGATTTCGACGAAAGAGAAAGAATAAGGATGATGAG
GTAAGGGAAAGCCGATTCAGCTTCACAGCCTATGGAATGGGACCATGTCTACAAGCAAAG
GATGGCATGACTCCAAAGGGCCCCAACCACCCTGTCCAGGTAATGCCAAAAAGTCCTGAT
GAAATGAGGAAGGTCTTTATCGACCGGGCCAAGAAGATTGATACCATCTCCCGAGCCTGC
TTCCCATTAGCTTTTTTGATTTTTAATATTTTCTACTGGGTTATCTATAAAATTCTTAGG
CATGAGGATATTCATCAGCAGCAAGATTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF02931</identifier>
            <name>Neur_chan_LBD</name>
          </pfam>
          <pfam>
            <identifier>PF02932</identifier>
            <name>Neur_chan_memb</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>axon terminus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cell junction</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>chloride channel complex</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>external side of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>neuron projection</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>postsynaptic membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>synapse</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>extracellular-glycine-gated chloride channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transmitter-gated ion channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>chloride transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>gamma-aminobutyric acid receptor clustering</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ion transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>neurological system process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>neuropeptide signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of membrane potential</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to amino acid</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>synaptic transmission, glycinergic</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transmembrane transport</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="23">
      <id>BE0000745</id>
      <name>Glycine receptor subunit alpha-2</name>
      <organism>Humans</organism>
      <actions>
        <action>ligand</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A9915</ref-id>
            <pubmed-id>16847326</pubmed-id>
            <citation>Young-Pearse TL, Ivic L, Kriegstein AR, Cepko CL: Characterization of mice with targeted deletion of glycine receptor alpha 2. Mol Cell Biol. 2006 Aug;26(15):5728-34.</citation>
          </article>
          <article>
            <ref-id>A9916</ref-id>
            <pubmed-id>17012403</pubmed-id>
            <citation>Qi Z, Stephens NR, Spalding EP: Calcium entry mediated by GLR3.3, an Arabidopsis glutamate receptor with a broad agonist profile. Plant Physiol. 2006 Nov;142(3):963-71. Epub 2006 Sep 29.</citation>
          </article>
          <article>
            <ref-id>A9914</ref-id>
            <pubmed-id>17550639</pubmed-id>
            <citation>Majumdar S, Heinze L, Haverkamp S, Ivanova E, Wassle H: Glycine receptors of A-type ganglion cells of the mouse retina. Vis Neurosci. 2007 Jul-Aug;24(4):471-87. Epub 2007 May 29.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P23416" source="Swiss-Prot">
        <name>Glycine receptor subunit alpha-2</name>
        <general-function>Transmitter-gated ion channel activity</general-function>
        <specific-function>The glycine receptor is a neurotransmitter-gated ion channel. Binding of glycine to its receptor increases the chloride conductance and thus produces hyperpolarization (inhibition of neuronal firing).</specific-function>
        <gene-name>GLRA2</gene-name>
        <locus>Xp22.1-p21.3</locus>
        <cellular-location>Cell junction</cellular-location>
        <transmembrane-regions>254-280
287-304
319-342
424-441</transmembrane-regions>
        <signal-regions>1-27</signal-regions>
        <theoretical-pi>9.2</theoretical-pi>
        <molecular-weight>52001.585</molecular-weight>
        <chromosome-location>X</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:4327</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GLRA2</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>X52008</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>31849</identifier>
          </external-identifier>
          <external-identifier>
            <resource>IUPHAR</resource>
            <identifier>424</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>424</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P23416</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GLRA2_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>Glycine receptor subunit alpha-2 precursor</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001486|Glycine receptor subunit alpha-2
MNRQLVNILTALFAFFLETNHFRTAFCKDHDSRSGKQPSQTLSPSDFLDKLMGRTSGYDA
RIRPNFKGPPVNVTCNIFINSFGSVTETTMDYRVNIFLRQQWNDSRLAYSEYPDDSLDLD
PSMLDSIWKPDLFFANEKGANFHDVTTDNKLLRISKNGKVLYSIRLTLTLSCPMDLKNFP
MDVQTCTMQLESFGYTMNDLIFEWLSDGPVQVAEGLTLPQFILKEEKELGYCTKHYNTGK
FTCIEVKFHLERQMGYYLIQMYIPSLLIVILSWVSFWINMDAAPARVALGITTVLTMTTQ
SSGSRASLPKVSYVKAIDIWMAVCLLFVFAALLEYAAVNFVSRQHKEFLRLRRRQKRQNK
EEDVTRESRFNFSGYGMGHCLQVKDGTAVKATPANPLPQPPKDGDAIKKKFVDRAKRIDT
ISRAAFPLAFLIFNIFYWITYKIIRHEDVHKK</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010525|Glycine receptor subunit alpha-2 (GLRA2)
ATGAACCGGCAGCTAGTGAACATTTTGACAGCCTTGTTTGCATTTTTCTTAGAGACAAAC
CACTTCAGGACGGCTTTCTGCAAAGACCATGACTCCAGGTCTGGAAAACAACCTTCACAG
ACCCTATCTCCTTCAGATTTCTTGGACAAGTTAATGGGAAGGACATCAGGATATGATGCA
AGAATCAGGCCAAATTTTAAAGGTCCTCCAGTAAACGTTACTTGCAATATTTTTATCAAC
AGTTTTGGATCAGTCACAGAAACGACCATGGACTACCGAGTGAATATTTTTCTGAGACAA
CAGTGGAATGATTCACGGCTGGCGTACAGTGAGTACCCAGATGACTCCCTGGACTTGGAC
CCATCCATGCTAGACTCCATTTGGAAACCAGATTTGTTCTTTGCCAATGAGAAGGGTGCC
AACTTCCACGATGTCACCACTGACAACAAATTGCTACGGATTTCGAAAAATGGCAAAGTG
CTCTACAGTATCAGACTCACCTTGACCTTATCCTGTCCCATGGACTTGAAGAACTTTCCG
ATGGATGTCCAGACCTGTACAATGCAGCTGGAGAGTTTTGGGTACACGATGAATGACCTG
ATATTTGAGTGGTTAAGTGATGGTCCAGTGCAAGTTGCTGAAGGATTGACCCTGCCCCAG
TTTATTTTGAAAGAAGAGAAGGAACTTGGCTACTGTACAAAGCACTACAACACTGGAAAG
TTTACCTGCATTGAGGTCAAGTTTCATCTGGAACGCCAAATGGGATATTATTTGATCCAG
ATGTACATCCCAAGCCTGCTTATAGTAATTTTGTCCTGGGTTTCCTTTTGGATAAATATG
GATGCAGCCCCTGCCAGGGTCGCACTGGGCATCACCACAGTCTTAACGATGACCACCCAG
AGTTCAGGCTCCAGGGCATCTCTGCCAAAGGTCTCCTATGTAAAAGCGATTGACATCTGG
ATGGCGGTGTGCCTTCTGTTTGTGTTTGCTGCCTTACTGGAATACGCAGCGGTGAACTTC
GTCTCCAGGCAACACAAGGAGTTCCTGCGCCTCCGAAGAAGACAGAAGAGGCAGAATAAG
GAAGAAGACGTTACTCGTGAAAGTCGTTTTAATTTTAGCGGTTATGGGATGGGTCACTGC
CTCCAAGTGAAAGATGGAACAGCTGTCAAGGCCACACCTGCCAACCCACTCCCACAACCG
CCAAAAGATGGAGATGCTATCAAGAAGAAGTTTGTGGACCGGGCAAAAAGGATTGACACG
ATATCTCGAGCTGCCTTCCCATTGGCCTTCCTCATTTTCAACATCTTTTACTGGATCACA
TACAAGATCATTCGGCATGAAGATGTCCACAAGAAATAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF02931</identifier>
            <name>Neur_chan_LBD</name>
          </pfam>
          <pfam>
            <identifier>PF02932</identifier>
            <name>Neur_chan_memb</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cell junction</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>chloride channel complex</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>neuron projection</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>postsynaptic membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>synapse</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>extracellular-glycine-gated chloride channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transmitter-gated ion channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>chloride transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ion transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ion transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>neurological system process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>neuropeptide signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of membrane potential</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to amino acid</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>synaptic transmission, glycinergic</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transmembrane transport</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="24">
      <id>BE0000372</id>
      <name>Glycine N-methyltransferase</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A9917</ref-id>
            <pubmed-id>17154529</pubmed-id>
            <citation>Soriano A, Castillo R, Christov C, Andres J, Moliner V, Tunon I: Catalysis in glycine N-methyltransferase: testing the electrostatic stabilization and compression hypothesis. Biochemistry. 2006 Dec 19;45(50):14917-25.</citation>
          </article>
          <article>
            <ref-id>A9918</ref-id>
            <pubmed-id>17158459</pubmed-id>
            <citation>Luka Z, Pakhomova S, Loukachevitch LV, Egli M, Newcomer ME, Wagner C: 5-methyltetrahydrofolate is bound in intersubunit areas of rat liver folate-binding protein glycine N-methyltransferase. J Biol Chem. 2007 Feb 9;282(6):4069-75. Epub 2006 Dec 7.</citation>
          </article>
          <article>
            <ref-id>A9919</ref-id>
            <pubmed-id>16851960</pubmed-id>
            <citation>Velichkova P, Himo F: Methyl transfer in glycine N-methyltransferase. A theoretical study. J Phys Chem B. 2005 Apr 28;109(16):8216-9.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q14749" source="Swiss-Prot">
        <name>Glycine N-methyltransferase</name>
        <general-function>Glycine n-methyltransferase activity</general-function>
        <specific-function>Catalyzes the methylation of glycine by using S-adenosylmethionine (AdoMet) to form N-methylglycine (sarcosine) with the concomitant production of S-adenosylhomocysteine (AdoHcy). Possible crucial role in the regulation of tissue concentration of AdoMet and of metabolism of methionine.</specific-function>
        <gene-name>GNMT</gene-name>
        <locus>6p12</locus>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>7.03</theoretical-pi>
        <molecular-weight>32742.0</molecular-weight>
        <chromosome-location>6</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:4415</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GNMT</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF101477</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>8671584</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q14749</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GNMT_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.1.1.20</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010119|Glycine N-methyltransferase
MVDSVYRTRSLGVAAEGLPDQYADGEAARVWQLYIGDTRSRTAEYKAWLLGLLRQHGCQR
VLDVACGTGVDSIMLVEEGFSVTSVDASDKMLKYALKERWNRRHEPAFDKWVIEEANWMT
LDKDVPQSAEGGFDAVICLGNSFAHLPDCKGDQSEHRLALKNIASMVRAGGLLVIDHRNY
DHILSTGCAPPGKNIYYKSDLTKDVTTSVLIVNNKAHMVTLDYTVQVPGAGQDGSPGLSK
FRLSYYPHCLASFTELLQAAFGGKCQHSVLGDFKPYKPGQTYIPCYFIHVLKRTD</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010120|Glycine N-methyltransferase (GNMT)
ATGGTGGACAGCGTGTACCGGACCCGCTCCCTGGGGGTGGCGGCCGAAGGGCTCCCGGAC
CAGTACGCGGACGGGGAGGCGGCGCGCGTGTGGCAGCTGTATATCGGAGACACCCGCAGC
CGCACCGCCGAGTACAAGGCATGGCTGCTTGGGCTGCTGCGCCAGCACGGCTGCCAGCGG
GTGCTCGACGTAGCCTGTGGCACTGGGGTGGACTCCATTATGCTGGTGGAAGAGGGCTTC
AGTGTGACGAGTGTGGATGCCAGTGACAAGATGCTGAAGTATGCACTTAAGGAGCGCTGG
AACCGGCGGCACGAGCCCGCCTTCGACAAGTGGGTCATCGAAGAAGCCAACTGGATGACT
CTGGACAAAGATGTGCCCCAGTCAGCAGAGGGTGGCTTTGATGCTGTCATCTGCCTTGGA
AACAGTTTCGCTCACTTGCCAGACTGCAAAGGGGACCAGAGTGAGCACCGGCTGGCGCTG
AAAAACATTGCGAGCATGGTGCGGGCAGGGGGCCTACTGGTCATTGATCATCGCAACTAC
GACCACATCCTCAGTACAGGCTGTGCACCCCCAGGGAAGAACATCTACTATAAGAGTGAC
TTGACCAAGGACGTCACAACATCAGTGCTGATAGTGAACAACAAGGCCCACATGGTGACC
CTGGACTATACGGTGCAGGTGCCGGGGGCTGGCCAGGATGGCTCTCCTGGCTTGAGTAAG
TTCCGGCTCTCCTACTACCCACACTGTCTGGCATCCTTCACGGAGCTGCTCCAAGCAGCC
TTCGGAGGTAAGTGCCAGCACAGCGTCCTGGGCGACTTCAAGCCTTACAAGCCAGGCCAA
ACCTACATTCCCTGCTACTTCATCCACGTGCTCAAGAGGACAGACTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF08242</identifier>
            <name>Methyltransf_12</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>folic acid binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine N-methyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular protein modification process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycogen metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>methionine metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>one-carbon metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein homotetramerization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of gluconeogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>S-adenosylmethionine metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="25">
      <id>BE0000347</id>
      <name>Glycine amidinotransferase, mitochondrial</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A4183</ref-id>
            <pubmed-id>17486546</pubmed-id>
            <citation>Wang L, Zhang Y, Shao M, Zhang H: Spatiotemporal expression of the creatine metabolism related genes agat, gamt and ct1 during zebrafish embryogenesis. Int J Dev Biol. 2007;51(3):247-53.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P50440" source="Swiss-Prot">
        <name>Glycine amidinotransferase, mitochondrial</name>
        <general-function>Glycine amidinotransferase activity</general-function>
        <specific-function>Catalyzes the biosynthesis of guanidinoacetate, the immediate precursor of creatine. Creatine plays a vital role in energy metabolism in muscle tissues. May play a role in embryonic and central nervous system development. May be involved in the response to heart failure by elevating local creatine synthesis.</specific-function>
        <gene-name>GATM</gene-name>
        <locus>15q21.1</locus>
        <cellular-location>Mitochondrion inner membrane</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>8.15</theoretical-pi>
        <molecular-weight>48455.01</molecular-weight>
        <chromosome-location>15</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:4175</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GATM</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>S68805</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>545385</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P50440</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GATM_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.1.4.1</synonym>
          <synonym>AGAT</synonym>
          <synonym>L-arginine:glycine amidinotransferase</synonym>
          <synonym>Transamidinase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000691|Glycine amidinotransferase, mitochondrial
MLRVRCLRGGSRGAEAVHYIGSRLGRTLTGWVQRTFQSTQAATASSRNSCAADDKATEPL
PKDCPVSSYNEWDPLEEVIVGRAENACVPPFTIEVKANTYEKYWPFYQKQGGHYFPKDHL
KKAVAEIEEMCNILKTEGVTVRRPDPIDWSLKYKTPDFESTGLYSAMPRDILIVVGNEII
EAPMAWRSRFFEYRAYRSIIKDYFHRGAKWTTAPKPTMADELYNQDYPIHSVEDRHKLAA
QGKFVTTEFEPCFDAADFIRAGRDIFAQRSQVTNYLGIEWMRRHLAPDYRVHIISFKDPN
PMHIDATFNIIGPGIVLSNPDRPCHQIDLFKKAGWTIITPPTPIIPDDHPLWMSSKWLSM
NVLMLDEKRVMVDANEVPIQKMFEKLGITTIKVNIRNANSLGGGFHCWTCDVRRRGTLQS
YLD</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010101|Glycine amidinotransferase, mitochondrial (GATM)
ATGCTGCGGGTGCGGTGTCTGCGCGGCGGGAGCCGCGGCGCCGAGGCGGTGCACTACATC
GGATCTCGGCTTGGACGAACCTTGACAGGATGGGTGCAGCGAACTTTCCAGAGCACCCAG
GCAGCTACGGCTTCCTCCCGGAACTCCTGTGCAGCTGACGACAAAGCCACTGAGCCTCTG
CCCAAGGACTGCCCTGTCTCTTCTTACAACGAATGGGACCCCTTAGAGGAAGTGATAGTG
GGCAGAGCAGAAAACGCCTGTGTTCCACCGTTCACCATCGAGGTGAAGGCCAACACATAT
GAAAAGTACTGGCCATTTTACCAGAAGCAAGGAGGGCATTATTTTCCCAAAGATCATTTG
AAAAAGGCTGTTGCTGAAATTGAAGAAATGTGCAATATTTTAAAAACGGAAGGAGTGACA
GTAAGGAGGCCTGACCCCATTGACTGGTCATTGAAGTATAAAACTCCTGATTTTGAGTCT
ACGGGTTTATACAGTGCAATGCCTCGAGACATCCTGATAGTTGTGGGCAATGAGATTATC
GAGGCTCCCATGGCATGGCGTTCACGCTTCTTTGAGTACCGAGCGTACAGGTCAATTATC
AAAGACTACTTCCACCGTGGCGCCAAGTGGACAACAGCTCCTAAGCCCACAATGGCTGAT
GAGCTTTATAACCAGGATTATCCCATCCACTCTGTAGAAGACAGACACAAATTGGCTGCT
CAGGGAAAATTTGTGACAACTGAGTTTGAGCCATGCTTTGATGCTGCTGACTTCATTCGA
GCTGGAAGAGATATTTTTGCACAGAGAAGCCAGGTTACAAACTACCTAGGCATTGAATGG
ATGCGTAGGCATCTTGCTCCAGACTACAGAGTGCATATCATCTCCTTTAAAGATCCCAAT
CCCATGCATATTGATGCTACCTTCAACATCATTGGACCTGGTATTGTGCTTTCCAACCCT
GACCGACCATGTCACCAGATTGATCTTTTCAAGAAAGCAGGATGGACTATCATTACTCCT
CCAACACCAATCATCCCAGACGATCATCCACTCTGGATGTCATCCAAATGGCTTTCCATG
AATGTCTTAATGCTAGATGAAAAACGTGTTATGGTGGATGCCAATGAAGTTCCAATTCAA
AAGATGTTTGAAAAGCTGGGTATCACTACCATTAAAGTTAACATTCGTAATGCCAATTCC
CTGGGAGGAGGCTTCCATTGCTGGACCTGCGATGTCCGGCGCCGAGGCACCTTACAGTCC
TACTTGGACTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF02274</identifier>
            <name>Amidinotransf</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial inner membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial intermembrane space</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine amidinotransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular nitrogen compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>creatine biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>creatine metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>embryonic liver development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>polyamine metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to mercury ion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to nutrient</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to oxidative stress</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to peptide hormone</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tissue regeneration</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes>
    <enzyme position="31">
      <id>BE0000010</id>
      <name>Aminomethyltransferase, mitochondrial</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A192417</ref-id>
            <pubmed-id>23615880</pubmed-id>
            <citation>Wang W, Wu Z, Dai Z, Yang Y, Wang J, Wu G: Glycine metabolism in animals and humans: implications for nutrition and health. Amino Acids. 2013 Sep;45(3):463-77. doi: 10.1007/s00726-013-1493-1. Epub 2013 Apr 25.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P48728" source="Swiss-Prot">
        <name>Aminomethyltransferase, mitochondrial</name>
        <general-function>Transaminase activity</general-function>
        <specific-function>The glycine cleavage system catalyzes the degradation of glycine.</specific-function>
        <gene-name>AMT</gene-name>
        <locus>3p21.2-p21.1</locus>
        <cellular-location>Mitochondrion</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>8.69</theoretical-pi>
        <molecular-weight>43945.65</molecular-weight>
        <chromosome-location>3</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:473</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>AMT</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>D13811</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>391721</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P48728</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GCST_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.1.2.10</synonym>
          <synonym>GCST</synonym>
          <synonym>GCVT</synonym>
          <synonym>Glycine cleavage system T protein</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000020|Aminomethyltransferase, mitochondrial
MQRAVSVVARLGFRLQAFPPALCRPLSCAQEVLRRTPLYDFHLAHGGKMVAFAGWSLPVQ
YRDSHTDSHLHTRQHCSLFDVSHMLQTKILGSDRVKLMESLVVGDIAELRPNQGTLSLFT
NEAGGILDDLIVTNTSEGHLYVVSNAGCWEKDLALMQDKVRELQNQGRDVGLEVLDNALL
ALQGPTAAQVLQAGVADDLRKLPFMTSAVMEVFGVSGCRVTRCGYTGEDGVEISVPVAGA
VHLATAILKNPEVKLAGLAARDSLRLEAGLCLYGNDIDEHTTPVEGSLSWTLGKRRRAAM
DFPGAKVIVPQLKGRVQRRRVGLMCEGAPMRAHSPILNMEGTKIGTVTSGCPSPSLKKNV
AMGYVPCEYSRPGTMLLVEVRRKQQMAVVSKMPFVPTNYYTLK</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0009870|Aminomethyltransferase, mitochondrial (AMT)
ATGCAGAGGGCTGTAAGTGTGGTGGCCCGTCTGGGCTTTCGCCTGCAGGCATTCCCCCCG
GCCTTGTGTCGTCCACTTAGTTGCGCACAGGAGGTGCTCCGCAGGACACCGCTCTATGAC
TTCCACCTGGCCCACGGCGGGAAAATGGTGGCGTTTGCGGGTTGGAGTCTGCCAGTGCAG
TACCGGGACAGTCACACTGACTCGCACCTGCACACACGCCAGCACTGCTCGCTCTTTGAC
GTGTCTCATATGCTGCAGACCAAGATACTTGGTAGTGACCGGGTGAAGCTGATGGAGAGT
CTAGTGGTTGGAGACATTGCAGAGCTAAGACCAAACCAGGGGACACTGTCGCTGTTTACC
AACGAGGCTGGAGGCATCTTAGATGACTTGATTGTAACCAATACTTCTGAGGGCCACCTG
TATGTGGTGTCCAACGCTGGCTGCTGGGAGAAAGATTTGGCCCTCATGCAGGACAAGGTC
AGGGAGCTTCAGAACCAGGGCAGAGATGTGGGCCTGGAGGTGTTGGATAATGCCCTGCTA
GCTCTGCAAGGCCCCACTGCAGCCCAGGTACTACAGGCCGGCGTGGCAGATGACCTGAGG
AAACTGCCCTTCATGACCAGTGCTGTGATGGAGGTGTTTGGCGTGTCTGGCTGCCGCGTG
ACCCGCTGTGGCTACACAGGAGAGGATGGTGTGGAGATCTCGGTGCCGGTAGCGGGGGCA
GTTCACCTGGCAACAGCTATTCTGAAAAACCCAGAGGTGAAGCTGGCAGGGCTGGCAGCC
AGGGACAGCCTGCGCCTGGAGGCAGGCCTCTGCCTGTATGGGAATGACATTGATGAACAC
ACTACACCTGTGGAGGGCAGCCTCAGTTGGACACTGGGGAAGCGCCGCCGAGCTGCTATG
GACTTCCCTGGAGCCAAGGTCATTGTTCCCCAGCTGAAGGGCAGGGTGCAGCGGAGGCGT
GTGGGGTTGATGTGTGAGGGGGCCCCCATGCGGGCACACAGTCCCATCCTGAACATGGAG
GGTACCAAGATTGGTACTGTGACTAGTGGCTGCCCCTCCCCCTCTCTGAAGAAGAATGTG
GCGATGGGTTATGTGCCCTGCGAGTACAGTCGTCCAGGGACAATGCTGCTGGTAGAGGTG
CGGCGGAAGCAGCAGATGGCTGTAGTCAGCAAGATGCCCTTTGTGCCCACAAACTACTAT
ACCCTCAAGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01571</identifier>
            <name>GCV_T</name>
          </pfam>
          <pfam>
            <identifier>PF08669</identifier>
            <name>GCV_T_C</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial matrix</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>aminomethyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transaminase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular nitrogen compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glyoxylate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
      <inhibition-strength/>
      <induction-strength/>
    </enzyme>
    <enzyme position="32">
      <id>BE0000618</id>
      <name>Glycine dehydrogenase [decarboxylating], mitochondrial</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A192417</ref-id>
            <pubmed-id>23615880</pubmed-id>
            <citation>Wang W, Wu Z, Dai Z, Yang Y, Wang J, Wu G: Glycine metabolism in animals and humans: implications for nutrition and health. Amino Acids. 2013 Sep;45(3):463-77. doi: 10.1007/s00726-013-1493-1. Epub 2013 Apr 25.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P23378" source="Swiss-Prot">
        <name>Glycine dehydrogenase (decarboxylating), mitochondrial</name>
        <general-function>Lyase activity</general-function>
        <specific-function>The glycine cleavage system catalyzes the degradation of glycine. The P protein (GLDC) binds the alpha-amino group of glycine through its pyridoxal phosphate cofactor; CO(2) is released and the remaining methylamine moiety is then transferred to the lipoamide cofactor of the H protein (GCSH).</specific-function>
        <gene-name>GLDC</gene-name>
        <locus>9p22</locus>
        <cellular-location>Mitochondrion</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>7.14</theoretical-pi>
        <molecular-weight>112728.805</molecular-weight>
        <chromosome-location>9</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:4313</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GLDC</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M63635</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>190287</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P23378</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GCSP_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1.4.4.2</synonym>
          <synonym>GCSP</synonym>
          <synonym>Glycine cleavage system P protein</synonym>
          <synonym>Glycine decarboxylase</synonym>
          <synonym>Glycine dehydrogenase (aminomethyl-transferring)</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010429|Glycine dehydrogenase (decarboxylating), mitochondrial
MQSCARAWGLRLGRGVGGGRRLAGGSGPCWAPRSRDSSSGGGDSAAAGASRLLERLLPRH
DDFARRHIGPGDKDQREMLQTLGLASIDELIEKTVPANIRLKRPLKMEDPVCENEILATL
HAISSKNQIWRSYIGMGYYNCSVPQTILRNLLENSGWITQYTPYQPEVSQGRLESLLNYQ
TMVCDITGLDMANASLLDEGTAAAEALQLCYRHNKRRKFLVDPRCHPQTIAVVQTRAKYT
GVLTELKLPCEMDFSGKDVSGVLFQYPDTEGKVEDFTELVERAHQSGSLACCATDLLALC
ILRPPGEFGVDIALGSSQRFGVPLGYGGPHAAFFAVRESLVRMMPGRMVGVTRDATGKEV
YRLALQTREQHIRRDKATSNICTAQALLANMAAMFAIYHGSHGLEHIARRVHNATLILSE
GLKRAGHQLQHDLFFDTLKIQCGCSVKEVLGRAAQRQINFRLFEDGTLGISLDETVNEKD
LDDLLWIFGCESSAELVAESMGEECRGIPGSVFKRTSPFLTHQVFNSYHSETNIVRYMKK
LENKDISLVHSMIPLGSCTMKLNSSSELAPITWKEFANIHPFVPLDQAQGYQQLFRELEK
DLCELTGYDQVCFQPNSGAQGEYAGLATIRAYLNQKGEGHRTVCLIPKSAHGTNPASAHM
AGMKIQPVEVDKYGNIDAVHLKAMVDKHKENLAAIMITYPSTNGVFEENISDVCDLIHQH
GGQVYLDGANMNAQVGICRPGDFGSDVSHLNLHKTFCIPHGGGGPGMGPIGVKKHLAPFL
PNHPVISLKRNEDACPVGTVSAAPWGSSSILPISWAYIKMMGGKGLKQATETAILNANYM
AKRLETHYRILFRGARGYVGHEFILDTRPFKKSANIEAVDVAKRLQDYGFHAPTMSWPVA
GTLMVEPTESEDKAELDRFCDAMISIRQEIADIEEGRIDPRVNPLKMSPHSLTCVTSSHW
DRPYSREVAAFPLPFVKPENKFWPTIARIDDIYGDQHLVCTCPPMEVYESPFSEQKRASS
</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010430|Glycine dehydrogenase (decarboxylating), mitochondrial (GLDC)
ATGCAGTCCTGTGCCAGGGCGTGGGGGCTGCGCCTGGGCCGCGGGGTCGGGGGCGGCCGC
CGCCTGGCTGGGGGATCGGGGCCGTGCTGGGCGCCGCGGAGCCGGGACAGCAGCAGTGGC
GGCGGGGACAGCGCCGCGGCTGGGGCCTCGCGCCTCCTGGAGCGCCTTCTGCCCAGACAC
GACGACTTCGCTCGGAGGCACATCGGCCCTGGGGACAAAGACCAGAGAGAGATGCTGCAG
ACCTTGGGGCTGGCGAGCATTGATGAATTGATCGAGAAGACGGTCCCTGCCAACATCCGT
TTGAAAAGACCCTTGAAAATGGAAGACCCTGTTTGTGAAAATGAAATCCTTGCAACTCTG
CATGCCATTTCAAGCAAAAACCAGATCTGGAGATCGTATATTGGCATGGGCTATTATAAC
TGCTCAGTGCCACAGACGATTTTGCGGAACTTACTGGAGAACTCAGGATGGATCACCCAG
TATACTCCATACCAGCCTGAGGTGTCTCAGGGGAGGCTGGAGAGTTTACTCAACTACCAG
ACCATGGTGTGTGACATCACAGGCCTGGACATGGCCAATGCATCCCTGCTGGATGAGGGG
ACTGCAGCCGCAGAGGCACTGCAGCTGTGCTACAGACACAACAAGAGGAGGAAATTTCTC
GTTGATCCCCGTTGCCACCCACAGACAATAGCTGTTGTCCAGACTCGAGCCAAATATACT
GGAGTCCTCACTGAGCTGAAGTTACCCTGTGAAATGGACTTCAGTGGAAAAGATGTCAGT
GGAGTGTTGTTCCAGTACCCAGACACGGAGGGGAAGGTGGAAGACTTTACGGAACTCGTG
GAGAGAGCTCATCAGAGTGGGAGCCTGGCCTGCTGTGCTACTGACCTTTTAGCTTTGTGC
ATCTTGAGGCCACCTGGAGAATTTGGGGTAGACATCGCCCTGGGCAGCTCCCAGAGATTT
GGAGTGCCACTGGGCTATGGGGGACCCCATGCAGCATTTTTTGCTGTCCGAGAAAGCTTG
GTGAGAATGATGCCTGGAAGAATGGTGGGGGTAACAAGAGATGCCACTGGGAAAGAAGTG
TATCGTCTTGCTCTTCAAACCAGGGAGCAACACATTCGGAGAGACAAGGCTACCAGCAAC
ATCTGTACAGCTCAGGCCCTCTTGGCGAATATGGCTGCCATGTTTGCAATCTACCATGGT
TCCCATGGGCTGGAGCATATTGCTAGGAGGGTACATAATGCCACTTTGATTTTGTCAGAA
GGTCTCAAGCGAGCAGGGCATCAACTCCAGCATGACCTGTTCTTTGATACCTTGAAGATT
CAGTGTGGCTGCTCAGTGAAGGAGGTCTTGGGCAGGGCCGCTCAGCGGCAGATCAATTTT
CGGCTTTTTGAGGATGGCACACTTGGTATTTCTCTTGATGAAACAGTCAATGAAAAAGAT
CTGGACGATTTGTTGTGGATCTTTGGTTGTGAGTCATCTGCAGAACTGGTTGCTGAAAGC
ATGGGAGAGGAGTGCAGAGGTATTCCAGGGTCTGTGTTCAAGAGGACCAGCCCGTTCCTC
ACCCATCAAGTGTTCAACAGCTACCACTCTGAAACAAACATTGTCCGGTACATGAAGAAA
CTGGAAAATAAAGACATTTCCCTTGTTCACAGCATGATTCCACTGGGATCCTGCACCATG
AAACTGAACAGTTCGTCTGAACTCGCACCTATCACATGGAAAGAATTTGCAAACATCCAC
CCCTTTGTGCCTCTGGATCAAGCTCAAGGATATCAGCAGCTTTTCCGAGAGCTTGAGAAG
GATTTGTGTGAACTCACAGGTTATGACCAGGTCTGTTTCCAGCCAAACAGCGGAGCCCAG
GGAGAATATGCTGGACTGGCCACTATCCGAGCCTACTTAAACCAGAAAGGAGAGGGGCAC
AGAACGGTTTGCCTCATTCCGAAATCAGCACATGGGACCAACCCAGCAAGTGCCCACATG
GCAGGCATGAAGATTCAGCCTGTGGAGGTGGATAAATATGGGAATATCGATGCAGTTCAC
CTCAAGGCCATGGTGGATAAGCACAAGGAGAACCTAGCAGCTATCATGATTACATACCCA
TCCACCAATGGGGTGTTTGAAGAGAACATCAGTGACGTGTGTGACCTCATCCATCAACAT
GGAGGACAGGTCTACCTAGACGGGGCAAATATGAATGCTCAGGTGGGAATCTGTCGCCCT
GGAGACTTCGGGTCTGATGTCTCGCACCTAAATCTTCACAAGACCTTCTGCATTCCCCAC
GGAGGAGGTGGTCCTGGCATGGGGCCCATCGGAGTGAAGAAACATCTCGCCCCGTTTTTG
CCCAATCATCCCGTCATTTCACTAAAGCGGAATGAGGATGCCTGTCCTGTGGGAACCGTC
AGTGCGGCCCCATGGGGCTCCAGTTCCATCTTGCCCATTTCCTGGGCTTATATCAAGATG
ATGGGAGGCAAGGGTCTTAAACAAGCCACGGAAACTGCGATATTAAATGCCAACTACATG
GCCAAGCGATTAGAAACACACTACAGAATTCTTTTCAGGGGTGCAAGAGGTTATGTGGGT
CATGAATTTATTTTGGACACGAGACCCTTCAAAAAGTCTGCAAATATTGAGGCTGTGGAT
GTGGCCAAGAGACTCCAGGATTATGGATTTCACGCCCCTACCATGTCCTGGCCTGTGGCA
GGGACCCTCATGGTGGAGCCCACTGAGTCGGAGGACAAGGCAGAGCTGGACAGATTCTGT
GATGCCATGATCAGCATTCGGCAGGAAATTGCTGACATTGAGGAGGGCCGCATCGACCCC
AGGGTCAATCCGCTGAAGATGTCTCCACACTCCCTGACCTGCGTTACATCTTCCCACTGG
GACCGGCCTTATTCCAGAGAGGTGGCAGCATTCCCACTCCCCTTCGTGAAACCAGAGAAC
AAATTCTGGCCAACGATTGCCCGGATTGATGACATATATGGAGATCAGCACCTGGTTTGT
ACCTGCCCACCCATGGAAGTTTATGAGTCTCCATTTTCTGAACAAAAGAGGGCGTCTTCT
TAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF02347</identifier>
            <name>GDC-P</name>
          </pfam>
          <pfam>
            <identifier>PF01212</identifier>
            <name>Beta_elim_lyase</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>glycine cleavage complex</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial matrix</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>electron carrier activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine dehydrogenase (decarboxylating) activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>lyase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular nitrogen compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine decarboxylation via glycine cleavage system</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glyoxylate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
      <inhibition-strength/>
      <induction-strength/>
    </enzyme>
    <enzyme position="33">
      <id>BE0000737</id>
      <name>Dihydrolipoyl dehydrogenase, mitochondrial</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A192417</ref-id>
            <pubmed-id>23615880</pubmed-id>
            <citation>Wang W, Wu Z, Dai Z, Yang Y, Wang J, Wu G: Glycine metabolism in animals and humans: implications for nutrition and health. Amino Acids. 2013 Sep;45(3):463-77. doi: 10.1007/s00726-013-1493-1. Epub 2013 Apr 25.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P09622" source="Swiss-Prot">
        <name>Dihydrolipoyl dehydrogenase, mitochondrial</name>
        <general-function>Nad binding</general-function>
        <specific-function>Lipoamide dehydrogenase is a component of the glycine cleavage system as well as of the alpha-ketoacid dehydrogenase complexes. Involved in the hyperactivation of spermatazoa during capacitation and in the spermatazoal acrosome reaction.</specific-function>
        <gene-name>DLD</gene-name>
        <locus>7q31-q32</locus>
        <cellular-location>Mitochondrion matrix</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>7.76</theoretical-pi>
        <molecular-weight>54176.91</molecular-weight>
        <chromosome-location>7</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:2898</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>DLD</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>J03490</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>307137</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P09622</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>DLDH_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1.8.1.4</synonym>
          <synonym>Dihydrolipoamide dehydrogenase</synonym>
          <synonym>GCSL</synonym>
          <synonym>Glycine cleavage system L protein</synonym>
          <synonym>LAD</synonym>
          <synonym>PHE3</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037066|Dihydrolipoyl dehydrogenase, mitochondrial
MQSWSRVYCSLAKRGHFNRISHGLQGLSAVPLRTYADQPIDADVTVIGSGPGGYVAAIKA
AQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNL
DKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNIL
IATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVT
AVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGK
AEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGP
MLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGK
FPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDI
ARVCHAHPTLSEAFREANLAASFGKSINF</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010519|Dihydrolipoyl dehydrogenase, mitochondrial (DLD)
ATGCAGAGCTGGAGTCGTGTGTACTGCTCCTTGGCCAAGAGAGGCCATTTCAATCGAATA
TCTCATGGCCTACAGGGACTTTCTGCAGTGCCTCTGAGAACTTACGCAGATCAGCCGATT
GATGCTGATGTAACAGTTATAGGTTCTGGTCCTGGAGGATATGTTGCTGCTATTAAAGCT
GCCCAGTTAGGCTTCAAGACAGTCTGCATTGAGAAAAATGAAACACTTGGTGGAACATGC
TTGAATGTTGGTTGTATTCCTTCTAAGGCTTTATTGAACAACTCTCATTATTACCATATG
GCCCATGGAAAAGATTTTGCATCTAGAGGAATTGAAATGTCCGAAGTTCGCTTGAATTTA
GACAAGATGATGGAGCAGAAGAGTACTGCAGTAAAAGCTTTAACAGGTGGAATTGCCCAC
TTATTCAAACAGAATAAGGTTGTTCATGTCAATGGATATGGAAAGATAACTGGCAAAAAT
CAAGTCACTGCTACGAAAGCTGATGGCGGCACTCAGGTTATTGATACAAAGAACATTCTT
ATAGCCACGGGTTCAGAAGTTACTCCTTTTCCTGGAATCACGATAGATGAAGATACAATA
GTGTCATCTACAGGTGCTTTATCTTTAAAAAAAGTTCCAGAAAAGATGGTTGTTATTGGT
GCAGGAGTAATAGGTGTAGAATTGGGTTCAGTTTGGCAAAGACTTGGTGCAGATGTGACA
GCAGTTGAATTTTTAGGTCATGTAGGTGGAGTTGGAATTGATATGGAGATATCTAAAAAC
TTTCAACGCATCCTTCAAAAACAGGGGTTTAAATTTAAATTGAATACAAAGGTTACTGGT
GCTACCAAGAAGTCAGATGGAAAAATTGATGTTTCTATTGAAGCTGCTTCTGGTGGTAAA
GCTGAAGTTATCACTTGTGATGTACTCTTGGTTTGCATTGGCCGACGACCCTTTACTAAG
AATTTGGGACTAGAAGAGCTGGGAATTGAACTAGATCCCAGAGGTAGAATTCCAGTCAAT
ACCAGATTTCAAACTAAAATTCCAAATATCTATGCCATTGGTGATGTAGTTGCTGGTCCA
ATGCTGGCTCACAAAGCAGAGGATGAAGGCATTATCTGTGTTGAAGGAATGGCTGGTGGT
GCTGTGCACATTGACTACAATTGTGTGCCATCAGTGATTTACACACACCCTGAAGTTGCT
TGGGTTGGCAAATCAGAAGAGCAGTTGAAAGAAGAGGGTATTGAGTACAAAGTTGGGAAA
TTCCCATTTGCTGCTAACAGCAGAGCTAAGACAAATGCTGACACAGATGGCATGGTGAAG
ATCCTTGGGCAGAAATCGACAGACAGAGTACTGGGAGCACATATTCTTGGACCAGGTGCT
GGAGAAATGGTAAATGAAGCTGCTCTTGCTTTGGAATATGGAGCATCCTGTGAAGATATA
GCTAGAGTCTGTCATGCACATCCGACCTTATCAGAAGCTTTTAGAGAAGCAAATCTTGCT
GCGTCATTTGGCAAATCAATCAACTTTTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF07992</identifier>
            <name>Pyr_redox_2</name>
          </pfam>
          <pfam>
            <identifier>PF02852</identifier>
            <name>Pyr_redox_dim</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>acrosomal matrix</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cilium</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial matrix</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>myelin sheath</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>oxoglutarate dehydrogenase complex</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>pyruvate dehydrogenase complex</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>dihydrolipoyl dehydrogenase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>flavin adenine dinucleotide binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>lipoamide binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>NAD binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>2-oxoglutarate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>aging</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>branched-chain amino acid catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell redox homeostasis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular nitrogen compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>dihydrolipoamide metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>gastrulation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glyoxylate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>lipoate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>lysine catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>mitochondrial acetyl-CoA biosynthetic process from pyruvate</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>mitochondrial electron transport, NADH to ubiquinone</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>proteolysis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>pyruvate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of acetyl-CoA biosynthetic process from pyruvate</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of membrane potential</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>sperm capacitation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tricarboxylic acid cycle</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
      <inhibition-strength/>
      <induction-strength/>
    </enzyme>
    <enzyme position="34">
      <id>BE0002302</id>
      <name>Glycine cleavage system H protein, mitochondrial</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A192417</ref-id>
            <pubmed-id>23615880</pubmed-id>
            <citation>Wang W, Wu Z, Dai Z, Yang Y, Wang J, Wu G: Glycine metabolism in animals and humans: implications for nutrition and health. Amino Acids. 2013 Sep;45(3):463-77. doi: 10.1007/s00726-013-1493-1. Epub 2013 Apr 25.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P23434" source="Swiss-Prot">
        <name>Glycine cleavage system H protein, mitochondrial</name>
        <general-function>Aminomethyltransferase activity</general-function>
        <specific-function>The glycine cleavage system catalyzes the degradation of glycine. The H protein (GCSH) shuttles the methylamine group of glycine from the P protein (GLDC) to the T protein (GCST).</specific-function>
        <gene-name>GCSH</gene-name>
        <locus>16q23.2</locus>
        <cellular-location>Mitochondrion</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>4.56</theoretical-pi>
        <molecular-weight>18884.37</molecular-weight>
        <chromosome-location>16</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:4208</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GCSH</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M69175</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>184348</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P23434</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GCSH_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>Lipoic acid-containing protein</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011658|Glycine cleavage system H protein, mitochondrial
MALRVVRSVRALLCTLRAVPSPAAPCPPRPWQLGVGAVRTLRTGPALLSVRKFTEKHEWV
TTENGIGTVGISNFAQEALGDVVYCSLPEVGTKLNKQDEFGALESVKAASELYSPLSGEV
TEINEALAENPGLVNKSCYEDGWLIKMTLSNPSELDELMSEEAYEKYIKSIEE</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0011659|Glycine cleavage system H protein, mitochondrial (GCSH)
ATGGCGCTGCGAGTGGTGCGGAGCGTGCGGGCCCTGCTCTGCACCCTGCGCGCGGTCCCG
TCACCCGCCGCGCCCTGCCCGCCGAGGCCCTGGCAGCTGGGGGTGGGCGCCGTCCGTACG
CTGCGCACTGGACCCGCTCTGCTCTCGGTGCGTAAATTCACAGAGAAACACGAATGGGTA
ACAACAGAAAATGGCATTGGAACAGTGGGAATCAGCAATTTTGCACAGGAAGCGTTGGGA
GATGTTGTTTATTGTAGTCTCCCTGAAGTTGGGACAAAATTGAACAAACAAGATGAGTTT
GGTGCTTTGGAAAGTGTGAAAGCTGCTAGTGAACTCTATTCTCCTTTATCAGGAGAAGTA
ACTGAAATTAATGAAGCTCTTGCAGAAAATCCAGGACTTGTAAACAAATCTTGTTATGAA
GATGGTTGGCTGATCAAGATGACACTGAGTAACCCTTCAGAACTAGATGAACTTATGAGT
GAAGAAGCATATGAGAAATACATAAAATCTATTGAGGAGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01597</identifier>
            <name>GCV_H</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>glycine cleavage complex</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial matrix</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>aminomethyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular nitrogen compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine decarboxylation via glycine cleavage system</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glyoxylate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>methylation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
      <inhibition-strength/>
      <induction-strength/>
    </enzyme>
  </enzymes>
  <carriers/>
  <transporters>
    <transporter position="26">
      <id>BE0003654</id>
      <name>Monocarboxylate transporter 10</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
        <action>inhibitor</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A16322</ref-id>
            <pubmed-id>11278508</pubmed-id>
            <citation>Kim DK, Kanai Y, Chairoungdua A, Matsuo H, Cha SH, Endou H: Expression cloning of a Na+-independent aromatic amino acid transporter with structural similarity to H+/monocarboxylate transporters. J Biol Chem. 2001 May 18;276(20):17221-8. Epub 2001 Feb 20.</citation>
          </article>
          <article>
            <ref-id>A16321</ref-id>
            <pubmed-id>11827462</pubmed-id>
            <citation>Kim DK, Kanai Y, Matsuo H, Kim JY, Chairoungdua A, Kobayashi Y, Enomoto A, Cha SH, Goya T, Endou H: The human T-type amino acid transporter-1: characterization, gene organization, and chromosomal location. Genomics. 2002 Jan;79(1):95-103.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q8TF71" source="Swiss-Prot">
        <name>Monocarboxylate transporter 10</name>
        <general-function>Transporter activity</general-function>
        <specific-function>Sodium-independent transporter that mediates the update of aromatic acid. Can function as a net efflux pathway for aromatic amino acids in the basosolateral epithelial cells (By similarity).</specific-function>
        <gene-name>SLC16A10</gene-name>
        <locus>6q21-q22</locus>
        <cellular-location>Cell membrane</cellular-location>
        <transmembrane-regions>67-87
115-135
145-165
172-192
201-221
229-249
292-312
330-350
352-372
397-417
420-440
452-472</transmembrane-regions>
        <signal-regions/>
        <theoretical-pi>7.77</theoretical-pi>
        <molecular-weight>55492.07</molecular-weight>
        <chromosome-location>6</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:17027</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AB057445</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>18640047</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q8TF71</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>MOT10_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>Aromatic amino acid transporter 1</synonym>
          <synonym>MCT 10</synonym>
          <synonym>MCT10</synonym>
          <synonym>Solute carrier family 16 member 10</synonym>
          <synonym>T-type amino acid transporter 1</synonym>
          <synonym>TAT1</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0007022|Monocarboxylate transporter 10
MVLSQEEPDSARGTSEAQPLGPAPTGAAPPPGPGPSDSPEAAVEKVEVELAGPATAEPHE
PPEPPEGGWGWLVMLAAMWCNGSVFGIQNACGVLFVSMLETFGSKDDDKMVFKTAWVGSL
SMGMIFFCCPIVSVFTDLFGCRKTAVVGAAVGFVGLMSSSFVSSIEPLYLTYGIIFACGC
SFAYQPSLVILGHYFKKRLGLVNGIVTAGSSVFTILLPLLLRVLIDSVGLFYTLRVLCIF
MFVLFLAGFTYRPLATSTKDKESGGSGSSLFSRKKFSPPKKIFNFAIFKVTAYAVWAVGI
PLALFGYFVPYVHLMKHVNERFQDEKNKEVVLMCIGVTSGVGRLLFGRIADYVPGVKKVY
LQVLSFFFIGLMSMMIPLCSIFGALIAVCLIMGLFDGCFISIMAPIAFELVGAQDVSQAI
GFLLGFMSIPMTVGPPIAGLLRDKLGSYDVAFYLAGVPPLIGGAVLCFIPWIHSKKQREI
SKTTGKEKMEKMLENQNSLLSSSSGMFKKESDSII</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0020707|Monocarboxylate transporter 10 (SLC16A10)
ATGGTGCTCTCCCAGGAGGAGCCGGACTCCGCGCGGGGCACGAGCGAGGCGCAGCCGCTC
GGCCCCGCGCCCACGGGGGCCGCTCCGCCGCCCGGCCCGGGACCCTCGGACAGCCCCGAG
GCGGCTGTCGAGAAGGTGGAGGTGGAGCTGGCGGGGCCGGCGACCGCGGAGCCCCATGAG
CCCCCCGAACCCCCCGAGGGCGGCTGGGGCTGGCTGGTGATGCTGGCGGCCATGTGGTGC
AACGGGTCGGTGTTCGGCATCCAGAACGCTTGCGGGGTGCTCTTCGTGTCCATGCTGGAA
ACCTTCGGCTCCAAAGACGATGACAAGATGGTCTTTAAGACAGCATGGGTAGGTTCTCTC
TCCATGGGGATGATTTTCTTTTGCTGCCCAATAGTCAGCGTCTTCACAGACCTATTTGGT
TGTCGGAAAACAGCTGTCGTGGGTGCTGCTGTTGGATTTGTTGGGCTCATGTCCAGTTCT
TTTGTAAGTTCCATCGAGCCTCTGTACCTTACCTATGGAATCATATTTGCCTGCGGCTGC
TCCTTTGCATACCAGCCTTCATTGGTCATTTTGGGACACTATTTCAAGAAGCGCCTTGGA
CTGGTGAATGGCATTGTCACTGCTGGCAGCAGTGTCTTCACAATCCTGCTGCCTTTGCTC
TTAAGGGTTCTGATTGACAGCGTGGGCCTCTTTTACACATTGAGGGTGCTCTGCATCTTC
ATGTTTGTTCTCTTTCTGGCTGGCTTTACTTACCGACCTCTTGCTACCAGTACCAAAGAT
AAAGAGAGTGGAGGTAGCGGATCCTCCCTCTTTTCCAGGAAAAAGTTCAGTCCTCCAAAA
AAAATTTTCAATTTTGCCATCTTCAAGGTGACAGCTTATGCAGTGTGGGCAGTTGGAATA
CCACTTGCACTTTTTGGATACTTTGTGCCTTATGTTCACTTGATGAAACATGTAAATGAA
AGATTTCAAGATGAAAAAAATAAAGAGGTTGTTCTCATGTGCATTGGCGTCACTTCAGGA
GTTGGACGACTGCTCTTTGGCCGGATTGCAGATTATGTGCCTGGTGTGAAGAAGGTTTAT
CTACAGGTACTCTCCTTTTTCTTCATTGGTCTGATGTCCATGATGATTCCTCTGTGTAGC
ATCTTTGGGGCCCTCATTGCTGTGTGCCTCATCATGGGTCTCTTCGATGGATGCTTCATT
TCCATTATGGCTCCCATAGCCTTTGAGTTAGTTGGTGCCCAGGATGTCTCCCAAGCAATT
GGATTTCTGCTCGGATTCATGTCTATACCCATGACTGTTGGCCCACCCATTGCAGGGTTA
CTTCGTGACAAACTGGGCTCCTATGATGTGGCATTCTACCTCGCTGGAGTCCCTCCCCTT
ATTGGAGGTGCTGTGCTTTGTTTTATCCCGTGGATCCATAGTAAGAAGCAAAGAGAGATC
AGTAAAACCACTGGAAAAGAAAAGATGGAGAAAATGTTGGAAAACCAGAACTCTCTGCTG
TCAAGTTCATCTGGAATGTTCAAGAAAGAATCTGACTCTATTATTTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF07690</identifier>
            <name>MFS_1</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>basolateral plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>aromatic amino acid transmembrane transporter activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>thyroid hormone transmembrane transporter activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transporter activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>amino acid transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>aromatic amino acid transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ion transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ion transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transmembrane transport</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </transporter>
    <transporter position="27">
      <id>BE0000536</id>
      <name>Proton-coupled amino acid transporter 1</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A13843</ref-id>
            <pubmed-id>15058382</pubmed-id>
            <citation>Bermingham JR Jr, Pennington J: Organization and expression of the SLC36 cluster of amino acid transporter genes. Mamm Genome. 2004 Feb;15(2):114-25.</citation>
          </article>
          <article>
            <ref-id>A13844</ref-id>
            <pubmed-id>16052352</pubmed-id>
            <citation>Broer A, Cavanaugh JA, Rasko JE, Broer S: The molecular basis of neutral aminoacidurias. Pflugers Arch. 2006 Jan;451(4):511-7. Epub 2005 Jul 29.</citation>
          </article>
          <article>
            <ref-id>A13845</ref-id>
            <pubmed-id>14718599</pubmed-id>
            <citation>Metzner L, Kalbitz J, Brandsch M: Transport of pharmacologically active proline derivatives by the human proton-coupled amino acid transporter hPAT1. J Pharmacol Exp Ther. 2004 Apr;309(1):28-35. Epub 2004 Jan 12.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q7Z2H8" source="Swiss-Prot">
        <name>Proton-coupled amino acid transporter 1</name>
        <general-function>L-proline transmembrane transporter activity</general-function>
        <specific-function>Neutral amino acid/proton symporter. Has a pH-dependent electrogenic transport activity for small amino acids such as glycine, alanine and proline. Besides small apolar L-amino acids, it also recognize their D-enantiomers and selected amino acid derivatives such as gamma-aminobutyric acid (By similarity).</specific-function>
        <gene-name>SLC36A1</gene-name>
        <locus>5q33.1</locus>
        <cellular-location>Cell membrane</cellular-location>
        <transmembrane-regions>52-72
79-99
142-162
191-211
216-236
258-278
290-310
343-363
373-393
398-418
440-460</transmembrane-regions>
        <signal-regions/>
        <theoretical-pi>7.0</theoretical-pi>
        <molecular-weight>53075.045</molecular-weight>
        <chromosome-location>5</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:18761</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>SLC36A1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF516142</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>31324239</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>1161</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q7Z2H8</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>S36A1_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>PAT1</synonym>
          <synonym>Proton/amino acid transporter 1</synonym>
          <synonym>Solute carrier family 36 member 1</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001070|Proton-coupled amino acid transporter 1
MSTQRLRNEDYHDYSSTDVSPEESPSEGLNNLSSPGSYQRFGQSNSTTWFQTLIHLLKGN
IGTGLLGLPLAVKNAGIVMGPISLLIIGIVAVHCMGILVKCAHHFCRRLNKSFVDYGDTV
MYGLESSPCSWLRNHAHWGRRVVDFFLIVTQLGFCCVYFVFLADNFKQVIEAANGTTNNC
HNNETVILTPTMDSRLYMLSFLPFLVLLVFIRNLRALSIFSLLANITMLVSLVMIYQFIV
QRIPDPSHLPLVAPWKTYPLFFGTAIFSFEGIGMVLPLENKMKDPRKFPLILYLGMVIVT
ILYISLGCLGYLQFGANIQGSITLNLPNCWLYQSVKLLYSIGIFFTYALQFYVPAEIIIP
FFVSRAPEHCELVVDLFVRTVLVCLTCILAILIPRLDLVISLVGSVSSSALALIIPPLLE
VTTFYSEGMSPLTIFKDALISILGFVGFVVGTYEALYELIQPSNAPIFINSTCAFI</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0020464|Proton-coupled amino acid transporter 1 (SLC36A1)
ATGTCCACGCAGAGACTTCGGAATGAAGACTACCACGACTACAGCTCCACGGACGTGAGC
CCTGAGGAGAGCCCGTCGGAAGGCCTCAACAACCTCTCCTCCCCGGGCTCCTACCAGCGC
TTTGGTCAAAGCAATAGCACAACATGGTTCCAGACCTTGATCCACCTGTTAAAAGGCAAC
ATTGGCACAGGACTCCTGGGACTCCCTCTGGCGGTGAAAAATGCAGGCATCGTGATGGGT
CCCATCAGCCTGCTGATCATAGGCATCGTGGCCGTGCACTGCATGGGTATCCTGGTGAAA
TGTGCTCACCACTTCTGCCGCAGGCTGAATAAATCCTTTGTGGATTATGGTGATACTGTG
ATGTATGGACTAGAATCCAGCCCCTGCTCCTGGCTCCGGAACCACGCACACTGGGGAAGA
CGTGTTGTGGACTTCTTCCTGATTGTCACCCAGCTGGGATTCTGCTGTGTCTATTTTGTG
TTTCTGGCTGACAACTTTAAACAGGTGATAGAAGCGGCCAATGGGACCACCAATAACTGC
CACAACAATGAGACGGTGATTCTGACGCCTACCATGGACTCGCGACTCTACATGCTCTCC
TTCCTGCCCTTCCTGGTGCTGCTGGTTTTCATCAGGAACCTCCGAGCCCTGTCCATCTTC
TCCCTGTTGGCCAACATCACCATGCTGGTCAGCTTGGTCATGATCTACCAGTTCATTGTT
CAGAGGATCCCAGACCCCAGCCACCTCCCCTTGGTGGCCCCTTGGAAGACCTACCCTCTC
TTCTTTGGCACAGCGATTTTTTCATTTGAAGGCATTGGAATGGTTCTGCCCCTGGAAAAC
AAAATGAAGGATCCTCGGAAGTTCCCACTCATCCTGTACCTGGGCATGGTCATCGTCACC
ATCCTCTACATCAGCCTGGGGTGTCTGGGGTACCTGCAATTTGGAGCTAATATCCAAGGC
AGCATAACCCTCAACCTGCCCAACTGCTGGTTGTACCAGTCAGTTAAGCTGCTGTACTCC
ATCGGGATCTTTTTCACCTACGCACTCCAGTTCTACGTCCCGGCTGAGATCATCATCCCC
TTCTTTGTGTCCCGAGCGCCCGAGCACTGTGAGTTAGTGGTGGACCTGTTTGTGCGCACA
GTGCTGGTCTGCCTGACATGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01490</identifier>
            <name>Aa_trans</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>endoplasmic reticulum</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>lysosomal membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine transmembrane transporter activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>hydrogen</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>hydrogen ion transmembrane transporter activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>L-alanine transmembrane transporter activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>L-proline transmembrane transporter activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>amino acid transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>hydrogen ion transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ion transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>L-alanine transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>proline transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>proton transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transmembrane transport</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </transporter>
    <transporter position="28">
      <id>BE0002308</id>
      <name>Vesicular inhibitory amino acid transporter</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A13848</ref-id>
            <pubmed-id>17418495</pubmed-id>
            <citation>Fujii M, Arata A, Kanbara-Kume N, Saito K, Yanagawa Y, Obata K: Respiratory activity in brainstem of fetal mice lacking glutamate decarboxylase 65/67 and vesicular GABA transporter. Neuroscience. 2007 May 25;146(3):1044-52. Epub 2007 Apr 5.</citation>
          </article>
          <article>
            <ref-id>A13849</ref-id>
            <pubmed-id>17554001</pubmed-id>
            <citation>Aubrey KR, Rossi FM, Ruivo R, Alboni S, Bellenchi GC, Le Goff A, Gasnier B, Supplisson S: The transporters GlyT2 and VIAAT cooperate to determine the vesicular glycinergic phenotype. J Neurosci. 2007 Jun 6;27(23):6273-81.</citation>
          </article>
          <article>
            <ref-id>A13850</ref-id>
            <pubmed-id>17652600</pubmed-id>
            <citation>Uchigashima M, Fukaya M, Watanabe M, Kamiya H: Evidence against GABA release from glutamatergic mossy fiber terminals in the developing hippocampus. J Neurosci. 2007 Jul 25;27(30):8088-100.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9H598" source="Swiss-Prot">
        <name>Vesicular inhibitory amino acid transporter</name>
        <general-function>Glycine transmembrane transporter activity</general-function>
        <specific-function>Involved in the uptake of GABA and glycine into the synaptic vesicles.</specific-function>
        <gene-name>SLC32A1</gene-name>
        <locus>20q11.23</locus>
        <cellular-location>Cytoplasmic vesicle membrane</cellular-location>
        <transmembrane-regions>134-154
205-225
243-263
266-286
306-326
342-362
384-404
439-459
462-482
490-510</transmembrane-regions>
        <signal-regions/>
        <theoretical-pi>6.63</theoretical-pi>
        <molecular-weight>57414.58</molecular-weight>
        <chromosome-location>20</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:11018</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>SLC32A1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AY044836</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>17975777</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>1133</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9H598</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>VIAAT_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>GABA and glycine transporter</synonym>
          <synonym>hVIAAT</synonym>
          <synonym>Solute carrier family 32 member 1</synonym>
          <synonym>Vesicular GABA transporter</synonym>
          <synonym>VGAT</synonym>
          <synonym>VIAAT</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004532|Vesicular inhibitory amino acid transporter
MATLLRSKLSNVATSVSNKSQAKMSGMFARMGFQAATDEEAVGFAHCDDLDFEHRQGLQM
DILKAEGEPCGDEGAEAPVEGDIHYQRGSGAPLPPSGSKDQVGGGGEFGGHDKPKITAWE
AGWNVTNAIQGMFVLGLPYAILHGGYLGLFLIIFAAVVCCYTGKILIACLYEENEDGEVV
RVRDSYVAIANACCAPRFPTLGGRVVNVAQIIELVMTCILYVVVSGNLMYNSFPGLPVSQ
KSWSIIATAVLLPCAFLKNLKAVSKFSLLCTLAHFVINILVIAYCLSRARDWAWEKVKFY
IDVKKFPISIGIIVFSYTSQIFLPSLEGNMQQPSEFHCMMNWTHIAACVLKGLFALVAYL
TWADETKEVITDNLPGSIRAVVNIFLVAKALLSYPLPFFAAVEVLEKSLFQEGSRAFFPA
CYSGDGRLKSWGLTLRCALVVFTLLMAIYVPHFALLMGLTGSLTGAGLCFLLPSLFHLRL
LWRKLLWHQVFFDVAIFVIGGICSVSGFVHSLEGLIEAYRTNAED</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0016750|Vesicular inhibitory amino acid transporter (SLC32A1)
ATGGCCACCTTGCTCCGCAGCAAGCTGTCCAACGTGGCCACGTCCGTGTCCAACAAGTCC
CAGGCCAAGATGAGCGGCATGTTCGCCAGGATGGGTTTTCAGGCGGCCACGGATGAGGAG
GCGGTGGGCTTCGCGCATTGCGACGACCTCGACTTTGAGCACCGCCAGGGCCTGCAGATG
GACATCCTGAAAGCCGAGGGAGAGCCCTGCGGGGACGAGGGCGCTGAAGCGCCCGTCGAG
GGAGACATCCATTATCAGCGAGGCAGCGGAGCTCCTCTGCCGCCCTCCGGCTCCAAGGAC
CAGGTGGGAGGTGGTGGCGAATTCGGGGGCCACGACAAGCCCAAAATCACGGCGTGGGAG
GCAGGCTGGAACGTGACCAACGCCATCCAGGGCATGTTCGTGCTGGGCCTACCCTACGCC
ATCCTGCACGGCGGCTACCTGGGGTTGTTTCTCATCATCTTCGCCGCCGTTGTGTGCTGC
TACACCGGCAAGATCCTCATCGCGTGCCTGTACGAGGAGAATGAAGACGGCGAGGTGGTG
CGCGTGCGGGACTCGTACGTGGCCATAGCCAACGCCTGCTGCGCCCCGCGCTTCCCAACG
CTGGGCGGCCGAGTGGTGAACGTAGCGCAGATCATCGAGCTGGTGATGACGTGCATCCTG
TACGTGGTGGTGAGTGGCAACCTCATGTACAACAGCTTCCCGGGGCTGCCCGTGTCGCAG
AAGTCCTGGTCCATTATCGCCACGGCCGTGCTGCTGCCTTGCGCCTTCCTTAAGAACCTC
AAGGCCGTGTCCAAGTTCAGTCTGCTGTGCACTCTGGCCCACTTCGTCATCAATATCCTG
GTCATAGCCTACTGTCTATCGCGGGCGCGCGACTGGGCCTGGGAGAAGGTCAAGTTCTAC
ATCGACGTCAAGAAGTTCCCCATCTCCATTGGCATCATCGTGTTCAGCTACACGTCTCAG
ATCTTCCTGCCTTCGCTGGAGGGCAATATGCAGCAGCCCAGCGAGTTCCACTGCATGATG
AACTGGACGCACATCGCAGCCTGCGTGCTCAAGGGCCTCTTCGCGCTCGTCGCCTACCTC
ACCTGGGCCGACGAGACCAAGGAGGTCATCACGGATAACCTGCCCGGCTCCATCCGCGCC
GTGGTCAACATCTTTCTGGTGGCCAAGGCGCTGTTGTCCTATCCTCTGCCATTCTTTGCC
GCTGTCGAGGTGCTGGAGAAGTCGCTCTTCCAGGAAGGCAGCCGCGCCTTTTTCCCGGCC
TGCTACAGCGGCGACGGGCGCCTGAAGTCCTGGGGGCTGACGCTGCGCTGCGCGCTCGTC
GTCTTCACGCTGCTCATGGCCATTTATGTGCCGCACTTCGCGCTGCTCATGGGCCTCACC
GGCAGCCTCACGGGCGCCGGCCTCTGTTTCTTGCTGCCCAGCCTCTTTCACCTGCGCCTG
CTCTGGCGCAAGCTGCTGTGGCACCAAGTCTTCTTCGACGTCGCCATCTTCGTCATCGGC
GGCATCTGCAGCGTGTCCGGCTTCGTGCACTCCCTCGAGGGCCTCATCGAAGCCTACCGA
ACCAACGCGGAGGACTAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01490</identifier>
            <name>Aa_trans</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cell tip</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cone cell pedicle</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>dendrite</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>dendrite terminus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>inhibitory synapse</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>neuron projection</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>neuron projection terminus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>presynaptic active zone</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>synaptic vesicle membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>amino acid transmembrane transporter activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>gamma-aminobutyric acid</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine transmembrane transporter activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>aging</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>amino acid transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ion transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>neurotransmitter secretion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>synaptic transmission</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transmembrane transport</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </transporter>
    <transporter position="29">
      <id>BE0002310</id>
      <name>Sodium- and chloride-dependent glycine transporter 2</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A9900</ref-id>
            <pubmed-id>16884688</pubmed-id>
            <citation>Eulenburg V, Becker K, Gomeza J, Schmitt B, Becker CM, Betz H: Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia. Biochem Biophys Res Commun. 2006 Sep 22;348(2):400-5. Epub 2006 Jul 26.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9Y345" source="Swiss-Prot">
        <name>Sodium- and chloride-dependent glycine transporter 2</name>
        <general-function>Neurotransmitter:sodium symporter activity</general-function>
        <specific-function>Terminates the action of glycine by its high affinity sodium-dependent reuptake into presynaptic terminals. May be responsible for the termination of neurotransmission at strychnine-sensitive glycinergic synapses.</specific-function>
        <gene-name>SLC6A5</gene-name>
        <locus>11p15.2-p15.1</locus>
        <cellular-location>Membrane</cellular-location>
        <transmembrane-regions>200-220
228-247
271-291
394-412
421-438
474-491
503-524
557-576
604-622
638-658
679-698
717-735</transmembrane-regions>
        <signal-regions/>
        <theoretical-pi>7.56</theoretical-pi>
        <molecular-weight>87433.13</molecular-weight>
        <chromosome-location>11</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:11051</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>SLC6A5</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF085412</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>4003525</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>936</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9Y345</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>SC6A5_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>GlyT-2</synonym>
          <synonym>GLYT2</synonym>
          <synonym>NET1</synonym>
          <synonym>Solute carrier family 6 member 5</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016746|Sodium- and chloride-dependent glycine transporter 2
MDCSAPKEMNKLPANSPEAAAAQGHPDGPCAPRTSPEQELPAAAAPPPPRVPRSASTGAQ
TFQSADARACEAERPGVGSCKLSSPRAQAASAALRDLREAQGAQASPPPGSSGPGNALHC
KIPFLRGPEGDANVSVGKGTLERNNTPVVGWVNMSQSTVVLATDGITSVLPGSVATVATQ
EDEQGDENKARGNWSSKLDFILSMVGYAVGLGNVWRFPYLAFQNGGGAFLIPYLMMLALA
GLPIFFLEVSLGQFASQGPVSVWKAIPALQGCGIAMLIISVLIAIYYNVIICYTLFYLFA
SFVSVLPWGSCNNPWNTPECKDKTKLLLDSCVISDHPKIQIKNSTFCMTAYPNVTMVNFT
SQANKTFVSGSEEYFKYFVLKISAGIEYPGEIRWPLALCLFLAWVIVYASLAKGIKTSGK
VVYFTATFPYVVLVILLIRGVTLPGAGAGIWYFITPKWEKLTDATVWKDAATQIFFSLSA
AWGGLITLSSYNKFHNNCYRDTLIVTCTNSATSIFAGFVIFSVIGFMANERKVNIENVAD
QGPGIAFVVYPEALTRLPLSPFWAIIFFLMLLTLGLDTMFATIETIVTSISDEFPKYLRT
HKPVFTLGCCICFFIMGFPMITQGGIYMFQLVDTYAASYALVIIAIFELVGISYVYGLQR
FCEDIEMMIGFQPNIFWKVCWAFVTPTILTFILCFSFYQWEPMTYGSYRYPNWSMVLGWL
MLACSVIWIPIMFVIKMHLAPGRFIERLKLVCSPQPDWGPFLAQHRGERYKNMIDPLGTS
SLGLKLPVKDLELGTQC</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0016747|Sodium- and chloride-dependent glycine transporter 2 (SLC6A5)
ATGGATTGCAGTGCTCCCAAGGAAATGAATAAACTGCCAGCCAACAGCCCGGAGGCGGCG
GCGGCGCAGGGCCACCCGGATGGCCCATGCGCTCCCAGGACGAGCCCGGAGCAGGAGCTT
CCCGCGGCTGCCGCCCCGCCGCCGCCACGTGTGCCCAGGTCCGCTTCCACCGGCGCCCAA
ACTTTCCAGTCAGCGGACGCGCGAGCCTGCGAGGCTGAGCGGCCAGGAGTGGGGTCTTGC
AAACTCAGTAGCCCGCGGGCGCAGGCGGCCTCTGCAGCTCTGCGGGACTTGAGAGAGGCG
CAAGGCGCGCAGGCCTCGCCCCCTCCCGGGAGCTCCGGGCCCGGCAACGCGCTGCACTGT
AAGATCCCTTTTCTGCGAGGCCCGGAGGGGGATGCGAACGTGAGTGTGGGCAAGGGCACC
CTGGAGCGGAACAATACCCCTGTTGTGGGCTGGGTGAACATGAGCCAGAGCACCGTGGTG
CTGGCCACGGATGGAATCACGTCCGTGCTCCCGGGCAGCGTGGCCACCGTTGCCACCCAG
GAGGACGAGCAAGGGGATGAGAATAAGGCCCGAGGGAACTGGTCCAGCAAACTGGACTTC
ATCCTGTCCATGGTGGGGTACGCAGTGGGGCTGGGCAATGTCTGGAGGTTTCCCTACCTG
GCCTTCCAGAACGGGGGAGGTGCTTTCCTCATCCCTTACCTGATGATGCTGGCTCTGGCT
GGATTACCCATCTTCTTCTTGGAGGTGTCGCTGGGCCAGTTTGCCAGCCAGGGACCAGTG
TCTGTGTGGAAGGCCATCCCAGCTCTACAAGGCTGTGGCATCGCGATGCTGATCATCTCT
GTCCTAATAGCCATATACTACAATGTGATTATTTGCTATACACTTTTCTACCTGTTTGCC
TCCTTTGTGTCTGTACTACCCTGGGGCTCCTGCAACAACCCTTGGAATACGCCAGAATGC
AAAGATAAAACCAAACTTTTATTAGATTCCTGTGTTATCAGTGACCATCCCAAAATACAG
ATCAAGAACTCGACTTTCTGCATGACCGCTTATCCCAACGTGACAATGGTTAATTTCACC
AGCCAGGCCAATAAGACATTTGTCAGTGGAAGTGAAGAGTACTTCAAGTACTTTGTGCTG
AAGATTTCTGCAGGGATTGAATATCCTGGCGAGATCAGGTGGCCACTAGCTCTCTGCCTC
TTCCTGGCTTGGGTCATTGTGTATGCATCATTGGCTAAAGGAATCAAGACTTCAGGAAAA
GTGGTGTACTTCACGGCCACGTTCCCGTATGTCGTACTCGTGATCCTCCTCATCCGAGGA
GTCACCCTGCCTGGAGCTGGAGCTGGGATCTGGTACTTCATCACACCCAAGTGGGAGAAA
CTCACGGATGCCACGGTGTGGAAAGATGCTGCCACTCAGATTTTCTTCTCTTTATCTGCT
GCATGGGGAGGCCTGATCACTCTCTCTTCTTACAACAAATTCCACAACAACTGCTACAGG
GACACTCTAATTGTCACCTGCACCAACAGTGCCACAAGCATCTTTGCCGGCTTCGTCATC
TTCTCCGTTATCGGCTTCATGGCCAATGAACGCAAAGTCAACATTGAGAATGTGGCAGAC
CAAGGGCCAGGCATTGCATTTGTGGTTTACCCGGAAGCCTTAACCAGGCTGCCTCTCTCT
CCGTTCTGGGCCATCATCTTTTTCCTGATGCTCCTCACTCTTGGACTTGACACTATGTTT
GCCACCATCGAGACCATAGTGACCTCCATCTCAGACGAGTTTCCCAAGTACCTACGCACA
CACAAGCCAGTGTTTACTCTGGGCTGCTGCATTTGTTTCTTCATCATGGGTTTTCCAATG
ATCACTCAGGGTGGAATTTACATGTTTCAGCTTGTGGACACCTATGCTGCCTCCTATGCC
CTTGTCATCATTGCCATTTTTGAGCTCGTGGGGATCTCTTATGTGTATGGCTTGCAAAGA
TTCTGTGAAGATATAGAGATGATGATTGGATTCCAGCCTAACATCTTCTGGAAAGTCTGC
TGGGCATTTGTAACCCCAACCATTTTAACCTTTATCCTTTGCTTCAGCTTTTACCAGTGG
GAGCCCATGACCTATGGCTCTTACCGCTATCCTAACTGGTCCATGGTGCTCGGATGGCTA
ATGCTCGCCTGTTCCGTCATCTGGATCCCAATTATGTTTGTGATAAAAATGCATCTGGCC
CCTGGAAGATTTATTGAGAGGCTGAAGTTGGTGTGCTCGCCACAGCCGGACTGGGGCCCA
TTCTTAGCTCAACACCGCGGGGAGCGTTACAAGAACATGATCGACCCCTTGGGAACCTCT
TCCTTGGGACTCAAACTGCCAGTGAAGGATTTGGAACTGGGCACTCAGTGCTAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00209</identifier>
            <name>SNF</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>integral component of membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>neurotransmitter</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine import</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>synaptic transmission</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>synaptic transmission, glycinergic</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transport</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </transporter>
    <transporter position="30">
      <id>BE0000940</id>
      <name>Sodium- and chloride-dependent glycine transporter 1</name>
      <organism>Humans</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A11698</ref-id>
            <pubmed-id>16899062</pubmed-id>
            <citation>Wiles AL, Pearlman RJ, Rosvall M, Aubrey KR, Vandenberg RJ: N-Arachidonyl-glycine inhibits the glycine transporter, GLYT2a. J Neurochem. 2006 Nov;99(3):781-6. Epub 2006 Aug 8.</citation>
          </article>
          <article>
            <ref-id>A11699</ref-id>
            <pubmed-id>17017963</pubmed-id>
            <citation>Lindsley CW, Wolkenberg SE, Kinney GG: Progress in the preparation and testing of glycine transporter type-1 (GlyT1) inhibitors. Curr Top Med Chem. 2006;6(17):1883-96.</citation>
          </article>
          <article>
            <ref-id>A11700</ref-id>
            <pubmed-id>17462677</pubmed-id>
            <citation>Igartua I, Solis JM, Bustamante J: Glycine-induced long-term synaptic potentiation is mediated by the glycine transporter GLYT1. Neuropharmacology. 2007 Jun;52(8):1586-95. Epub 2007 Mar 14.</citation>
          </article>
          <article>
            <ref-id>A11701</ref-id>
            <pubmed-id>17504107</pubmed-id>
            <citation>Sur C, Kinney GG: Glycine transporter 1 inhibitors and modulation of NMDA receptor-mediated excitatory neurotransmission. Curr Drug Targets. 2007 May;8(5):643-9.</citation>
          </article>
          <article>
            <ref-id>A11702</ref-id>
            <pubmed-id>17597258</pubmed-id>
            <citation>Raiteri L, Stigliani S, Usai C, Diaspro A, Paluzzi S, Milanese M, Raiteri M, Bonanno G: Functional expression of release-regulating glycine transporters GLYT1 on GABAergic neurons and GLYT2 on astrocytes in mouse spinal cord. Neurochem Int. 2008 Jan;52(1-2):103-12. Epub 2007 May 16.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P48067" source="Swiss-Prot">
        <name>Sodium- and chloride-dependent glycine transporter 1</name>
        <general-function>Neurotransmitter:sodium symporter activity</general-function>
        <specific-function>Terminates the action of glycine by its high affinity sodium-dependent reuptake into presynaptic terminals. May play a role in regulation of glycine levels in NMDA receptor-mediated neurotransmission.</specific-function>
        <gene-name>SLC6A9</gene-name>
        <locus>1p33</locus>
        <cellular-location>Membrane</cellular-location>
        <transmembrane-regions>109-129
136-156
188-208
286-306
315-335
360-380
407-427
450-470
506-526
530-550
570-590
610-630</transmembrane-regions>
        <signal-regions/>
        <theoretical-pi>7.74</theoretical-pi>
        <molecular-weight>78259.625</molecular-weight>
        <chromosome-location>1</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:11056</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>SLC6A9</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>S70609</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>546769</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>935</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P48067</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>SC6A9_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>GlyT-1</synonym>
          <synonym>Solute carrier family 6 member 9</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037103|Sodium- and chloride-dependent glycine transporter 1
MSGGDTRAAIARPRMAAAHGPVAPSSPEQVTLLPVQRSFFLPPFSGATPSTSLAESVLKV
WHGAYNSGLLPQLMAQHSLAMAQNGAVPSEATKRDQNLKRGNWGNQIEFVLTSVGYAVGL
GNVWRFPYLCYRNGGGAFMFPYFIMLIFCGIPLFFMELSFGQFASQGCLGVWRISPMFKG
VGYGMMVVSTYIGIYYNVVICIAFYYFFSSMTHVLPWAYCNNPWNTHDCAGVLDASNLTN
GSRPAALPSNLSHLLNHSLQRTSPSEEYWRLYVLKLSDDIGNFGEVRLPLLGCLGVSWLV
VFLCLIRGVKSSGKVVYFTATFPYVVLTILFVRGVTLEGAFDGIMYYLTPQWDKILEAKV
WGDAASQIFYSLGCAWGGLITMASYNKFHNNCYRDSVIISITNCATSVYAGFVIFSILGF
MANHLGVDVSRVADHGPGLAFVAYPEALTLLPISPLWSLLFFFMLILLGLGTQFCLLETL
VTAIVDEVGNEWILQKKTYVTLGVAVAGFLLGIPLTSQAGIYWLLLMDNYAASFSLVVIS
CIMCVAIMYIYGHRNYFQDIQMMLGFPPPLFFQICWRFVSPAIIFFILVFTVIQYQPITY
NHYQYPGWAVAIGFLMALSSVLCIPLYAMFRLCRTDGDTLLQRLKNATKPSRDWGPALLE
HRTGRYAPTIAPSPEDGFEVQPLHPDKAQIPIVGSNGSSRLQDSRI</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010660|Sodium- and chloride-dependent glycine transporter 1 (SLC6A9)
ATGGTAGGAAAAGGTGCCAAAGGGATGCTGAATGGTGCTGTGCCCAGCGAGGCCACCAAG
AGGGACCAGAACCTCAAACGGGGCAACTGGGGCAACCAGATCGAGTTTGTACTGACGAGC
GTGGGCTATGCCGTGGGCCTGGGCAATGTCTGGCGCTTCCCATACCTCTGCTATCGCAAC
GGGGGAGGCGCCTTCATGTTCCCCTACTTCATCATGCTCATCTTCTGCGGGATCCCCCTC
TTCTTCATGGAGCTCTCCTTCGGCCAGTTTGCAAGCCAGGGGTGCCTGGGGGTCTGGAGG
ATCAGCCCCATGTTCAAAGGAGTGGGCTATGGTATGATGGTGGTGTCCACCTACATCGGC
ATCTACTACAATGTGGTCATCTGCATCGCCTTCTACTACTTCTTCTCGTCCATGACGCAC
GTGCTGCCCTGGGCCTACTGCAATAACCCCTGGAACACGCATGACTGCGCCGGTGTACTG
GACGCCTCCAACCTCACCAATGGCTCTCGGCCAGCCGCCTTGCCCAGCAACCTCTCCCAC
CTGCTCAACCACAGCCTCCAGAGGACCAGCCCCAGCGAGGAGTACTGGAGGCTGTACGTG
CTGAAGCTGTCAGATGACATTGGGAACTTTGGGGAGGTGCGGCTGCCCCTCCTTGGCTGC
CTCGGTGTCTCCTGGTTGGTCGTCTTCCTCTGCCTCATCCGAGGGGTCAAGTCTTCAGGG
AAAGTGGTGTACTTCACGGCCACGTTCCCCTACGTGGTGCTGACCATTCTGTTTGTCCGC
GGAGTGACCCTGGAGGGAGCCTTTGACGGCATCATGTACTACCTAACCCCGCAGTGGGAC
AAGATCCTGGAGGCCAAGGTGTGGGGTGATGCTGCCTCCCAGATCTTCTACTCACTGGGC
TGCGCGTGGGGAGGCCTCATCACCATGGCTTCCTACAACAAGTTCCACAATAACTGTTAC
CGGGACAGTGTCATCATCAGCATCACCAACTGTGCCACCAGCGTCTATGCTGGCTTCGTC
ATCTTCTCCATCCTCGGCTTCATGGCCAATCACCTGGGCGTGGATGTGTCCCGTGTGGCA
GACCACGGCCCTGGCCTGGCCTTCGTGGCTTACCCCGAGGCCCTCACACTACTTCCCATC
TCCCCGCTGTGGTCTCTGCTCTTCTTCTTCATGCTTATCCTGCTGGGGCTGGGCACTCAG
TTCTGCCTCCTGGAGACGCTGGTCACAGCCATTGTGGATGAGGTGGGGAATGAGTGGATC
CTGCAGAAAAAGACCTATGTGACCTTGGGCGTGGCTGTGGCTGGCTTCCTGCTGGGCATC
CCCCTCACCAGCCAGGCAGGCATCTATTGGCTGCTGCTGATGGACAACTATGCGGCCAGC
TTCTCCTTGGTGGTCATCTCCTGCATCATGTGTGTGGCCATCATGTACATCTACGGGCAC
CGGAACTACTTCCAGGACATCCAGATGATGCTGGGATTCCCACCACCCCTCTTCTTTCAG
ATCTGCTGGCGCTTCGTCTCTCCCGCCATCATCTTCTTTATTCTAGTTTTCACTGTGATC
CAGTACCAGCCGATCACCTACAACCACTACCAGTACCCAGGCTGGGCCGTGGCCATTGGC
TTCCTCATGGCTCTGTCCTCCGTCCTCTGCATCCCCCTCTACGCCATGTTCCGGCTCTGC
CGCACAGACGGGGACACCCTCCTCCAGCGTTTGAAAAATGCCACAAAGCCAAGCAGAGAC
TGGGGCCCTGCCCTCCTGGAGCACCGGACAGGGCGCTACGCCCCCACCATAGCCCCCTCT
CCTGAGGACGGCTTCGAGGTCCAGCCACTGCACCCGGACAAGGCGCAGATCCCCATTGTG
GGCAGTAATGGCTCCAGCCGCCTCCAGGACTCCCGGATATGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00209</identifier>
            <name>SNF</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>integral component of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>neurotransmitter</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>L-alpha-amino acid transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of synaptic transmission, glycinergic</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transport</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </transporter>
  </transporters>
</drug>